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MRI Magnetic resonance imaging 
MRS Magnetic resonance spectroscopy 
NMR Nuclear magnetic resonance 
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PRESS Point resolved spectroscopy 
RF Radiofrequency 
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Proton magnetic resonance spectroscopy (1H MRS) in the human brain is a non-invasive 
technique capable of aiding the investigation of the neurochemical composition. The 
clinical importance of 1H MRS can be seen in pathological diagnosis, understanding 
disease mechanisms or in treatment monitoring. 
Reliable detection and quantification of metabolites is of paramount importance in 
establishing potential biomarkers for several neurological pathologies. Furthermore, 
broad macromolecular resonances underlying metabolite peaks in a proton spectrum also 
hold a wealth of information. These macromolecular resonances originate from amino 
acids within cytosolic peptides and proteins. Some studies in the past have even 
discussed their clinical relevance in pathologies such as acute multiple sclerosis, glioma, 
and traumatic encephalopathy. However, the characteristics of these macromolecular 
resonances are yet to be fully explored. In-depth knowledge about the macromolecules 
could open up a new horizon of potential biomarkers for neurological diseases. In 
addition, characterizing macromolecular resonances may help the MR community answer 
some of the lingering research questions such as identifying the biological background of 
the individual macromolecular peaks, assigning macromolecular peaks to particular 
amino acids, and investigating other contributions to the macromolecular signal such as 
sugars, DNA or RNA. 
Detection capabilities of MRS have increased to a great extent with increasing static 
magnetic field. Ultra-high field (≥7 T) MRS benefits from increased signal-to-noise ratio 
(SNR) and improved spectral resolution. There is also constant development in 
localization techniques and quantification methods to accurately measure concentrations 
of metabolites and macromolecules with lower signal-to-noise ratio and complex spectral 
pattern due to J-coupling. 
The first part of the thesis focuses on characterizing the physical properties of 
macromolecular resonances in the human brain at 9.4 T and understanding their 
contribution to the metabolite spectrum. T2 relaxation times are calculated and a 
quantitative linewidth analysis is performed to understand the degree of overlap and J- 
viii 
 
coupling effects in the observed macromolecular peaks. Moreover, a novel double 
inversion recovery method is proposed to determine T1 relaxation times of individual 
macromolecular resonance lines. 
The second part of the thesis focuses on quantification of metabolites in the human brain 
at 9.4 T using one-dimensional and two-dimensional MRS techniques. Metabolite 
concentrations are reported in millimoles/kg after correcting for T1- and T2-weighting 
effects and the tissue composition. The concentration values measured from both the 





Die Protonen-Magnetresonanzspektroskopie (1H-MRS) ist eine nicht-invasive Technik, 
die die Untersuchung der neurochemischen Zusammensetzung des menschlichen 
Gehirns ermöglicht. Bedeutende klinische Anwendungen von 1H-MRS ergaben sich in 
der Diagnose von Erkrankungen, in dem Verständnis von Krankheitsmechanismen oder 
in der Behandlungsüberwachung. 
Die zuverlässige Erkennung und Quantifizierung der Metaboliten ist von größter 
Bedeutung, um Biomarker für verschiedene neurologische Krankheiten zu etablieren. 
Zusätzlich enthalten Makromoleküle, die in dem Protonen-Spektrum breite Spektrallinien 
unter dem Metaboliten-Spektrum bilden, zahlreiche, wertvolle Informationen. Die 
Spektrallinien der Makromoleküle stammen von Aminosäuren aus Proteinen und 
Peptiden des Cytosols. Frühere Studien haben die klinische Relevanz von 
Makromolekülen in Erkrankungen wie Multiple Sklerose, Tumoren oder chronisch- 
traumatische Enzephalopathie gezeigt. Jedoch müssen mehrere Charakteristiken der 
Makromoleküle noch erforscht werden. Ein tiefgehendes Verständnis der Makromoleküle 
könnte dabei die Entdeckung neuer Biomarker für neurologische Krankheiten 
ermöglichen. Zusätzlich kann die Charakterisierung der makromolekularen Spektrallinien 
helfen folgende offene Fragen der MR Spektroskopie zu beantworten: den biologischen 
Ursprung der einzelnen makromolekularen Spektrallinien, die Zuordnung der 
makromolekularen Spektrallinien zu einzelnen Aminosäuren sowie die Untersuchung von 
anderen möglichen Beiträgen zum Signal der Makromoleküle wie z.B. verschiedene 
Zucker, DNA oder RNA. 
Die Sensitivität von MRS wurde durch stärkere Magnetfelder erheblich verbessert. MRS 
Messungen am Ultrahochfeld (≥7 T) profitieren von einem höheren Signal-Rausch- 
Verhältnis und einer höheren spektralen Auflösung. Zusätzlich wurden 
Lokalisierungsmethoden und Quantifizierungsmethoden weiterentwickelt, die es 
ermöglichen, die Konzentrationen auch der Metaboliten und Makromoleküle akkurat zu 
bestimmen, die ein kleines Signal-Rausch-Verhältnis haben oder komplexere spektrale 





Im Fokus des ersten Teils dieser Doktorarbeit steht die Charakterisierung der 
physikalischen Eigenschaften der makromolekularen Spektrallinien und die Frage, wie 
diese das Metaboliten-Spektrum beeinflussen. Dazu wurden Spektren am 9.4 T im 
menschlichen Gehirn aufgenommen, um hiermit T2 Relaxationszeiten zu bestimmen bzw. 
Linienbreiten quantitativ zu analysieren. Diese Analysen liefern Erkenntnisse über die 
spektrale Überlappung und J-Kopplungseffekte, die man in den makromolekularen 
Spektrallinien beobachtet. Zusätzlich wird eine neue „double inversion recovery“ Methode 
vorgestellt, um damit die T1 Relaxationszeiten von einzelnen makromolekularen 
Spektrallinien zu bestimmen. 
Der zweite Teil dieser Doktorarbeit beschäftigt sich mit der Quantifizierung von den 
Metaboliten des menschlichen Gehirns am 9.4 T mittels ein- und zweidimensionaler MRS 
Methoden. Die Konzentrationen der Metaboliten werden in mmol/kg berichtet. Hierbei 
wurden T1- und T2-Gewichtungen korrigiert sowie die Zusammensetzung des 
gemessenen Gewebes berücksichtigt. Die resultierenden Konzentrationen, die mittels 
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Nuclear magnetic resonance (NMR) spectroscopy is a sought-after technique often used 
to understand the three-dimensional structure of molecules, to determine concentrations 
of certain molecules present in a complex mixture or to observe chemical reactions and 
binding of different components to each other. It is used in a wide range of applications 
including chemistry, medicine, geology, biology and so on. 
An atomic nucleus, composed of protons and neutrons, possesses certain important 
physical properties such as mass, electric charge, magnetism and spin. Out of these 
physical properties, the NMR technique exploits nuclear magnetism and nuclear spin. 
The nucleus in a strong external static magnetic field is perturbed by a weak oscillating 
magnetic field. Resonance occurs when the frequency of the oscillating field matches the 
frequency of the nucleus that depends on the static magnetic field strength, chemical 
environment of the nucleus, and magnetic properties of the nucleus. The energies 
absorbed correspond to the radiofrequency (RF) part of the electromagnetic spectrum. 
Extending the application of NMR to in vivo tissues, single voxel magnetic resonance 
spectroscopy (MRS) allows for non-invasive detection and quantification of the 
concentrations of neurochemicals and metabolites in biological tissues. More specifically, 
the complex biochemical changes contributing to metabolism in the human brain tissues 
are extremely intriguing. MRS enables both neuroscientific and clinical researchers to 
understand the metabolic processes in the in vivo healthy human brain, respective 
changes in case of pathological conditions and during treatment monitoring. 
This chapter focuses on familiarizing with the most important concepts of NMR/MRS and 
concludes with introducing the primary goals of this thesis. The introductory chapter 
attempts to cover only the basic concepts of NMR/MRS that would aid in understanding 
the scientific work presented here. For a more thorough explanation of the NMR/MRS 
spin physics in classical and quantum mechanical perspectives and for the derivations of 
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the equations used, referring to the textbooks by de Graaf1, Keeler2, and Levitt3 is 
suggested. 
1.1.1 Larmor frequency 
 
An intrinsic property possessed by the nucleus is angular momentum. The nuclear spin 
angular momentum (𝑰) is often denoted as nuclear spin. It is a vector quantity with both 
magnitude and direction. According to quantum mechanics, angular momentum is 
quantized. 
Protons and neutrons have 𝐼 = 1/2. Nuclei with even numbers of both protons and 
neutrons have 𝐼 = 0 whereas nuclei containing odd number of both protons and neutrons 
have 𝐼 = 1. For the other nuclei with odd-even or even-odd numbers of protons and 
neutrons respectively have half integral values of 𝐼. When nuclei have 𝐼 = 0, the nuclei 
are said to be NMR silent. However, the nuclei are said to be NMR active when 𝐼 has half- 
integral or integral values. Out of these nuclei, the NMR behavior of the half-integral 
nuclear spins is easier to understand and detect because of their spherically distributed 
electric charge. 
Each nuclear spin is associated with a nuclear magnetic moment 𝝁. When placed in an 
external static magnetic field (𝑩𝟎) 𝝁 experience a torque (𝑟) and precess about the 𝑩𝟎 
axis at a frequency given by 
 
𝑚𝟎 = − 𝛾 𝑩𝟎 (1) 
 
where 𝑚𝟎 is the angular frequency, famously known as the Larmor frequency, and 𝛾 the 
gyromagnetic ratio which is a constant for a given nucleus. Figure 1 shows a proton spin 
precessing around an external static magnetic field 𝑩𝟎. 
3  
 
Figure 1: A proton spin precessing in an external magnetic field 𝑩𝟎. The Larmor 
frequency 𝑚𝟎 is proportional to 𝑩𝟎. Gyromagnetic ratio 𝛾 of a proton is positive; therefore, 
it undergoes a negative precession according to Equation 1. 
For in vivo MRS, detection of metabolically valuable and MR-visible nuclei such as 1H, 
13C and 31P are feasible. Among them proton (1H) MRS is quite a popular technique due 
to the high natural abundance (>99.9%) of proton nucleus and its high 𝛾 and thus 
sensitivity. Therefore, 1H MRS allows for the detection of a large number of brain 
metabolites. 
1.1.2 Energy levels 
 
In general, spectroscopy techniques exploit the energy difference between quantized 
energy states and detect the frequency absorbed by the object. The number of nuclear 
spin states for nuclear spin 𝐼 is given by 2𝐼 + 1. In the absence of external field, the 
nuclear spin states are degenerate. However, for example, in the presence of an external 
magnetic field, the nuclear spin states have different energies. This is called the Zeeman 
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effect and the splitting of the energy levels in the presence of a magnetic field is known 
as Zeeman splitting. 
Considering proton (𝐼 = 1/2), there are two possible energy levels corresponding to the 
two nuclear spin states. These two spin states are known as parallel or spin-up (𝛼) and 
anti-parallel or spin-down (𝛽) depending on their orientation with the external magnetic 
field. This is illustrated in Figure 2. 
Borrowing concepts from quantum mechanics, the energy corresponding to the magnetic 
quantum states are given by 
 
ℎ 





where 𝑚 is the magnetic quantum number and can take 2𝐼 + 1 values between −𝐼 and 
+𝐼 in steps of 1. 
 
More specifically, in NMR electromagnetic waves in the RF range of 10-800 MHz are 
absorbed by the spins when there is an induced energy difference created by the external 
static magnetic field (𝑩𝟎) in a nucleus between the parallel and anti-parallel nuclear spin 
states. This energy difference ∆𝐸 between the quantized states is given by the Planck 
relation: 
 
∆𝐸 = ℎ𝜈 (3) 
 
where ℎ is the Planck’s constant and 𝜈 is the absorbed frequency. 
 
The energy of a magnetic dipole moment 𝝁 when placed in an external static magnetic 
field is given by 
 
𝐸 = −𝝁. 𝑩𝟎 = −𝜇 𝐵0 cos 𝜃 (4) 
 
where 𝜃 is the angle between 𝝁 and 𝑩𝟎. Therefore, 𝐸 is minimum when 𝜃 = 0° and 
maximum when 𝜃 = 180°. Therefore, classically speaking 𝐸 can take any value between 
+𝜇𝐵0 to −𝜇𝐵0 since 𝝁 can assume any orientation between 0° and 180°. However, it is 
not true since the resonance condition for magnetic resonance spectroscopy cannot be 
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derived that way. Therefore, a quantum mechanical treatment is necessary (∆𝐸 = ℎ𝜈). 
That way it can be explained why the angle 𝜃 between 𝝁 and 𝑩𝟎 is also quantized. 
 
 
Figure 2: Spin energy level diagram for a proton (𝐼 = 1/2). Therefore, there are two 
possible magnetic quantum numbers (𝑚 = -1/2, +1/2) and therefore two possible energy 
states corresponding to 𝑚. The energy level difference between the two spin states 𝛼 and 
𝛽 corresponds to energy in the RF range. 
 
When the spin transitions from 𝑚 = +1/2 (𝛼) to −1/2 (𝛽) state (Figure 2), the energy 
difference is given by 
 
ℎ 




Therefore, the resonance occurs when 
 
𝛾 




with 𝜈 being the Larmor frequency in Hz. The resonance condition is satisfied by applying 
RF energy equal to the Larmor frequency, which is then absorbed by the spins. This will 
result in a resonance line in the nuclear magnetic resonance spectrum at the given 
frequency 𝜈. 
Moreover, cosine of the angle between 𝝁 and 𝑩𝟎 is given by 
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𝑚 
cos θ = 




which indicates θ = 54.75° relative to the z-axis for protons (𝐼 = 1/2). This means that the 
protons are distributed on the surface of the two cones (with 𝝁 parallel or anti-parallel to 
𝑩𝟎) rotating about the static field 𝑩𝟎 at 𝜈. We have seen that the energy of interaction 
between the magnetic moment of the nucleus and the external static magnetic field (𝑩𝟎) 
is dependent on the angle 𝜃 between them (Equation 4). Therefore, in order to have the 
preferred minimum energy the spins align with the applied field. The population difference 
between the two spin states is given by the Boltzmann equation1. 
The nuclear spin angular momentum can point in any possible direction and the direction 
of the spin angular momentum is known as the spin polarization. For nuclei with 𝛾 > 0 
(such as 1H), magnetic moment 𝝁 of the nucleus points in the same direction as the spin 
polarization and for nuclei with 𝛾 < 0, magnetic moment of the nucleus points in the 
opposite direction to the spin polarization. In the absence of an external magnetic field, 
the magnetic moments in a sample point in all possible directions. However, despite the 
random thermal motion of the molecules, the magnetic moments are aligned over time in 
such a way that the average over the sample is parallel to the external magnetic field. 
This is represented by a bulk magnetization vector denoted by 𝑴 which is the sum of all 
magnetic moments. There are slightly more spins aligned parallel to the magnetic field 
than anti-parallel to the field making the total net magnetization the so-called macroscopic 
magnetization - parallel to the static magnetic field. Since there is no net component along 
the transverse XY plane, the net macroscopic magnetization is parallel to +Z-axis and is 
called the longitudinal magnetization 𝑴𝟎. 
An RF transmitter/receiver system (transceiver) is used for generating an oscillating 
magnetic field (𝑩𝟏) along the XY-plane. This results in the initial longitudinal 
magnetization 𝑴𝟎 experiencing a torque. Hence, the macroscopic magnetization vector 
rotates towards the transverse XY-plane in the case of a 90° excitation RF pulse or rotates 
towards the antiparallel state –Z in the case of a 180° inversion RF pulse. At this point, 
the external magnetic field 𝑩𝟎 acts on the nuclear spins in order to attain a phase 
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coherence between a large number of spins in the sample under investigation resulting 
in a detectable net transverse magnetization 𝑴𝑿𝒀. This magnetization rotates about the 
𝑩𝟎 field at Larmor frequency inducing an electromotive force (emf) in the receiver coil, 
thereby detecting the NMR/MRS signal. 
1.1.3 Chemical shift 
 
Depending on the chemical environment of the nucleus, the effective magnetic field 
experienced by the spin of the nucleus is given by 𝑩 is not the same as the external 
magnetic field 𝑩𝟎 (Figure 3). 
 
𝑩 = 𝑩𝟎 (1 − 𝜎) (8) 
 




Figure 3: A proton is shielded by the electron orbital thereby making it experience not 𝑩𝟎, 
but a slightly lower field strength 𝑩. 
Therefore, the resonance condition becomes 
 
ℎ 




The resonance frequency not only depends on the gyromagnetic ratio and external static 
magnetic field, but also on the chemical environment of the nucleus. This is termed as 
chemical shift. As an example, a more shielded proton will experience a larger 𝜎𝑩𝟎, 
therefore a lower field 𝑩. This results in a decrease in the difference between the energy 
states 𝛼 and 𝛽. Consequently, it gives rise to a signal in the lower frequency range. On 
the other hand, a more deshielded proton results in a signal in the higher frequency range. 
In a 1H MRS spectrum, protons from aliphatic chains resonate at lower frequencies 
(upfield); and protons that belong to aromatic rings, amide or amine groups resonate at 




Figure 4: A proton spectral range from 0 to 12 ppm is depicted here with aliphatic chains 
resonating at lower frequency (upfield) and aromatic rings, amide or amine groups 
resonating at higher frequency (downfield). Two protons belonging to the water molecule 
resonate close to 4.7 ppm. The ppm scale is preferred for plotting NMR/MRS spectra as 
it is field strength independent which makes the proton spectrum of a particular sample 
comparable across different field strengths. (Courtesy: American Medical Colleges and 
Khan Academy, www.khanacademy.org CC BY-NC-SA 3.0) 
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From Equation 9 it can be observed that the resonance frequency 𝜈 is dependent on 
external static magnetic field 𝐵0. So comparing NMR spectra across different field 
strengths becomes tedious when the chemical shift is expressed in hertz (Hz). In order to 
avoid the field strength dependence, chemical shift scale in parts per million (ppm) was 
introduced. The chemical shift scale requires a reference compound such as 2.2- 
dimethyl-2-silapentane-5-sulfonate (DSS) whose chemical shift has been assigned 
chemical shift 𝛿 = 0 ppm. 
The position of a peak in a spectrum is taken as the frequency separation between the 
peak of interest and reference peak divided by the frequency of the reference peak. 
Chemical shift 𝛿 in ppm is therefore defined as 
 
𝜈 − 𝜈𝑟𝑒𝑓 




where 𝜈 is the resonance frequency of a spectral line representing the molecule of interest 
and 𝜈𝑟𝑒𝑓 is the frequency of a spectral line from a reference compound. Traditionally, the 
lower frequency resonances are displayed to the right of the water resonance (known as 
upfield) in the 1H MRS spectrum and higher frequency resonances to the left of the water 
resonance (known as downfield) in the spectrum (Figure 4). 
1.1.4 J-coupling 
 
J-coupling or scalar coupling is a phenomenon that occurs as a result of indirect magnetic 
interaction between two nuclei and their spins which is brought about by the electron spins 
contributing to the chemical bonds between the nuclei. The effect can be seen in the 
spectrum as splitting of peaks into multiplets in the NMR spectrum. The spacing between 
the peaks in the multiplet is given by the coupling constant 𝐽. The J-coupling constant is 
independent of the external magnetic field and is reported in Hz. 
The hyperfine interactions between the nuclear spin and the electron spin is governed by 
Fermi contact. The s-electrons play a significant role in this interaction since they have a 
finite probability of being at the nucleus. According to Fermi contact, the nuclear and the 
electron spins favor an anti-parallel arrangement. Therefore, four nuclear spin 
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combinations (and hence four corresponding energy levels) are possible for a coupled 
spin system containing two nuclei as shown in Figure 5. Introducing Pauli exclusion 
principle which states that two or more fermions (particles with half integral spins) cannot 
occupy the same quantum state within a same quantum system. Therefore, the 
interacting bonding electrons need to be antiparallel. These rules influence the energy 
level of the coupled spin system resulting in changes in the energy levels. Compared to 
energy levels of a non-coupled spin system, in a coupled system, high-energy 𝛽𝛽 state 
is energetically less favorable. Therefore, there is an increase in the energy level of 𝛽𝛽 
state. Similarly, there is an increase in the energy level of the 𝛼𝛼 state. 𝛼𝛽 and 𝛽𝛼 states 
have antiparallel electron spins leading to more favorable with a decrease in their energy 
levels. A more thorough explanation of the energy levels is given in the text book by de 
Graaf1. 
The multiplicity of the peak is given by the 𝑛 + 1 empirical rule where 𝑛 is the number of 
hydrogens attached to the immediate neighboring carbon atom. It means that the number 
of line splitting of a peak can be predicted as one more than the number of hydrogens 
attached to the immediately neighboring carbon atom. Additionally, the relative heights of 
the subpeaks are given by the binomial coefficients of Pascal’s triangle. 
There is a rapid decrease in the J-coupling effect with increasing number of bonds and 
the effect can be ignored for four or more bonds. Considering an AX spin system where 
A and X are two coupled nuclei, if |𝜈𝐴 − 𝜈𝑋| ≫ 𝐽𝐴𝑋 then the system is known as a weakly 
coupled system. The spectrum corresponding to a weakly coupled system is known as a 
first-order spectrum. If the frequency difference is about the same order as the coupling 
constant 𝐽𝐴𝐵, then the spin system AB where A and B are two coupled nuclei is known as 
a strongly coupled system. In such a spin system, 𝛼𝛽 and 𝛽𝛼 spin states are mixed 
leading to more complicated spectral pattern since both peak intensities and frequencies 
are perturbed. The outer peaks are lesser in amplitude and in the so-called roof effect 
with an imaginary roof forming from the outer to inner resonances. These spectra are also 
referred to as second-order spectra. Since J-coupling is field strength independent, higher 
external static magnetic field improves the spectral dispersion and reduces strong 






Figure 5: In an uncoupled spin system, there are two possible energy states 
corresponding to parallel and anti-parallel spin states as shown in Figure 2. Here the 
figure shows energy level diagram of a weakly coupled AX spin system. There are four 
possible combinations of parallel and anti-parallel spin states for both nuclei which 
correspond to four different energy levels. Four transitions are allowed with respect to 
spin quantum number 𝑚 = ±1 (single quantum coherences). Therefore, the 
corresponding spectrum would contain four resonance lines at 𝜈𝐴 + 𝐽𝐴𝑋/2, 𝜈𝐴 − 𝐽𝐴𝑋/2, 
𝜈𝑋 + 𝐽𝐴𝑋/2, and 𝜈𝑋 − 𝐽𝐴𝑋/2, where 𝜈𝐴 and 𝜈𝑋 are resonance frequencies corresponding 
to non-coupled A and X spin systems and 𝐽𝐴𝑋 is the J-coupling constant. In addition, 𝑚 = 
0 𝑜𝑟 ± 2 (zero and double quantum coherences) are also allowed resulting in two more 
transitions. But they are not observable directly4. 
Magnetically equivalent nuclei (such as protons within an isolated CH3 group) have 
identical scalar coupling constants with a third non-equivalent nucleus (such as an 
additional CH group in the molecule) whereas for chemically equivalent nuclei, the scalar 
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coupling constant of the two nuclei with the third nucleus is different. All magnetically 
equivalent nuclei are also chemically equivalent and chemically equivalent nuclei do not 
show first-order splitting in the spectrum. 
The concept of J-coupling is used in multi-dimensional spectroscopy5–7 (section 1.1.7 and 
1.3). The coupled spin systems undergo J-evolution with increasing echo time TE. 
Therefore, an incremental delay in the pulse sequence is introduction for J-coupling to 
undergo evolution. A thorough quantum mechanical treatment using product operator 
formalism is necessary to explain the scalar coupling evolution and it is beyond the scope 
of this thesis. Therefore, it is suggested to refer to the text books of Levitt3 and Keeler2 to 
understand about the concept of J-evolution. In principle, the magnetization vector of the 
coupled spins oscillates between in-phase and anti-phase terms in the transverse XY 
plane and this leads to what is observed as J-evolution and inversion of the J-coupled 
resonances in the spectrum. The spectral peaks are fully inverted by 180° when 𝑇𝐸 = 
1/𝐽. 
1.1.5 T1 and T2 relaxation times 
 
The concepts of T1 and T2 relaxation are essential to understand even a basic NMR 
experiment. A single RF pulse or a sequence of different RF pulses perturbs the spins 
thereby causing a change in the net magnetization. 
T1 relaxation time (also known as spin-lattice relaxation or longitudinal relaxation) is the 
time that it takes to return the longitudinal net magnetization to its equilibrium 𝑀0 which is 
parallel to the external static magnetic field 𝐵0. The recovered magnetization at time 𝑡 is 
given by 
 
𝑀 (𝑡) = 𝑀 (1 − 𝑒
−𝑡⁄𝑇 ) 
𝑍 0 1 
(11) 
 
When 𝑡 > 5𝑇1, 𝑀𝑍(𝑡) = 𝑀0 . Therefore, the knowledge of metabolite specific T1 
relaxation times is necessary to optimize the data acquisition parameters such as the flip 
angle and repetition time TR for a spectroscopy experiment. A repetition time TR that is 
short in comparison to 5T1 gives the spectrum a T1-weighting. Moreover, it is important to 
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correct for T1 relaxation effects for accurate concentration estimates of metabolites and 
the calculation of chemical exchange rates. T1 relaxation times are dependent on external 
magnetic field and get longer with increasing static magnetic field strength 𝐵0. T1 
relaxation time in vivo is also tissue-specific and dependent on temperature. 
T1 relaxation times are measured using inversion recovery techniques or using a 
progressive saturation approach with a repetition time series. This results in the spectral 
signal sweeping a range of magnetizations from positive to negative. Fitting the resulting 
signal to inversion recovery equation or to Equation 11 with 𝑡 = 𝑇𝑅, T1 relaxation times 
can be calculated. Section 1.2 describes the use of a double inversion recovery sequence 
for measuring T1 relaxation times of the macromolecular peaks. 
T2 relaxation is the exponential decay process of the transverse magnetization with time. 
It is also known as transverse relaxation or spin-spin relaxation. T2 relaxation time is the 
time taken by the transverse magnetization MXY to fall to 37% (1/e) of its initial value. For 
a simple spin-echo sequence, the transverse magnetization at a specific time 𝑡 is given 
by 
 
𝑀 (𝑡) = 𝑀 (0)𝑒
−𝑡⁄𝑇 
𝑋𝑌 𝑋𝑌 2 
(12) 
 
The relationship between echo time 𝑡 = 𝑇𝐸 and T2 relaxation time is an exponential 
curve according to Equation 12 and it is used to measure the T2 relaxation times in section 
1.2 and 1.3. A non-zero TE gives a T2-weighting to the spectrum. Various factors 
contributing to the exponential decay of the NMR signal include microscopic magnetic 
susceptibility differences, dipole-dipole interaction, chemical shift anisotropy, molecular 
translation, fluid flow, J-coupling and chemical exchange. T2 relaxation times decrease 
with increasing field strength. 
The Lorentzian linewidth component of the spectral peaks arise from the T2 relaxation. 
The T2 component contributing to linewidth of the peaks is metabolite/resonance-specific. 
On the other hand, the linewidth component arising from 𝐵0 inhomogeneities is identical 
to all the spins present in the sample/voxel of interest. The 𝐵0 inhomogeneities originate 
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from microscopic and macroscopic susceptibility effects as well as tissue compartment 
effects8 contributing to the Gaussian linewidth component. 
Bloembergen-Purcell-Pound (BPP) theory9 explains the relaxation of pure substances in 
a magnetic field. However, the relaxation phenomenon gets more complex in in vivo 
samples. The relaxation times are also shown to vary with pathological or physiological 
changes. Unlike the metabolites, relaxation times of water have been studied in detail 
and they are governed by a principle known as dipole-dipole interaction. Their relaxation 
property is explained as a result of the fast exchange of free bulk water and the bound 
water near macromolecular surfaces. 
Molecules undergo translational, rotational and vibrational motion. Out of these, 
frequencies corresponding to the rotational motion are in the MHz range thereby having 
an impact on the MR signal. Smaller molecules rotate faster compared to larger 
molecules. Also, as temperature increases, increase in the kinetic energy of the 
molecules make them rotate faster. Therefore, with increasing tumbling rate, both T1 and 
T2 relaxation times increase. Therefore, for larger macromolecules with shorter tumbling 
rates, T1 and T2 relaxation times are shorter compared to those of metabolites. 
In vivo, T1 relaxation times are predominantly tissue specific. On the other hand, in 
addition to being field strength specific, T2 relaxation times are also sequence specific 
depending primarily on whether the sequence employs adiabatic pulses or not. For 
instance, the adiabatic pulses cause a spin-locking effect10 which suppresses the 
evolution of spins to some extent for the pulse duration. Furthermore, T2 relaxation times 
are not only tissue specific, but they are also specific to the region of the brain since they 
depend on the iron content11. 
Analyzing relaxation times can also lead to spectral assignment of unknown compounds 
in sample mixtures. In the later sections, the necessity of knowing T1 and T2 relaxation 
times of water and metabolites for the quantification of metabolites in comparable units 
(molar or molal) is emphasized. 
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1.1.6 Bloch equations 
 
Looking at the macroscopic magnetization gives an equation of motion from the classical 
mechanics point of view. Bloch proposed a set of equations for the time dependence of 
the net magnetization during an NMR experiment involving RF pulses. The bulk 
magnetization 𝑴 experiences a torque and therefore precesses around the external static 
magnetic field 𝑩𝟎: 
 
𝑑𝑴(𝑡) 




The magnetic field 𝑩(𝑡) is time dependent when RF pulses are applied. The vector 𝑴 has 
three components: 𝑀𝑥 and 𝑀𝑦 which are the transverse components and 𝑀𝑧 which is the 
longitudinal component. Solving the cross product yields 
 
𝑑𝑀𝑥(𝑡) 












Bloch assumed the spins to relax differently in the transverse (spin-spin relaxation) and 
longitudinal planes (spin-lattice relaxation); however, the Bloch equations follow first order 
kinetics. Considering the relaxation process where T1 and T2 are relaxation time 







𝑀𝑧(𝑡) − 𝑀0 
, − ) 
𝑇1 
 
Therefore, accounting for relaxation in Equations 14, 15, and 16 and since 𝐵𝑧(𝑡) in the 
laboratory frame is 𝐵0, the Bloch equations in the laboratory frame are written as 
16  
𝑑𝑀𝑥(𝑡) 𝑀𝑥(𝑡) 




= 𝛾[𝑀𝑧(𝑡)𝐵𝑥(𝑡) − 𝑀𝑥(𝑡)𝐵0] − 
𝑑𝑡 𝑇2 
(18) 
𝑑𝑀𝑧(𝑡) 𝑀𝑧(𝑡) − 𝑀0 





Considering a rotating frame (x’, y’, z’) with frequency ω around the static magnetic field 
B0 = - γω0, 
 
𝑀′𝑥 = 𝑀𝑥 cos 𝜔𝑡 + 𝑀𝑦 sin 𝜔𝑡 (20) 
𝑀′𝑦 = 𝑀𝑦 cos 𝜔𝑡 − 𝑀𝑦 sin 𝜔𝑡 (21) 
𝑀′𝑧 = 𝑀𝑧 (22) 
the equations above transform as follows: 
 
𝑑𝑀′𝑥(𝑡) 𝑀′𝑥(𝑡) 




= [ (𝜔0 − 𝜔)𝑀′𝑥(𝑡) + 𝛾𝑀′𝑧(𝑡)𝐵′𝑥(𝑡)] − 
𝑑𝑡 𝑇2 
(24) 
𝑑𝑀′𝑧(𝑡) 𝑀′𝑧(𝑡) − 𝑀0 
= 𝛾[𝑀′𝑥(𝑡)𝐵′𝑦(𝑡) − 𝑀′𝑦(𝑡)𝐵′𝑥(𝑡)] − 
𝑑𝑡 𝑇1 
(25) 
A detailed derivation can be found in the paper by Bloch12. The Bloch equations are used 
in section 1.2.2 to determine the longitudinal magnetizations of MM peaks for different 
combinations of inversion times in a double inversion recovery sequence to find optimal 
sequence parameters to measure T1 relaxation times of MM. 
1.1.7 Single voxel spectroscopy techniques 
 
Application of concepts from physics in medicine has been of immense importance. The 
branch of medical physics has grown tremendously and yielded diagnostic, therapeutic 
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and theranostic methods. Magnetic resonance imaging (MRI) and spectroscopy are used 
for diagnostic purposes and for monitoring treatment response. Single voxel proton MRS 
is a non-invasive technique that has complemented MRI by providing a means to detect 
and quantify concentrations of metabolites in the human brain. About 18 brain metabolites 
can be detected at ultra-high field (UHF) (≥ 7 T) using this technique13. MRS is used to 
not only understand the regular metabolism in the human brain, but also in establishing 
biomarkers for diagnostics and therapy response monitoring in a range of pathologies in 
the human brain, therefore proving to be clinically useful14. Quite contrasting to MRI, in 
MRS, one aims to suppress tissue water and fat signal, and measure the concentrations 
of metabolites. The sensitivity of 1H MRS allows for detection of metabolites with 
concentrations in the millimolal range. Therefore, 1H MRS provides more specificity since 
this technique can detect several metabolite peaks of interest. Figure 6 a) shows 1H MRS 
spectrum acquired at 9.4 T. 
The most common in vivo spectroscopy pulse sequences for single voxel localization are 
PRESS15, STEAM16, semiLASER17,18, LASER19 and SPECIAL20 . They differ from each 
other with respect to type and number of radiofrequency pulses needed for 3D 
localization, the resulting chemical shift displacement and SNR. Typically, the most suited 
pulse sequence is chosen for a study depending on the metabolites of interest, hardware 
constraints and feasibility of acquisition duration and other parameters such as TE, TR 
and number of averages required to yield a good quality spectrum. A recent experts’ 
consensus article21 compares the pulse sequences based on various characteristics and 
recommends sequences for different situations such as lower/higher field strengths, 
reducing chemical shift displacement and to overcome inhomogeneous B1+ fields. 
Another interesting review article by Landheer et al.,22 describes the pulse sequences 




Figure 6: a) Proton spectrum acquired in vivo in the human brain at 9.4 T using a one- 
dimensional metabolite-cycled semiLASER sequence with an inlay showing the voxel 
placement in an anatomical image. A gray matter rich voxel of interest in the occipital lobe 
was chosen. The spectrum shows regions of severe spectral overlap highlighted with red 
boxes in the spectrum. These regions contain spectral peaks from J-coupled metabolites 
such as aspartate, glutamine, glutamate and myo-inositol. b) A in vivo human brain two- 
dimensional J-resolved metabolite-cycled semiLASER spectrum acquired from the same 
voxel shows well-resolved spectral patterns of these metabolites with J-coupled spin 
systems across the indirect dimension f1. The spectral range containing most metabolites 
with J-coupled spin systems are shown with white boxes. In both a) and b) major singlet 
resonance lines of metabolites such as NAA, tCr and tCho are labeled to serve as spectral 
landmarks for comparison between the two figures. Further explanation about the 
sequences and acquisition parameters are given in section 3. 
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UHF pose several technical challenges13 and they have to be addressed in order to reap 
the benefits offered by UHF. Some of the challenges include B1+ inhomogeneity23, and 
increased chemical shift displacement effect. In this thesis, semiLASER17 (semi 
localization by adiabatic selective refocusing) sequence is used for localization. The 
semiLASER24 sequence employed 90° sinc pulse of 8000 Hz bandwidth for excitation. 
Higher bandwidth adiabatic full passage (AFP) pulses (pulse duration: 3.5 ms; bandwidth: 
8000 Hz) can minimize chemical shift displacement thereby improving the localization of 
the voxel of interest. In addition, adiabatic pulses are also relatively insensitive to B1+ 
inhomogeneity. This helps overcome the B1+ field inhomogeneity especially at UHF. Even 
though LASER offers better localization since it uses adiabatic pulses also for excitation 
as well, semiLASER allows shorter TEs since it has lesser number of RF pulses. This is 
beneficial since T2 relaxation times of metabolites are shorter at UHF compared to lower 
field strengths, therefore using a shorter TE sequence is better. The sequence is 
described in detail in Giapitzakis et al24. 
Another important aspect of acquiring MRS data is a water suppression scheme. Water 
molecule is present in abundance in the human brain resulting in a huge water peak at 
~4.7 ppm in the 1H spectrum. Therefore, it is essential to suppress the water peak in order 
to detect metabolites that are present in millimolal range. The water suppression also 
needs to be robust in order to avoid any baseline distortions or water tails affecting the 
detection of metabolites closer to 4.7 ppm. However, water suppression techniques25,26 
uses a combination of RF pulses which increases RF power deposition at UHF. 
Therefore, metabolite-cycling (MC) technique was proposed27 which is an alternative to 
using water suppression techniques. The MC technique24 used in this thesis employed 
an asymmetric adiabatic inversion pulse. The MC inversion pulse preceeded the 
semiLASER localization24. It works by selectively alternatively inverting the upfield and 
the downfield part of the proton spectrum (upfield and downfield parts are inverted in the 
odd and even numbered acquisitions respectively). Therefore, adding the even and odd 
numbered acquisitions gives the water spectrum and their difference results in the 
metabolite spectrum. The inversion of the upfield and the downfield part of the spectrum 
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without affecting the water peak also enables detection of some of the peaks that 
exchange their proton with water28. 
Using proper preprocessing steps (such as averaging, eddy current correction, RF coil 
combination, frequency and phase drift correction, etc.,) in order to reconstruct the raw 
data from the MRI scanner is just as important as choosing the appropriate pulse 
sequence with optimized parameters for a study. This is aptly illustrated in experts’ 
consensus recommendations on preprocessing, analysis and quantification in single 
voxel MRS29. 
As a next step, in order to quantify the concentrations of metabolites, a linear combination 
of simulated basis spectra are fit to model the acquired spectrum. There are several 
software packages such as LCModel30, FiTAID31 or jMRUI32, which perform spectral 
fitting. The most preferred way to generate the basis spectra for individual metabolites is 
using software tools such as Vespa33 by performing density matrix calculations on the 
spin-system of the metabolites that are expected to be observed in the acquired 
spectrum. All the acquisition parameters are taken into consideration. Major metabolites 
observed in the in vivo neurochemical profile are N-acetyl aspartate (NAA), NAA 
glutamate (NAAG), 𝛾-aminobutyric acid (GABA), aspartate (Asp), creatine (Cr), glutamate 
(Glu), glutamine (Gln), glutathione (GSH), glucose (Glc), glycerophosphocholine (GPC), 
glycine (Glyc), myo-inositol (mI), scyllo-inositol (Scy), lactate (Lac), phosphocreatine 
(PCr), phosphocholine (PCho), phosphoethanolamine (PE), and taurine (Tau). These are 
typically included as basis vectors in the basis set. The acetyl and aspartate moieties of 
NAA is represented as NAA(CH3) and NAA(CH2) respectively. The total creatine singlets 
at 3.028 and 3.925 ppm are given as tCr(CH3) and tCr(CH2) respectively. tCho 
corresponds to total choline combining PCho and GPC. The resulting relative 
concentrations from the spectral fitting are often converted to molar or molal units after 
correcting for various factors that are described in detail in section 1.1.8. 
Several challenges are encountered when one attempts to perform spectral fitting due to 
complex spectral patterns and severe overlap of peaks in a proton spectrum acquired 
using the techniques/pulse sequences discussed so far. It becomes difficult to distinguish 
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some peaks of metabolic importance such as GABA, Gln, Glu, Lac, etc., since these 
peaks appear as multiplets and also overlap with other metabolite peaks. 
One technique to acquire well-resolved MR spectroscopy data is by utilizing 1D MRS at 
ultra-high field strength (UHF)13 since it benefits from higher SNR and increased spectral 
resolution. Therefore, acquisition of spectra at UHF helps distinguishing metabolites with 
lower SNR peaks and/or J-coupled spin systems better. 
Another technique used by the NMR community to reduce spectral overlap is multi- 
dimensional spectroscopy34,35. Among these multi-dimensional spectroscopy techniques 
that exist, two-dimensional J-resolved spectroscopy is shown to be feasible and also to 
be promising in vivo36–38. The principle of 2D J-resolved spectroscopy7 exploits the 
concept of J-evolution and the consequential amplitude and phase modulation of spectral 
pattern. It simply consists of a series of signals acquired with different TEs encoding the 
indirect f1 dimension. The direct f2 dimension consists the chemical shift and J-coupling 
information as in 1D MR spectroscopy experiments. The second dimension (f1) in two- 
dimensional J-resolved spectrum contains J-coupling information. After a Fourier 
transformation in both dimensions, the spectrum displays the J-coupling information in 
the indirect dimension eliminating the overlap of J-coupled resonances. Figure 6 a) and 
b) illustrates a spectral comparison between 1D and 2D MC-semiLASER spectra (section 
1.3) acquired in vivo from the human brain at 9.4 T. In this thesis, quantification of 
metabolites using one-dimensional MRS and two-dimensional MRS semiLASER 
localization at UHF is compared in section 1.3. 
1.1.8 Quantification of metabolites 
 
The relative metabolite concentrations obtained from the fitting software are not directly 
comparable between various time points measured during treatment monitoring or across 
different acquisition methods, field strengths, or vendors. Hence, it is necessary to 
introduce correction factors in order to convert these relative concentrations to standard 
comparable values such as molal or molar units. To perform the corrections a reference 
of known concentration is essential. Several approaches39–47 exist in order to measure 
the concentrations of metabolites. One such method uses the internal water signal as the 
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reference48. This thesis uses the quantification formula described in detail by Gasparovic 
et al.,48 to calculate the concentration values in millimoles/kg (millimolal) using the internal 
water referencing method. The concentrations of metabolites are obtained after correcting 
for the fractional tissue compositions and T1 and T2 corrections for both water and 
metabolite signals. 
The quantification values are reported after applying the necessary correction factors 
(unless stated otherwise) for determining concentrations using the internal water 
referencing method. For external concentration reference methods certain factors such 
as coil loading, RF homogeneity, temperature differences need to be considered. While 
using internal water referencing method, the unsuppressed water spectrum is acquired 
from the same voxel as the metabolites. Since the metabolite signal and water signal are 
acquired similarly, internal water referencing is advantageous in comparison to external 
concentration references. 
In order to estimate the fractional tissue compositions, this work uses segmentation of 
acquired high-resolution MP2RAGE49 images into WM, GM and CSF (white-matter, gray 
matter and cerebrospinal fluid) using Statistical Parametric Mapping 12 (SPM 12) 50 
software. Later the tissue fractions were calculated using an in-house written script in 
Python (v3.7). Finally, the concentrations of metabolites were calculated using the 
formula48 given below: 
 
2 
[M]𝑚𝑚𝑜𝑙𝑎𝑙 = [M]obs × 𝑐𝑜𝑛𝑐𝑝𝑢𝑟𝑒_𝐻2𝑂 × 1 + Fs 
(fGM × 𝑅𝐻2𝑂_𝐺𝑀 + fWM × 𝑅𝐻2𝑂_𝑊𝑀+fCSF × 𝑅𝐻2𝑂_𝐶𝑆𝐹 ) 
× 
(1 − fCSF) × 𝑅𝑀 
 
  𝑓𝑦_𝑣𝑜𝑙 × 𝑎𝑦  where 𝑓𝑦 = 𝑓 × 𝑎 + 𝑓 × 𝑎 +𝑓 × 𝑎 





where 𝑦 corresponds to either GM, WM or CSF; 𝑓𝑦_𝑣𝑜𝑙 is the fraction of the respective 
tissue type determined by segmentation; 𝑎𝐺𝑀, 𝑎𝑊𝑀, 𝑎𝐶𝑆𝐹 (78%, 65%, 97% respectively) 
are the relative densities of MR-visible water for the given tissue type; The pure water 
concentration (55,510 millimolal) is used along with the MR visible fractions of water in 
GM, WM, and CSF. 
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]] is the relaxation correction factor for each 
water compartment 𝑦. 𝑇1𝐻2𝑂𝑦  and 𝑇2𝐻2𝑂_𝑦 are the 𝑇1 and 𝑇2 relaxation times of water in 
the compartment 𝑦. 
𝑅 = exp [− 
𝑇𝐸 
] [1 − exp[− 
TR 
]] is the relaxation correction term for metabolites 
  
𝑀 𝑇2𝑀 𝑇1𝑀 
(section 1.3). For macromolecules 𝑅𝑀 was replaced by 𝑅𝑀𝑀 as the macromolecular 
spectra were acquired using double inversion recovery (DIR) the relaxation (section 
𝑇𝐼2 













]] . The denominator 1 − 𝑓𝐶𝑆𝐹 was implemented 
for partial-volume correction. The factor 2 
1+Fs 
was introduced to correct for the 
multiplication of even-numbered acquisitions with the scaling factor (F𝑠), originating from 
the metabolite-cycling data processing. [M]obs is the concentration obtained from LCModel 
(section 1.2 and 1.3.2) or ProFit 2.0 (section 1.3.3). For metabolite concentrations 
(section 1.3), number of protons contributing to the metabolite peaks were accounted. 
However, for macromolecules since the proton contributions to each macromolecular 
peak is not known, the proton contribution was not corrected (section 1.2.3). 
1.1.9 Macromolecules 
 
Broad macromolecular resonances underlie narrow higher intensity metabolite resonance 
lines in short TE 1H MR spectra. Macromolecules (MMs) between 0.5 and 4.5 ppm are 
attributed to mobile methyl, methylene, and methine groups of amino acids from cytosolic 
peptides and proteins51. Several studies at field strengths between 1.5 to 3 T have 
highlighted the clinical relevance of MMs in aging52 and in pathologies such as traumatic 
encephalopathy53, Kennedy’s disease54, acute multiple sclerosis55, and glioma56. Figure 
7 shows a MM spectrum (summed from eleven healthy volunteers) acquired at 9.4 T 
(section 1.2). Due to increased spectral dispersion, SNR, and resolution, more MM peaks 
are distinguishable at ultra-high field57; hence, it is possible to more accurately 
characterize the behavior of individual MM peaks. 
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On the other hand, the well-resolved underlying MM spectrum at UHF often distorts the 
metabolite spectrum. Therefore, characterizing MM peaks additionally improves accuracy 
in quantifying metabolite concentrations. Various techniques have been used to handle 
MM signals in metabolite spectra. Cudalbu et al.,58 suggested that using prior information 
from experimentally acquired MM spectra may prove to be the best solution at UHF. 
 
 
Figure 7: Macromolecular spectrum summed from eleven healthy volunteers acquired 
from a gray matter rich voxel in the human brain using a double inversion recovery MC- 
semiLASER sequence59 with inversion times set to 2360 and 625 ms at 9.4 T. Further 
details are provided about acquisition set up and parameters in section 1.2. The MM 
peaks are labeled as MX.XX where the subscript X.XX represents the chemical shift of the 
MM peak in ppm. A sharper metabolite residual tCr-CH2 peak is seen at 3.925 ppm. 
Macromolecules have shorter T1 relaxation times when compared to metabolites57. 
Exploiting this difference in T1 relaxation times MM spectra are acquired using inversion 




MRS spectrum. In addition, MMs have shorter T2 relaxation times compared to 
metabolites. Therefore, some studies use longer TE spectra are acquired in order to avoid 
the MM contribution to the proton spectrum. However, it results in SNR loss for shorter 
T2 and J-coupled metabolites. 
 
1.1.10 Objectives and outcome of doctoral research 
 
Reliable detection and quantification of the concentration of metabolites and 
macromolecules in the human brain using proton single voxel spectroscopy at an ultra- 
high field strength of 9.4T was the prime goal of this thesis. Increased spectral dispersion 
and SNR at UHF provides better detection and distinction of the metabolite peaks13. 
However, this also implies that the MM peaks are more distinguishable at UHF, which 
may negatively impact the accuracy and precision of metabolite concentration estimates. 
Furthermore, the MM spectrum itself contains potentially clinically relevant information. 
This makes it necessary to characterize and understand the contribution of MM peaks 
better. Therefore, the first part of this thesis focuses on characterizing the relaxation times 
of MMs (Publication 1, Publication 2) and to quantify their brain tissue concentrations 
(Publication 2). This work helps in accounting for the contribution of MMs in the metabolite 
spectrum and to understand the nature of MMs. The effective T2 relaxation times (𝑇𝑒𝑓𝑓) 
of MMs (Publication 1) are reported for gray and white matter-rich voxels in the human 
brain at 9.4 T. The 𝑇𝑒𝑓𝑓 relaxation times were calculated for MM peaks from an echo 
time series of a double inversion recovery (DIR) metabolite-cycled (MC) semiLASER 
sequence. In Publication 2, T1 relaxation times of MM peaks for gray and white-matter 
rich (GM and WM respectively) voxels are calculated by using a novel DIR technique. 
These two publications helped in understanding the sequence and scan parameter 
dependency of the contribution of MMs to the metabolite spectrum and led to the 
development of a respective simulated relaxation corrected sequence specific MM 
model60 (co-author paper not a part of this thesis). 
The second part of the thesis focuses on quantifying the concentrations of brain 
metabolites (Publication 1, Publication 3) reliably. This is done using two different single 
26  
voxel spectroscopy localization techniques namely one-dimensional (Publication 1) and 
two-dimensional spectroscopy (Publication 3) and comparing their performance. The MC 
semiLASER sequence was used for acquiring one dimensional spectroscopy data from 
a GM-rich voxel in the occipital lobe. In addition, a two-dimensional J-resolved MC 
semiLASER sequence with a maximum echo sampling scheme was developed and used 
to acquire two-dimensional spectroscopy data from a GM-rich voxel in the occipital lobe 
as well. MM contributions to the metabolite spectra in both 1D and 2D MC semiLASER 
were accounted for by including experimentally acquired 1D and 2D MM spectra using 
1D and 2D double inversion recovery MC semiLASER respectively. T1 relaxation times61 
(co-author paper not part of this thesis) and T2 relaxation times of metabolites (Publication 
1) were determined and used in the correction factors to obtain concentration values. 
This thesis is written in a cumulative form and includes three publications that arose 
during my PhD work. The results from Publication 1, Publication 2, and Publication 3 are 
summarized and presented here. The full articles as published in peer reviewed journals 
are appended in this thesis and can be found in Chapter 5. 
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1.2 Characterization and Quantification of Macromolecules 
 
The broad macromolecular peaks underlying the metabolite spectrum in 1H MRS 
experiments with short echo time are often viewed as a distortion due to the negative 
impact on the quantification accuracy and precision of metabolite concentrations. 
Therefore, characterizing these macromolecular peaks is necessary in understanding 
their influence in quantifying metabolite concentrations in dependence of sequence 
parameters. Moreover, several studies52–54,58,62 have highlighted the clinical importance 
of MMs since respective changes have been detected in various pathologies in the rat 
brain and human brain. Hence, in order to understand the mechanisms behind different 
pathologies and to improve the diagnostic capability for several diseases of clinical 
relevance by establishing potential biomarkers, assimilation of MMs and their behavior is 
essential. A recent consensus article about MRS visible MM57 also emphasized that the 
knowledge of T1 and T2 relaxation times of individual peaks at different field strengths is 
necessary. In the following sections, characterization of T2 (Publication 1) and T1 
(Publication 2) relaxation times of MM peaks in GM- and WM-rich voxels at 9.4 T is 
described in detail. Finally, the concentration of MM peaks (Publication 2) in the human 
brain are reported after correcting for tissue fractions of the respective voxels and for the 
tissue type specific relaxation effects. 




At the time when this study was performed, T2 relaxation times of all individual MM peaks 
detectable in the human brain have not been reported at any field strength to the best of 
our knowledge. The T2 relaxation times of MM peaks have been reported in the rat 
brain63–66 at 4.0, 9.4, 11.7, and 17.2 T and for the non-overlapping M0.92 peak in the human 
brain at 2.1 T by Behar et al67. Therefore, the primary goal of this study was to measure 
the effective T2 relaxation times (𝑇𝑒𝑓𝑓; includes the J-evolution effects) of individual MM 
peaks in both GM- and WM-rich voxels in the human brain at 9.4 T. Another interesting 




FWHM (∆1/2) of the MM peaks compared to the respective contributions by T2 relaxation 




In this study, eleven and five healthy volunteers participated for data acquisition in the 
GM- and WM-rich voxels respectively. A 2 × 2 × 2 cm3 GM-rich voxel was chosen in the 
occipital lobe and a WM-rich voxel of same dimensions was chosen in the occipital- 
parietal transition. A home-built coil with 8 transmit and 16 receive channels68 was used 
for the study, by driving power to only the bottom three channels for the single-voxel 
spectroscopy experiments as described in Giapitzakis et al24. 
First- and second-order B0 shimming using FAST(EST)MAP69 (acronym for fast, 
automatic shim technique using echo-planar signal readout using mapping along 
projections), and voxel-based power calibration70,71 were performed. A non-linearly 
spaced TE series (TE: 25, 32, 40, 52, and 60 ms) of MM spectra was acquired using a 
DIR59 MC semiLASER sequence (TR: 10 s, Averages per TE: 32, transmit reference 
frequency: 2.4 ppm) to estimate the 𝑇𝑒𝑓𝑓of MM peaks. 
 
All raw data were preprocessed with in-house written software in MATLAB (version 
2016a; MathWorks, Natrick, MA) as described in Publication 1. MM spectral fitting was 
performed in LCModel V6.3-1L30 using simulated Voigt lines. The following MM peaks 
were included in the basis set: M0.92, M1.21, M1.39, M1.67, M2.04, M2.26, M2.56, M2.70, M2.99, 
M3.21, M3.62, M3.75, M3.86, M4.03, and M4.17 where the corresponding subscripts indicate their 
chemical shifts in ppm. For the fitting of the MM peaks, the chemical shifts and ∆1/2 were 
systematically varied to achieve minimum possible standard deviation of the 𝑇𝑒𝑓𝑓 
relaxation time values among subjects, to maximize R2 values, and to minimize the mean 
Cramer-Rao lower bounds. After considering the above-mentioned criterions, the values 
chosen by Lopez et al63   best suited the data. Hence, these chemical shifts and 
∆1/2values, with minor deviations were used as input for the spectral fitting model. 
Creatine (tCr-CH2) metabolite residual was subtracted by adding a narrower Voigt peak 
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Figure 8: Echo time series (TE: 24, 32, 40, 52, and 60 ms from top to bottom) 
macromolecular spectra from GM- and WM-rich voxels. The MM spectra shown here are 
summed from all the healthy volunteers for the respective voxels. The figure has been 
adapted from Publication 1. 
To calculate the 𝑇𝑒𝑓𝑓 relaxation of MM peaks, the resulting concentrations of MM peaks 
across the TE series were fit to a mono-exponential decay for the individual subject data 
and spectra summed across all volunteers. The mean coefficient of determination R2 was 
used to evaluate the goodness of the exponential fits. 
The FWHM of the MM peaks were extracted from the LCModel .coord files. The 
contribution of 𝑇𝑒𝑓𝑓 relaxation times to ∆1/2 was calculated as (𝜋𝑇𝑒𝑓𝑓)−1. The residual 
2 2 
linewidth was calculated as 
 
∆𝜈 =  ∆ − (𝜋𝑇𝑒𝑓𝑓)
−1 
− ∆𝜈 






Figure 9: Exponential decay plots of M0.92, M2.04, M2.26 and M2.99 from MM spectra 
summed for all healthy volunteers for GM- and WM-rich voxels. The scatter points show 
the fitted concentrations for the respective TEs and the line shows the exponential decay 
fit. The y-axis has arbitrary units. Therefore, conclusions should not be drawn about the 
differences between GM and WM plots. The figure is adapted from Publication 1. 
The B0 components deduced from the tCr(CH2) residual as 
 
∆𝜈 =  ∆ − (𝜋𝑇𝑒𝑓𝑓)
−1   
≈  ∆𝜈 + ∆𝜈 








Figure 8 shows the TE series of MM spectra from GM- and WM-rich voxels. The shaded 
area represents the standard deviation in the signal between subjects illustrating the high 
reproducibility of the data quality. The exponential decay fits for M0.92, M2.04, M2.26 and 
M2.99 peaks in the GM- and WM-rich voxels are shown in Figure 9. The LCModel fit 
residual was minimum and showed minimal structured noise indicating a good fit quality 
for all individual data from GM- and WM-rich voxels (Publication 1). M2.70 is observed to 






to account for this effect in fitting, the M2.70 peak was simulated as a negative peak at the 
aforementioned TEs. 
The 𝑇𝑒𝑓𝑓relaxation times calculated from fits of the individual subject data and the across 
subjects summed spectra were in good agreement. The box plots of the 𝑇𝑒𝑓𝑓relaxation 
times are given in Figure 10. The values lie between 13 and 37 ms for GM-rich voxels 
and between 13 and 40 ms for WM-rich voxels. The mean R2 values of the exponential 




Figure 10: The boxplots show 𝑇𝑒𝑓𝑓 relaxation times calculated for 14 MM peaks in GM- 
rich (dark blue) and WM-rich (light blue) voxels. Horizontal lines inside the boxes indicate 
median values (50% quartile). The boundaries at the bottom and the top represent 25 
and 75 % quartiles respectively. Red and magenta crosses represent the 𝑇𝑒𝑓𝑓,𝑠𝑢𝑚 
relaxation times calculated for the subject-wise summed spectrum from GM- and WM- 
rich voxels respectively. The figure is adapted from Publication 1. 
The measured ∆1/2 of the MM peaks ranged between 35 and 85 Hz across all TEs. 






and 30 Hz. The ∆𝜈𝑟𝑒𝑠𝑖𝑑𝑢𝑎𝑙 for MM peaks calculated after using the ∆𝜈𝑠𝑖𝑛𝑔𝑙𝑒𝑡 of tCr(CH2) 
varied between 10 and 60 Hz (Figure 11). 
Discussion 
 
𝑇𝑒𝑓𝑓 relaxation time values are comparable between the GM- and WM-rich voxels in the 
occipital lobe and the occipital-parietal transition respectively. These values are brain 
region specific as the difference in T2 relaxation times is primarily governed by the iron 
concentrations across the human brain as shown by Hasan et al11. 
 
Figure 11: Residual linewidths calculated using Equation 27 for the MM peaks and 
metabolite residual tCr(CH2) at 3.925 ppm. The figure is adapted from Publication 1. 
Table 1 shows a comparison of 𝑇𝑒𝑓𝑓 relaxation time values across field strengths. Most 
MM peaks show a mild B0 dependence. As discussed in the MM experts’ consensus 
article57, even though the 𝑇𝑒𝑓𝑓 relaxation times tend to decrease with field strength, they 
have a very mild B0 dependence. M0.92 peak shows maximum deviation from the field 










3 T72,73. In addition, Hoefemann et al72 reported lower 𝑇𝑒𝑓𝑓 relaxation times for M1.22 and 
M1.43 peaks combined. The 𝑇𝑒𝑓𝑓 relaxation times of MMs obtained from this study was 
utilized also to develop the relaxation corrected MM simulation model60. In addition, the 
knowledge of 𝑇𝑒𝑓𝑓 relaxation times of MMs was essential to optimize the acquisition 
parameters in the two-dimensional spectroscopy study (Publication 3). 
The linewidth of the MM peaks were not explained by contribution of the T2 relaxation 
times and the microsusceptibility and macrosusceptibility effects. The ∆𝜈𝑟𝑒𝑠𝑖𝑑𝑢𝑎𝑙 values 
for the MM peaks (Figure 11) varied consistently between 10 and 60 Hz for both GM- and 
WM-rich voxels indicating the magnitude of chemical shift anisotropy, potential spectral 
overlap and/or J-evolution components for each MM peak is similar between different 
tissue types. These peaks could originate from amino acids74 which, depending on the 
larger protein structure they belong to, can have different chemical shifts, but are 
distributed around a main resonance frequency for the bulk of protein peaks. 
Conclusion 
 
In this study, for the first time, 𝑇𝑒𝑓𝑓 relaxation times of 14 individual MM peaks ranging 
from 13 to 45 ms were measured in both GM- and WM-rich voxels. The 𝑇𝑒𝑓𝑓relaxation 
times follow the decreasing trend of T2 relaxation times with increasing B0 field strength. 
The 𝑇𝑒𝑓𝑓 relaxation time values were utilized to quantify the concentrations of the MMs in 
human brain tissue (section 1.2.3) and for the development of a generalized relaxation- 
corrected MM simulation model for accurate quantification of metabolite concentrations60. 
Finally, this work quantitatively shows the contribution of 𝑇𝑒𝑓𝑓relaxation times and B0 
components to the linewidths of the MM peaks and demonstrates a substantial additional 
contribution by chemical shift anisotropy, potential spectral overlap and J-coupling 
components to the residual linewidth of amino acid proton groups. 
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Landheer (2020)73 Hoefemann (2020)72 Behar (1994)67 
B0 (T) 9.4 3 3 2.1 




Echo Time (ms) 24 - 60 20.1 - 62.1 20 - 95 19.4 - 145.2 
Repetition Time 
(ms) 
10000 2000 3000 - 4000 3300 
 
 
Region of Interest 










M0.94 36 ± 7 35 ± 10 27 ± 2 21 44 ± 4 
M1.22 34 ± 13 25 ± 0 39 ± 13  
19 
 
M1.43 32 ± 7 40 ± 24 18 ± 4 
M1.70  
18 ± 4 
 
18 ± 8 
 







16 ± 2 
 
19 ± 2 
 
14 ± 1 M2.05 
M2.07 
M2.17  
18 ± 2 
 
18 ± 1 
 




M2.47     
M2.57 20 ± 3 24 ± 3  
26 ± 4 
M2.74 14 ± 3 13 ± 2 16 
M2.97  
19 ± 2 
 
19 ± 1 
 




M3.09    
[35] 
M3.21  
18 ± 3 
 
16 ± 5 
 
18 ± 5 
M3.26-3.28 [35] 
M3.4-3.6 14 ± 6 16 ± 5  
 
 
21 ± 2 
 
24 M3.71  
25 ± 7 
 
25 ± 7 
M3.79 
M3.87 22 ± 5 24 ± 7  
34 
M3.97 21 ± 8  
M4.20    
Table 1: T2 relaxation times of macromolecular peaks from Publication 1 and from 
previous studies performed at other field strengths. The T2 relaxation times given with 
square brackets indicate that the values reached the maximum limits set in the FitAid 
software used for spectral fitting. The table is adapted from the MM consensus article57 
(co-author publication). 
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Estimating T1 relaxation times can help elucidate the exchange dynamics and can lead 
to spectral assignments. Previous literature reported T1 relaxation times of MMs in the 
human brain for MM spectra as a whole75, only for the non-overlapping MM peak at ~0.94 
ppm63,67,76 or for groups of MM peaks72. The T1 relaxation times of individual MM peaks 
are yet to be reported at any field strength in vivo. Therefore, the prime goal of this study 
is to report T1 relaxation times of individual MM peaks. 
Inversion recovery (IR) techniques are often utilized as a reliable method for acquiring 
MM spectra. This method exploits the difference in the T1 relaxation times between MMs 
and metabolites57. MM peaks are known to have faster T1 relaxation times compared to 
those of metabolites. In order to determine T1 relaxation times of MM peaks, it is 
necessary to suppress the metabolite signal while still sweeping through a range of 
magnetizations for the MM peaks. A range of longitudinal magnetization of MM peaks is 
necessary to plot the T1 relaxation curve. Even though single IR sequences are popular 
to acquire MM spectra, in the case of characterizing T1 relaxation times for all individual 
MM peaks a single IR technique would be a difficult choice due to eventual contribution 
from metabolites. More specifically, using a single IR technique would result in metabolite 
signal contaminating the inversion series MM spectra at most of the TIs; consequently, 
making it challenging to estimate the T1 relaxation times of most MM peaks with a 
sufficient range of longitudinal magnetization. As a result, a DIR technique was chosen 
for this study as it allowed flexibility for more consistent metabolite nulling while allowing 
for the observation of a range of different magnetizations of MM peaks simultaneously. 
Moreover, using a DIR technique proved to be advantageous as this approach is shown 
to be insensitive to inhomogeneity of the transmit field B1+. 
Depending on the chosen inversion time (TI) and repetition time (TR), the use of IR 
techniques results in a T1-weighting of the MM peaks. Therefore, it is likely that using T1- 
weighted MM spectra to account for MM contribution while fitting metabolite spectra will 
influence quantitative accuracy. This is because the metabolite spectra are typically 
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acquired without inversion pulses, and thus often also with a shorter TR. Hence, it is 
necessary to characterize the T1-relaxation behavior of the MM peaks for improved 
metabolite spectral fitting and accurate quantification of both MMs and metabolites. 
Study design 
 
Exhaustive Bloch simulations (section 1.1.6) assuming a single proton spin were 
performed in order to determine a range of longitudinal magnetization values for MM 
signals ranging from negative to positive MZ, which are required to calculate T1 relaxation 
times of the MM peaks. The magnetization vector (M(x,y,z)) was calculated for the actual 
inversion pulse shape implemented at the 9.4 T MRI scanner and the inversion times TI1 
and TI2 as depicted in the DIR scheme (Figure 12). The ratio of the available 
magnetization following a DIR block to the initial magnetization (MZ/M0) was calculated 
for the inversion pulse with a frequency offset ranging from -2000 to 2000 Hz, which is 
equal to the actual bandwidth of the pulse. 
For the Bloch simulations, T1 relaxation times of metabolites and MMs were considered 
from previous in vivo results at 9.4 T77 and at 7 T75 respectively. TI1/TI2 combinations were 
chosen such that the corresponding spectra had minimal metabolite residual while 
sweeping a range of longitudinal magnetizations for MM peaks. Finally, the resultant 
TI1/TI2 combinations were further tested in vivo to ensure good quality MM spectra with 
minimal residual metabolite contributions. 
Eleven healthy volunteers participated in the study. All measurements were performed 
on a 9.4T Siemens Magnetom whole-body MRI scanner using a home-built 8Tx/16Rx 
coil68. A 2 × 2 × 2 cm3 voxel was placed spanning the longitudinal fissure of the occipital 
lobe for GM measurements, and a voxel was placed within the left occipital-parietal 
transition for WM measurements. Second-order B0 shimming with FAST(EST)MAP69,78 




Figure 12: (Top) Schematic pulse sequence diagram of the double inversion recovery 
metabolite-cycled semiLASER localization. Eleven different combination of inversion 
times TI1/TI2 were employed to obtain a range of magnetization values for the MM peaks 
with almost nulled metabolite signal. (Bottom) GM- and WM-rich voxels in the occipital 
lobe and occipital-parietal transition respectively. The figure is adapted from Publication 
2. 
A DIR MC semiLASER59 (TE: 24 ms, TR: 8000 ms, averages per TI1/TI2 combination: 32, 
transmit reference frequency: 2.4 ppm) sequence was used to acquire MM data. 11 MM 
spectra were acquired per subject with 11 different TI1/TI2 combinations chosen (TI1/TI2: 
2360/625, 2150/600, 2000/575, 1900/550, 1800/525, 1050/238, 1300/80, 1200/20, 
1250/20, and 1300/20 ms). Additional unsuppressed water signals (averages: 16, 
transmit reference frequency: 4.7 ppm) were acquired without MC. All MM raw data were 
processed as described in Publication 2 and then the preprocessed spectra were fitted in 
LCModel (v6.3-1L)30 using CHSIMU simulated Voigt lines to fit 13 MM peaks. Tailored 
basis sets corresponding to each TI1/TI2 combination were established with adjusted 
phases to consider metabolite residuals. 
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The individual LCModel concentrations from all subjects sorted by TI1/TI2 combinations 
were fitted to the DIR signal equation 
 
𝑎 −𝑇𝐼2 𝑇𝐼1+𝑇𝐼2 








to determine T1 relaxation times for each of the MM peaks. The differences in T1 
relaxation times between GM- and WM-rich voxels were evaluated using Welch’s t-test 
(α = 0.05) for all 13 MM peaks. Adjusted P-values were calculated using the Bonferroni 
correction to account for multiple comparisons. 
Results 
 
Metabolite-nulled MM spectra were acquired from GM- and WM-rich voxels with the 11 
chosen TI1/TI2 combinations encompassing a range of magnetizations. All the spectral 
fits showed good quality with minimal fit residue, which lacked structured noise (Figure 
13). Figure 14 shows M0.92 peak amplitudes fitted to Equation 29. Figure 15 reports the 
T1 relaxation times of MM peaks from GM- and WM-rich voxels. Additionally, since T1 
relaxation times are mostly tissue-type but not brain region dependent, T1 relaxation times 
for pure GM- and WM-voxels are also reported assuming a linear relationship between 
T1 relaxation time and the contribution of tissue-type. 
The T1 relaxation times of MM peaks range from 204 to 510 ms and 253 to 564 ms in 
GM- and WM-rich voxels respectively. Significant differences in T1 relaxation times 
between GM- and WM-rich voxels are denoted in Figure 15 by an asterisk: *P<0.0038. 
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Figure 13: Spectral fitting of MM peaks in LCModel for DIR MM spectra (summed across 
all the healthy volunteers) with TI1/TI2: 2360/625 and 1300/20 ms. The figure is adapted 







Figure 14: A DIR series signal scatter plot for the M0.92 peak from a GM-rich voxel. Black 
crosses represent data points from eleven healthy volunteers and the dark blue dashed 
line is the fitted solution to DIR signal Equation 29. No data points were excluded for this 





Figure 15: The bar plots show calculated T1 relaxation times for 13 individual MM peaks 
in GM-pure, GM-rich, WM-rich, and WM-pure voxels. T1 relaxation times for MM peaks 
that have significant differences (P<0.0038) between GM- and WM-rich voxels from 
Welch’s t-test and Bonferroni corrections are indicated with an asterisk *. The figure is 
adapted from Publication 2. 
Discussion 
 
Although it is possible to estimate T1 relaxation times of the MM peaks using a single 
inversion recovery technique by simultaneously fitting metabolites, this approach may 
lead to wrong estimation in the concentration of MM peaks that are overlapped by the 
metabolite peaks. In contrast, the proposed DIR technique reduced metabolite residuals 
to a large extent at the expense of T1-weighting. 
Out of the eleven TI1/TI2 combinations chosen, five of them had negative MZ/M0 ranging 
from -0.82 to -0.58, and five of them had positive MZ/M0 ranging from 0.42 to 0.53 when 
assuming a T1 relaxation time of the whole MM spectrum of 420 ms as reported by Xin et 
al75 at 7 T. The range of magnetizations chosen was limited by the additional need to 
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suppress the metabolite signal. However, the chosen range appeared to be sufficient 
since the R2 of the T1 curve and low standard deviations in the T1 relaxation times of the 
MM peaks represented good confidence. The negative MZ/M0 points of M2.99, M3.62, and 
M3.75 had a higher signal amplitude which skewed the 3D signal fits thereby resulting in 
longer T1 relaxation times of these peaks. This might be due to lower weight metabolites 
contributing to MM resonance at these chemical shifts, which may have led to an 
overestimation of the respective T1 relaxation times. 
T1 relaxation times of MM peaks strongly increase with increasing field strength, which is 
in agreement with BPP theory57. Table 2 shows T1 relaxation times of MM peaks reported 
so far across various field strengths. 
The broad range of T1 relaxation times of MM peaks suggests that approximating these 
values as a single value for the entire MM spectrum may neither be ideal for quantifying 
the concentrations of MM peaks with high accuracy nor to consider MM contributions to 
metabolite spectra correctly. A linear relationship between T1 relaxation times and tissue 
type was assumed and the values for pure GM and WM voxels were calculated. Pure GM 
and WM T1 relaxation times can in a next step be utilized for correct modeling of MM 
contributions in voxels with arbitrary tissue composition which is especially useful in 
sequences with strong T1-weighting such as the FID-MRSI. 
Conclusion 
 
The demonstrated novel method to determine T1 relaxation times of MM peaks at 9.4 T 
is extendible to all field strengths. T1 relaxation times of 13 MM peaks in GM- and WM- 
rich voxels in the human brain at 9.4 T are reported for the first time. The calculated T1 
relaxation times were used in the quantification of MM peaks (section 1.2.3) and were a 
key in the development of the relaxation-corrected sequence-specific MM simulation 
model60. 
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B0 (T) 9.4 7 3 2.1 1.5 
Sequence DIR-MC-semiLASER IR-SPECIAL 
2DJ-IR 
MC-PRESS 
IR-3D ISIS IR-PRESS 
Echo Time (ms) 24 12 20 - 95 17 20 
Repetition Time 
(ms) 
8000 7500 3000 - 4000 4450 400-9000 
 
Region of Interest 











GM rich WM rich 

















420 ± 20 
290 250 ± 36 220 ± 60 


















200 ± 50 
M1.43 326 ± 21 270 ± 24 
M1.70 231 ±13 253 ± 17 225 






279 ± 8 
 
319 ± 9 
M2.07 
M2.17   
M2.27 281 ± 7 313 ± 9  
 
263 
M2.36   
M2.47 
M2.57 309 ± 20 327 ± 18 
M2.74 306 ± 19 383 ± 22 [400] 
M2.97  
463 ± 15 
 




M3.09    
[400] 
M3.21 204 ± 20 379 ± 29 
M3.26-3.28   [400] 
M3.4-3.6 510 ± 30 564 ± 35  
[400] M3.71 280 ± 24 434 ± 25 
M3.79   
M3.87 280 ± 27 307 ± 22  
347 
M3.97   
M4.20  
 
Table 2: T1 relaxation times of macromolecular peaks in the human brain from Publication 
2 and other studies performed at different field strengths. The values in brackets reached 
the maximum limits set in the FitAid software. The table is adapted from the MM 
consensus article57 (co-author publication). 
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Several clinical biomarkers exist based on the changes in metabolite concentrations for 
neurological pathologies. Calculating MM concentrations reliably and to be able to 
compare them across different vendors and sites will open a completely new possibility 
of establishing potential biomarkers for various diseases. For example, changes in 
concentrations of MMs have been reported previously in multiple sclerosis79, brain 
tumors80, and stroke81. 
Since inversion recovery techniques used to acquire MM spectra introduce a severe T1- 
weighting, it is essential to correct for the relaxation effects when estimating tissue 
concentrations of MM. Previous works have reported concentrations for some or all MM 
peaks without correcting for T1 or T2 relaxation times. Here in this section, the 
concentrations of MM peaks are reported for the first time after correcting for both spin- 
lattice and spin-spin relaxation effects using T1 relaxation times from Publication 2 and 




MP2RAGE images were acquired by using the home-built coil68 in volume mode and 
driving power to all 8 transmit channels. The high-resolution anatomical images were then 
segmented into GM, WM, and CSF tissue content with SPM1250. 
GM- and WM-rich voxels (2×2×2 cm3) were chosen in the occipital lobe and occipital- 
parietal transition respectively. Spectra were acquired using a DIR MC semiLASER 
sequence (TE/TR: 24/8000 ms) with TI1/TI2 = 2360/625 ms (Publication 2) since it 
corresponded to maximal MM signal retention and minimal metabolite residuals. Water 
reference spectra (TE/TR: 24/8000 ms) were acquired without MC. The acquired water 
spectra were used as internal reference. Spectral fitting was performed as described in 
section 1.2.2 using LCModel30 using simulated Voigt peaks for 13 MM peaks. 
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The LCModel MM concentrations were then corrected for tissue fractions and relaxation 
effects of both MM peaks and water as described in section 1.1.8. Using the calculated 
T1 relaxation times from Publication 2 (section 1.2.2) and 𝑇𝑒𝑓𝑓 relaxation times of MM 
peaks from Publication 1 (section 1.2.1), MM concentrations were quantified in protons 
mmol/kg48 in both GM- and WM-rich voxels using internal water reference. Wilcoxon rank- 
sum tests (𝛼 = 0.05) were performed to assess for different concentrations for all MM 
peaks between tissue types. 
Results 
 
The average tissue content in the voxels were calculated to be GM/WM/CSF = 72 ± 2 / 
22 ± 3 / 6 ± 4% and 35 ± 6 / 62 ± 7 / 3 ± 3% respectively. The concentrations of 13 MM 
peaks after correcting for tissue type specific water content and water and MM relaxation 
effects are reported in Figure 16 in protons per mmol/kg. M2.04 has the highest 
concentration with 78.4 ± 10.7 and 76.6 ± 10.9 protons per mmol/kg in GM- and WM-rich 
voxels respectively. 
 
Figure 16: Concentrations of MM peaks in GM- and WM-rich voxels are reported in 
protons mmol/kg. Black plus signs represent data points that were not within the 95% 
confidence interval when assuming a Gaussian distribution. The figure is adapted from 
Publication 2. 
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B0 (T) 9.4 3 9.4 3 7 
Sequence DIR MC semiLASER 
DIR 
semiLASER 
DIR MC semiLASER IR-semiLASER IR-semiLASER 
Echo Time (ms) 24 20.1 24 31 31 
Repetition Time 
(ms) 
8000 2000 10000 1559 3000 
Inversion Time(s) 
[ms] 
2360/625 920/330 2360/625 600 900 
T1 correction Yes No No No No 
T2 correction Yes Yes No No No 
Tissue fraction 
correction 




























M0.92 21.1 ± 3.3 21.0 ± 2.6 33.0 ± 4.1 8.31 7.05 ~ 16 ~ 15 
M1.21 8.2 ± 4.6 7.9 ± 2.2 6.8 ± 1.7 1.82 2.63 ~ 4 ~ 5 
M1.39 20.4 ± 5.3 12.6 ± 6.4 39.1 ± 15.1 5.48 5.97 ~ 15 ~ 14 
M1.67 48.0 ± 11.2 46.7 ± 12.6 63.5 ± 15.1 8.63 5.34 ~ 7 ~ 6 
M2.04 78.4 ± 10.7 76.6 ± 10.9 122.1 ± 33.1 11.31 11.56 ~ 18 ~ 19 
M2.26 50.4 ± 6.8 49.0 ± 7.9 43.5 ± 13.7 9.54 9.42 ~ 6 ~ 5 
M2.56 11.9 ± 2.0 13.0 ± 3.7  
- 
0.96 1.93 ~ 5 ~ 8 












M2.99 29.1 ± 3.0 34.7 ± 6.5 28.0 ± 6.1 3.97 3.89 
M3.21 10.0 ± 2.1 14.9 ± 4.6 17.2 ± 8.9 2.62 3.03 
M3.62 23.5 ± 8.1 23.5 ± 8.1  
57.0 ± 7.1 
1.10 1.23 
M3.75 4.8 ± 1.0 4.8 ± 1.0 3.34 3.66 
M3.86 11.8 ± 1.3 11.9 ± 2.3 0.83 1.36 
M3.87 
- - - 
7.59 7.00 
M4.20 1.83 1.70 
 
 
Table 3: Concentration of macromolecular peaks [mmol/kg] reported from previous 
studies73,82,83 is compared with the concentrations reported from Publication 2. 
Publication 2 has corrected for relaxation effects of the individual MM peaks whereas the 
other studies have not performed this correction. This leads to varying values of 
concentrations across different studies since the respective MM spectra have 






Since MM peaks are not yet assigned to specific proteins, peptides or amino acids, the 
number of protons contributing to each peak is unknown and hence not accountable. 
Therefore, the concentrations are reported with respect to each MM peak in protons per 
mmol/kg. Significant differences in concentration of M3.75 peak was found between GM- 
and WM-rich voxels. Nevertheless, future work with a larger number of datasets is 
required to claim statistical differences with higher certainty. 
Previous publications73,82,83 have reported the concentrations for some or all MM peaks 
without correcting either for T1 or T2 relaxation times or both. Since inversion recovery 
techniques used to measure the MM peaks introduce some T1-weighting of the MM 
spectrum and MM T2 relaxation times are short in comparison to TEs of the utilized 
sequences, not correcting for relaxation effects would result in differences in MM 
concentration estimates across sites. Therefore, they might not be directly comparable. 
The concentration values reported by Landheer et al73 appear to be somewhat in 
agreement with values from Publication 2; however, since Landheer et al73 did not correct 
for T1-weighting, there could be some discrepancy between the results. A comparison 
between the concentrations of MM peaks in the human brain reported from previous 
studies73,82,83 and this study is presented in Table 3. 
Conclusion 
 
The concentrations of 13 individual MM peaks in both GM- and WM-rich voxels are 
reported. The values are reported in protons × mmol/kg using internal water referencing 
after correcting for tissue type specific water and MM T1 and 𝑇𝑒𝑓𝑓 relaxation times. This 
is the first study to report the concentrations of MM peaks in the human brain after 
correcting for both T1 and 𝑇𝑒𝑓𝑓 relaxation times of the MM peaks. The importance of 
performing such a correction is illustrated as it enables easier comparison across sites, 
sequences, field strengths and vendors. 
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1.3 Quantification of metabolites 
 
MRS at UHF benefits from improved SNR, increase in frequency dispersion and more 
simplified spectral patterns from strong J-coupled systems13. This allows better detection 
of metabolites at UHF. Methodologies at UHF have underwent significant development in 
order to overcome the challenges that are posed by UHF such as B0 inhomogeneity, 
inhomogeneous B1+ and B1- (transmit and receive respectively) fields, shorter T2 
relaxation times and so on. 
Even though in NMR it is common to use both one-dimensional (1D) and two-dimensional 
(2D) spectroscopy techniques, the most commonly utilized method for in vivo 1H MRS is 
one-dimensional spectroscopy. This is because of the fact that the 2D MRS techniques, 
especially in vivo, have longer scan durations and they require more advanced post- 
processing and dedicated spectral fitting routines. On the other hand, 2D MRS techniques 
may hold advantages in terms of quantifying low concentration and J-coupled metabolites 
more reliably. 
This section of the thesis primarily aims at quantification of metabolite concentrations in 
the human brain at 9.4 T using both 1D (1.3.2) and 2D (1.3.3) MRS techniques and 
compare both approaches with each other. In addition, T2 relaxation times of metabolites 
are calculated in section 1.3.1 in order to facilitate correction for T2 relaxation times of 
metabolites in sections 1.3.2 and 1.3.3. 




As discussed in section 1.1.8, concentrations of metabolites are comparable across 
different field strengths, vendors or localization schemes after correcting for tissue fraction 
composition and for T1 and T2 relaxation effects of both water and metabolites. Therefore, 
in order to quantify metabolite concentrations at 9.4 T, the knowledge of T1 and T2 
relaxation times is essential. For this, T1 and T2 relaxation times of water in GM, WM and 
CSF at 9.4 T were considered from Hagberg et al49. T1 relaxation times of metabolites at 
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9.4 T were taken from Wright et al60,61 (co-author paper not a part of this thesis). T2 
relaxation times of metabolites at a given field strength, as mentioned in section 1.1.5, 
are not only tissue- and sequence-specific, but also specific to the brain region from where 
the values were measured11. Other than as a correction factor in the quantification of 
metabolites, the knowledge of T2 relaxation estimates are also helpful in optimizing the 
acquisition parameters for 2D MRS (section 1.3.3). Moreover, T2 relaxation times of 
metabolites have been observed to undergo changes in pathologies such as Alzheimer’s 
disease84. This section of the thesis focuses on calculating T2 relaxation times of 
metabolites in a GM-rich voxel in the occipital lobe from an echo-time series experiment 
using MC-semiLASER. The contribution of MM signal to the metabolite TE series was 
accounted for using the corresponding TE series of MM acquired in section 1.2.1. 
Study Design 
 
Eleven healthy volunteers participated in the study after providing written informed 
consent before the examination. The measurements were performed on a 9.4 T 
Magnetom whole-body MRI scanner using a home-built proton coil with 8 transmit and 16 
receive channels68. For the spectroscopy experiments, the coil was driven in surface 
mode with the three bottom channels using an unbalanced three-way Wilkinson splitter 
as described in Giapitzakis et al24. The metabolite-cycled semiLASER24 localization 
scheme was employed to acquire the 1D MRS data from a GM-rich voxel in the occipital 
lobe. For the calculation of the T2 relaxation times of metabolites, an echo time series of 
MC-semiLASER24 spectra (TE: 24, 32, 40, 52, and 60 ms; TR: 6000 ms; averages: 96; 
excitation frequency: 7.0 ppm) were acquired. 
Raw data were preprocessed with an in-house written software in MATLAB. The 
preprocessing steps are described in detail in Publication 1. Metabolite basis sets were 
simulated using Vespa33,85 (version 0.9.3) for the semiLASER sequence for real pulses. 
The following metabolites were included in the basis set: NAA, NAAG, GABA, Asp, Cr, 
Glu, Gln, GSH, GPC, Glyc, mI, Scy, Lac, PCr, PCho, PE, and Tau. The abbreviations of 
these metabolites are given in section 1.1.7. Also TE-specific MM spectrum (section 
1.2.1) were included in the corresponding basis sets. Finally, the data were fitted in 
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LCModel30 with the simulated basis set. The relative concentrations of metabolites 
obtained from LCModel for the TE series were fit to a mono-exponential decay. 
T2 relaxation times of metabolites were derived from the exponential decay curves. The 
mean coefficient of determination (R2) was calculated for the exponential fit. T2 relaxation 
times estimated from exponential fits that had R2 < 0.5 were discarded. Therefore, T2 




Figure 17: Echo time series spectra of metabolites (TE: 24, 32, 40, 52, and 60 ms) 
obtained using MC-semiLASER localization for determining T2 relaxation times of human 




Figure 17 shows the TE series of metabolite spectra from the GM-rich voxel in the 
occipital lobe. For TE = 32, 40, 52 and 60 ms, the J-evolution of Asp, Glu, mI, NAA(CH2), 
and Tau can be observed. Spectral fitting for TE = 24 ms is shown in Figure 18. 
The T2 relaxation times calculated from both individual data and summed data (across 11 
healthy volunteers) are shown as box plots in Figure 19. The T2 relaxation times are 
reported along with respective R2 values in Publication 1. The values range from 55 to 
105 ms, except for NAAG with ~40 ms. R2 values for all the reported metabolites were 





Figure 18: LCModel spectral fit of metabolite basis vectors simulated using Vespa to 




This study reported the T2 relaxation times of J-coupled metabolites at 9.4 T for the first 
time. The values of the T2 relaxation times of singlet resonances from a previous study at 
9.4 T8 are lower compared to the values reported in this study. The higher values in this 
work may be attributed to TE specific MM spectra included in the basis set for spectral 
fitting. It is known that the underlying MM spectra are faster decaying components whose 
presence could have caused shorter T2 relaxation values reported in the previous study 
at 9.4 T8. 
The T2 relaxation times of metabolites reported in this study followed the same trend 
compared to previous literature63,86–88 in terms of singlets such as NAA(CH3), tCho and 
tCr(CH3) having longer T2 relaxation times than tCr(CH2). NAAG has shorter T2 relaxation 
times compared to NAA moieties86. All the reported T2 relaxation times in this study 
followed the field strength trend, values decreasing with increasing field strength. T2 
relaxation time of Glu is higher than that of Gln86. However, the difference between the 
values was unexpected given that they have a similar distribution89 in the human brain 
and that they have similar molecular weight. Therefore, most likely the T2 relaxation time 
of Gln was underestimated in this study. 
 
 
Figure 19: T2 relaxation times of metabolites are reported in ms for metabolites in box 




T2 relaxation times of 12 metabolites and metabolite moieties are reported for a GM-rich 
voxel in the occipital lobe at 9.4 T. The T2 relaxation times ranged from 40 to 110 ms and 
are in line with the prediction of a decrease in T2 relaxation times with increasing field 
strength. These values were further used in the correction factor for quantification of 
metabolite concentrations in sections 1.3.2 and 1.3.3. 




Quantitative investigation of metabolite profiles in the human brain using 1H MRS 
techniques have shown to aid clinical management of several brain pathologies90. 
Utilizing the advantages of UHF, non-invasive detection of up to 20 metabolites is 
possible using robust MRS acquisition methods13. Therefore, measuring the 
neurochemical profile of the human brain at UHF may help the neuroscientific and clinical 
research communities understand the disease mechanisms. This section focuses on the 
quantification of metabolite concentrations in the human brain using 1D MRS acquisition 
technique (MC-semiLASER) at 9.4T. 
Study design 
 
The experimental set up for this study was similar to the study design in section 1.3.1. 
For the quantification of metabolite concentrations, metabolite spectra were acquired with 
TE/TR: 24/6000 ms using MC-semiLASER24 localization (averages: 32; excitation 
frequency: 2.4 ppm). In addition, unsuppressed water spectra (averages: 16; excitation 
frequency: 4.7 ppm) were acquired in order to quantify metabolite concentrations based 
on internal water signal. 
Spectral fitting was performed in LCModel using a simulated basis set from Vespa. Same 
metabolites that were listed in section 1.3.1 were included here. 
The high-resolution MP2RAGE91 images (resolution: 0.6 mm3) were segmented using 
SPM1250 and the tissue compositions of the GM-rich voxels were calculated as GM: 
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32.9% ± 9.3%, WM: 64.7% ± 11.1%, and CSF: 2.4% ± 3.7%. The concentrations of the 
metabolites were then calculated using the formula given by Gasparovic et al48 (section 
1.1.8) including the relaxation time corrections for both water91 and metabolites. For the 
quantification of metabolite concentrations, knowledge of relaxation times are necessary 
in order to correct for the T1 and T2 weighting in the MRS spectrum. T1 relaxation times 
of metabolites were used from Wright et al61 and T2 relaxation times calculated in section 




Good spectral quality was achieved for all data and therefore, no data sets were excluded 
from further analysis. 
The calculated concentrations of metabolites with and without T2 correction are shown in 
Figure 20 for a fair comparison between this work and other studies, since some of those 
studies did not include a T2 correction. Additionally, a consolidated comparison of 
concentrations of metabolites in mmol/kg was presented in a table in Publication 1. 
Discussion 
 
Corresponding MM spectra were included for each subject to account for the MM 
contribution in the metabolite spectrum. The residual tCr(CH2) metabolite peak at 3.925 
ppm was subtracted from the MM spectra before including the MM spectra in the basis 
set. 
Previous metabolite quantification study24 at 9.4 T using MC- semiLASER reported 
concentrations for 18 metabolites. However, the basis set was simulated assuming a a 
simple spin-echo sequence with TE: 6.5 ms due to the complex nature of the adiabatic 
pulses and their spin-locking effect10. This study included real adiabatic RF pulse shapes 
while simulating the basis set. The J-evolution pattern in the spectral data was mimicked 
well by the basis set both in this study and for the TE series basis sets that were simulated 
in section 1.3.1. 
Mean T2 relaxation times from all metabolites were used for correcting the concentrations 
of GABA, PE, and Scy as R2 < 0.5 for the T2 exponential curve fits in the previous section 
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1.3.1.NAA, Cr, tCho, PE, Tau, GABA, and mI concentrations with T2 correction agree with 
previous literature77,87,92–94. However, Asp, Gln, Glyc, and Glu concentrations were 
significantly higher with T2 correction. When considered without T2 correction, the 
concentration values match with prvious literature for these metabolites. These 
discrepancies could have aroused because of the underestimated T2 relaxation times of 
these metabolites. Particularly, the spline baseline behavior near the Gln chemical shift 
was negative, and this could not be compensated even when the stiffness factor 
DKNTMN in LCModel was set to 0.25. Therefore, there is a possibility of higher estimation 
of Gn concentrations. In addition, the T1-weighting acquired in the DIR MM spectra 
(section 1.2.2) could also have influenced the concentration differences in some of these 
metabolites. The consolidated concentration comparison table provided in Publication 1 
also described the relaxation corrections included in the previous literature, the sequence 
and the acquisition parameters considered77,87,92–94. 
 
Figure 20: Metabolite concentration box plots are shown here in mmol/kg with and 




The concentration values of metabolites measured in a GM-rich voxel in the occipital lobe 
are reported in mmol/kg both with and without T2 correction. Most of the metabolite 
concentrations matched with previous literature with T2 correction while some of the 
metabolite concentrations (Asp, Gln, Glyc and Glu) were higher compared to previous 
literature while including T2 correction. 




The NMR community has used the technique of multi-dimensional spectroscopy in order 
to reduce spectral overlap of peaks. Homonuclear two-dimensional techniques are also 
utilized in vivo and show promising results in detection and quantification of low SNR and 
J-coupled metabolite concentrations. Spectral acquisitions using correlation 
spectroscopy and J-resolved spectroscopy were shown to be feasible in vivo in humans 
at 1.5, 3 and 7 T36–38. The 2D techniques in vivo have longer scan durations and require 
sophisticated pre-processing and spectral fitting routines. 
The detection capabilities are enhanced in 2D J-resolved spectroscopy7 by spreading the 
spectral information into two dimensions by adding a step-wise increasing J-evolution 
delay during acquisition. In order to further improve the detection sensitivity, maximum 
echo sampling 7,95,96 is used where the data acquisition begins right after the final crusher 
gradients. This adds a tilt to the peak tails thereby further reducing spectral overlap7. 
This study shows the implementation of a 2D J-resolved MC-semiLASER sequence with 
a maximum echo sampling scheme at 9.4 T for human brain application and quantifies 
metabolite concentrations using ProFit v2.097, a dedicated 2D spectral fitting tool. In 




Initially phantom measurements were performed in order to test the implementation of the 
2D J-resolved MC-semiLASER sequence (Figure 21) and to optimize the sequence 
parameters. 
2D metabolite spectra were then acquired from eleven healthy volunteers. Five healthy 
volunteers returned for the acquisition of 2D MM spectra. J-resolved MC-semiLASER with 
maximum echo sampling scheme (TR: 6000 ms, n: 85, ∆t: 2ms, averages per TE: 8, 
transmit reference frequency: 2.4 ppm) acquisition was performed after second-order B0 
shimming69 and voxel-based power calibration70,78. The encoding of the J-evolution in the 
second (indirect) dimension was created by inserting an incrementally increasing time 
delay of ∆t/2 between the last pair of AFP pulses. TEs ranged from 24 to 194 ms 
incremented in steps of 2 ms. The MC pulse was turned off for the acquisition of 2D water 




Figure 21: Sequence diagram of J-resolved MC-semiLASER sequence is shown. The 
first two RF pulses are turned on for double inversion recovery in order to acquire a MM 
spectrum with two inversion times TI1/TI2 set as 2360/625 ms. They are turned off when 
acquiring the metabolite spectrum. The increasing J-evolution delay which corresponds 
to a progressively longer TE time is introduced between the last two AFP pulses in the 
sequence. Maximum echo sampling is implemented by beginning data acquisition right 
after the final set of crusher gradients after the last AFP pulse. The figure is adapted from 
Publication 3. 
58  
MM spectra were acquired with DIR59 (TI1/TI2: 2360/625 ms) J-resolved MC semiLASER 
sequence with all acquisition parameters set identical to metabolite spectra except TR 
set to 8000 ms. 
Raw data were pre-processed as described in Publication 3 using an in-house MATLAB 
tool and J-resolved spectroscopy pre-processing tool which is a part of ProFit 
software97,98 package. MP2RAGE91 images were segmented into GM, WM and CSF 
tissue fractions using SPM1250 in order to calculate the tissue composition specific tissue 
water content and metabolite and water relaxation correction factors during quantification 
of metabolite concentrations using internal water referencing (see section 1.1.8.). 
Metabolite basis vectors (NAA, NAAG, GABA, Asp, Cr, Glu, Gln, Glc, GSH, GPC, Glyc, 
mI, Scyllo, Lac, PCr, PCho, PE and Tau) corresponding to 85 TE steps were simulated 
using Vespa33 for the semiLASER sequence including real pulse shapes and sequence 
timings. All the 85 1D MRS basis sets were combined to form a 2D J-resolved MRS basis 
set. In addition, the summed MM spectrum from five healthy volunteers was also included 
in the 2D basis set. 
As a next step, the 2D basis set were fitted to each of the metabolite spectra using ProFit 
2.097. Finally, metabolite concentrations were quantified in mmol/kg after the peak 
amplitudes obtained from the fitting software were referenced against the internal water 




Figure 22 shows a metabolite spectrum acquired from a phantom with brain metabolites. 
There are no prominent artifacts due to truncation or t1 noise in the indirect dimension. 
Also no visible J-refocused38,99 peaks are seen. A representative 2D metabolite spectrum 
from a GM-rich voxel in the human occipital lobe (average content: GM/WM/CSF: 67 ± 8/ 




Figure 22: Phantom spectrum acquired using the developed 2D J-resolved MC 
semiLASER sequence. To the right, zoomed in view of the lactate doublet present at 1.3 
ppm is shown. The yellow arrows indicate the J-resolved peaks. The figure is adapted 




Figure 23: 2D J-resolved MC-semiLASER spectrum from a representative volunteer is 
shown with labeled metabolite peaks. The direct f2 dimension has the chemical shift 
information and the indirect f1 dimension has the J-coupling information. The figure inlay 
shows an anatomical MP2RAGE image with a gray matter rich voxel of interest in the 
occipital lobe. The figure is adapted from Publication 3. 
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Spectral fitting of the 2D metabolite spectrum using ProFit 2.097 (Figure 24) yielded a 
minimum residual and demonstrate good agreement between model and experimental 
data. Finally, the metabolite concentration values after correcting for relaxation effects 
and tissue composition48 are shown in bar plots in Figure 25. The bar plots aim at 
comparing the concentrations from this study and other recent 1D MRS studies at 
UHF8,60,61,87,100,101. 
 
Figure 24: Spectral fitting result for a representative in vivo 2D spectrum using ProFit 2.0. 
Top to bottom 2D MRS data, spectral fit and residue are shown. Minimum residual without 
any structured noise is achieved indicating that the tailored 2D basis set (simulated for 16 
metabolites on Vespa including real pulses, sequence timings and experimentally 






Figure 25: Bar plots showing concentration of metabolites from this study and other 
recent 1D MRS studies8,60,61,87,100,101 at UHF from a similar voxel location in the occipital 
lobe. The concentration values shown here are the mean and standard deviation of the 




Edden et al99 showed that the chemical shift displacement effect causes spatially 
dependent differences in J-evolution of coupled spin systems for JPRESS spectra using 
both simulation and experimental methods at 3 and 7 T. This in turn can result in 
additional J-refocused peaks along the f1 = 0 axis. The appearance of these unwanted 
additional peaks cause a loss of intensity in J-resolved peaks and more spectral overlap. 
Later Lin et al38 demonstrated that the use of higher bandwidth pulses reduced the 







where ∆𝛿 is the chemical shift difference in ppm of the spins A and X in an AX spin system, 
𝐵0 is the frequency of the static magnetic field in MHz and 𝐵𝑊 is the bandwidth of the 
refocusing pulse. For the most separated lactate coupled peaks in upfield, the reduction 
in the intensity of the J-refocused peaks calculated is 86%. Therefore, it can be seen from 
Figure 22 that there are barely any J-refocused peaks present in the 2D spectrum. 
Furthermore, this study reports the concentration of 16 metabolites in mmol/kg after 
correcting for relaxation effects and tissue content. Figure 25 compares the reported 
concentration from this study to concentration values from previous 1D MRS 
studies8,60,61,87,100,101 at UHF for similarly located voxels in the occipital lobe. It can be 
observed from the figure that all the concentration values reported in this study lie within 
the range of values that were reported in previous studies except mI. The higher 
concentration of mI could possibly be due to a possible oppositely phased residual mI in 
the MM spectra as shown in a previous study (Publication 2). While removal of metabolite 
residuals is easier in 1D MRS, it is more complicated in 2D MRS especially with maximum 
echo sampling. Therefore, removal of metabolite residuals in the experimentally acquired 
2D MM spectra or avoiding metabolite residuals using a relaxation-corrected sequence- 
specific MM simulation model60 is necessary in the future for accurate estimation of mI 
concentration. For Asp, GABA, and Gln, the concentration values from this study are 
closer to previous literature8,87,101 compared to values from 1D MRS studies60,61,100 at 9.4 
T. In addition, Glc and Lac are quantifiable with 2D MRS at 9.4T, while quantification of 
concentrations of these metabolites remains challenging with 1D MRS even at 9.4 
T60,61,100. Statistical analysis was also performed to compare the 1D and 2D MRS 
acquisition techniques (Publication 3). 
Not only the 2D metabolite spectrum show J-resolved peaks, but also the 2D MM 
spectrum and the 2D downfield spectrum show some well-resolved peaks. Given the 
efforts to assign MM and DF resonances to amino acids and metabolites, the 2D J- 
resolved acquisition technique may prove useful in assigning these peaks. Therefore, 
despite the longer scan durations of 2D MRS acquisition techniques at UHF, this may still 
be a good option to answer some open basic science questions in the field of MRS and 
brain metabolism. Open research questions include assigning unlabeled peaks in the DF 
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part of the spectrum, understanding the J-coupling behavior of MM peaks and aid 
assignment to amino acids, or in quantifying lower SNR J-coupled metabolite 
concentrations that are of importance in the brain energy metabolism in the healthy brain 
or in pathologies. 
Conclusion 
 
A two-dimensional J-resolved MC-semiLASER acquisition sequence with maximum echo 
sampling was implemented at 9.4 T. The concentration values of 16 metabolites in a GM- 
rich voxel in the occipital lobe are reported. Quantification of lower SNR and J-coupled 
metabolite concentrations such as Asp, GABA, Gln, Glc, and Lac was possible. The 2D 
MRS acquisition may prove beneficial to assign so far unlabeled downfield peaks 
between ~5.5 to 10.0 ppm, to understand the J-coupling behavior and the overlap of MM 
peaks, and for detection and quantification of lower SNR J-coupled metabolite 
concentrations such as Glc, and Glyc which are otherwise hard to assess. 
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1.4 Summary and Outlook 
 
Extensive information about the neurochemical profile in the human brain can be obtained 
using in vivo 1H MRS acquisition techniques. Therefore, MRS has steadily made its way 
as a key tool in the fields of neuroscience research and clinical diagnostics of brain 
disorders. In this thesis, characterization and quantification of concentrations and 
relaxation times of macromolecules and metabolites in the human brain using single voxel 
1H MRS at 9.4 T is presented. 
There is very limited knowledge about the broad macromolecular resonances and several 
of their properties are yet to be thoroughly investigated. In view of this, a recent consensus 
article57 on MRS visible macromolecules stressed the importance of studying the 
relaxation properties of the individual macromolecular peaks at various field strengths. As 
a first step towards this suggestion, this thesis achieved characterizing T1 and T2 
relaxation times of individual macromolecular peaks at 9.4 T. In fact, the novel method 
proposed to determine the T1 relaxation times of macromolecular peaks is extendible to 
all field strengths. The calculated T1 and T2 relaxation times of MM peaks were also 
discussed in the context of other studies performed at different field strengths. 
The quantitative linewidth analysis of the MM peaks aided better understanding of the 
contribution to the residual linewidths of the MM peaks. Unlike the metabolite singlets 
whose linewidths were explainable by T2 relaxation contribution and B0 effects, the 
broader linewidths of the MM peaks were not explainable by T2 relaxation contribution 
and B0 effects alone. Therefore, it was concluded that the residual linewidth originated 
either from J-evolution effects or from spectral overlap of MM resonances that could 
originate from amino acids of the cytosolic protein. Depending on the large protein 
structure amino acids belong to, they can have different chemical shifts. However, these 
chemical shifts are distributed around a main resonance frequency for the bulk of 
proteins. This motivated fitting of macromolecular spectra to histograms of amino acids 
given in the Biological Magnetic Resonance Bank BMRB102 (co-author abstract not a part 
of this thesis)74. The preliminary fits showed promising results with amino acids fitting 
model representing the MM spectra. Further development of a better spectral fitting model 
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of amino acids to MM peaks may allow characterization and quantification of amino acids 
from the MM spectra. This might also potentially help assign some of the unlabeled peaks 
in the downfield part of the proton spectrum to amino acids74,102 and characterize the 
downfield peaks better103 (co-author paper not a part of this thesis). Furthermore, the 
measured T1 and T2 relaxation times of macromolecules enabled T1- and T2-weighting 
corrections during quantification of these peaks. This, in turn, makes the concentration of 
the macromolecular peaks comparable across field strengths, vendors or sites opening a 
new possibility for potential clinical biomarkers for neurological diseases. 
All the more, utilizing the T1 and T2 relaxation times of MM peaks as prior knowledge, a 
relaxation-corrected sequence-specific MM simulation model60 (co-author paper not a 
part of this thesis) was constructed. This MM simulation model helps tackle some of the 
major challenges regarding the acquisition of MM spectra such as saving scan time in 
clinical applications or enable correct handling of MM in presence of short TR and TE 
magnetic resonance spectroscopic imaging89,104 acquisitions. 
Quantification of metabolite concentrations in mmol/kg was performed using one- 
dimensional MC-semiLASER acquisition at 9.4 T. T2 relaxation times of metabolites were 
also reported which enabled T2-weighting correction for quantification of metabolite 
concentrations. 
Two-dimensional J-resolved MC-semiLASER acquisition method with maximum echo 
sampling was introduced and optimized at 9.4 T. It is seen as a good candidate for studies 
that aim at understanding the J-coupling and overlap in the macromolecular spectrum, 
assigning unlabeled downfield resonances or reliably quantifying J-coupled and lower 
SNR metabolite concentrations to understand changes in the energy metabolism in the 
healthy brain and in brain pathologies. The two-dimensional J-resolved semiLASER 
sequence was also optimized for 3 T105 (own conference abstract) and is currently used 
in a clinical psychiatry study involving major depression disorder patients for a 
collaboration project during the course of my PhD. This also shows a potential clinical 
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4 Statement of Contributions 
 
4.1 T2 relaxation times of macromolecules and metabolites in the human 
brain at 9.4 T 
 
T2 relaxation times of individual macromolecular peaks at 9.4 T are reported for GM- and 
WM-rich voxels. Furthermore, the contribution of T2 relaxation times and B0 components 
to the linewidth of the macromolecular peaks are quantitatively analyzed in this work. 
Metabolite T2 relaxation times are estimated in a GM-rich voxel in the occipital lobe. The 
obtained T2 relaxation times were used as a correction factor, and fitted concentration 
values were corrected for tissue content and relaxation effects of both metabolites and 
water. The concentration of the metabolites are reported in mmol/kg. 
 S. Murali-Manohar – Had the scientific idea to calculate T2 relaxation times of 
macromolecules and metabolites. Set up the experiment, recruited volunteers and 
acquired in vivo data. Contributed in data analysis and data interpretation. Wrote 
majority of the manuscript. 
 T. Borbath – Had the scientific idea of quantitatively analyzing the linewidth 
contributions to the macromolecular peaks. Simulated basis sets, and performed 
spectral fitting and quantification. Wrote parts of the manuscript. 
 A.M. Wright – Reconstructed the anatomical images and performed tissue 
segmentation. Proofread the manuscript. 
 B. Soher – Provided simulation code for semiLASER in VesPA software. 
 R. Mekle – Provided the code for voxel-based power optimization. Proofread the 
manuscript. 
 A. Henning – Supervised the project. Advised on the manuscript and proofread it. 
 
4.2 A novel method to measure T1-relaxation times of macromolecules and 
quantification of the macromolecular resonances 
 
A novel double inversion recovery method is proposed to determine the T1 relaxation 
times of 13 individual macromolecular peaks. Bloch simulations were performed to 
optimize inversion times for the double inversion recovery series. The fitted 
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concentrations of the individual macromolecule peaks from the double inversion series 
data were used to calculate the T1 relaxation times. T1 relaxation times are reported for 
both GM- and WM-rich voxels at 9.4 T. The proposed method is extendible to all field 
strengths. In addition, macromolecular concentrations in protons×mmol/kg are reported 
after correcting for relaxation effects and tissue content. 
 S. Murali-Manohar – Wrote Bloch simulation script for double inversion recovery. 
Performed Bloch simulations and optimized sequence parameters. Acquired in 
vivo data at 9.4 T. Pre-processed the acquired data. Set up the spectral fitting 
pipeline and fit the MM data. Wrote parts of the manuscript. 
 A.M. Wright – Performed Bloch simulations and optimized sequence parameters. 
Collected in vivo data at 9.4 T. Reconstructed the anatomical images and 
performed tissue segmentation. Wrote scripts to calculate T1 relaxation times and 
quantification. Wrote parts of the manuscript. 
 T. Borbath – Provided ideas for fitting. Proofread the manuscript. 
 N. Avdievich – Provided the RF coil for 9.4 T. 
 A. Henning – Provided ideas for the methodology and supervised the project. 
Advised on the manuscript and proofread it. 
4.3 Quantitative two-dimensional J-resolved metabolite-cycled semiLASER 
at 9.4 T in the human brain 
 
Two-dimensional J-resolved MC semiLASER pulse sequence is implemented for the first 
time at 9.4 T. The metabolite concentration values in gray matter rich voxel in the occipital 
lobe were reported in mmol/kg after correction for tissue content and relaxation effects. 
Quantification of 2D MRS data was performed and the values were compared against 
previous quantification results from 1D data. 
 S. Murali-Manohar – Developed the pulse sequence and implemented it on the 
9.4 T MRI scanner. Tested the sequence with phantom experiments and optimized 
the sequence parameters. Acquired single voxel MRS data in vivo. Pre-processed 
the acquired MRS data. Simulated basis sets for fitting and established the post- 
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processing pipeline for 2D proton spectra. Performed spectral fitting of the 2D data. 
Analyzed the data. Wrote the manuscript. 
 T. Borbath – Provided ideas for 2D spectral fitting. 
 A.M. Wright – Reconstructed the anatomical images and performed tissue 
segmentation. 
 N. Avdievich – Provided the RF coil for 9.4 T. 
 A. Henning – Supervised the project and provided ideas for fitting and comparison 
of the 1D vs. 2D data sets. Advised on the manuscript and proofread it. 
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Purpose: Relaxation times can contribute to spectral assignment. In this study, 
effective T relaxation times ( 2 T   ) of macromolecules are reported for gray and white 
eff 
2 
matter–rich voxels in the human brain at 9.4 T. The T of macromolecules are help- 
eff 
2 
ful to understand their behavior and the effect they have on metabolite quantification. 
Additionally, for absolute quantification of metabolites with magnetic resonance 
spectroscopy, appropriate T2 values of metabolites must be considered. The T2 relax- 
ation times of metabolites are calculated after accounting for TE/sequence-specific 
macromolecular baselines. 
Methods: Macromolecular and metabolite spectra for a series of TEs were acquired 
at 9.4 T using double inversion–recovery metabolite-cycled semi-LASER and 
metabolite-cycled semi-LASER, respectively. The T2 relaxation times were cal- 
culated by fitting the LCModel relative amplitudes of macromolecular peaks and 
metabolites to a mono-exponential decay across the TE series. Furthermore, absolute 
concentrations of metabolites were calculated using the estimated relaxation times 
and internal water as reference. 
Results: The T of macromolecules are reported, which range from 13 ms to 
eff 
2 
40 ms, whereas, for metabolites, they range from 40 ms to 110 ms. Both macro- 
molecular and metabolite T2 relaxation times are observed to follow the decreasing 
trend, with increasing B0. The linewidths of metabolite singlets can be fully attrib- 
uted to T2 and B0 components. However, in addition to these components, macro- 
molecule linewidths have contributions from J-coupling and overlapping resonances. 
 
2 
Conclusion: The T2 relaxation times of all macromolecular and metabolite peaks at 
9.4 T in vivo are reported for the first time. Metabolite relaxation times were used to 
calculate the absolute metabolite concentrations. 
K E Y W O R D S   
absolute quantification, macromolecules, MR spectroscopy, T2 relaxation time, ultrahigh magnetic field 
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1 | INTRODUCTION  
Single-voxel proton MRS, a noninvasive technique, has com- 
plemented MRI by providing a means to detect and quan- 
tify concentrations of metabolites in the human brain. This 
has proven clinically useful, as shown in the review paper by 
Öz et al,
1 
in establishing biomarkers for pathologies in the brain. 
Advantages of MRS using ultrahigh-field scanners (≥7 T) 
include higher SNR and increased spectral resolution.
2 
Hence, the macromolecular background signal (MMB) lying 
underneath the metabolites has to be characterized more pre- 
cisely. Especially for short TE sequences, reliable metabolite 
quantification is more challenging without accounting for the 
MMB. Therefore, a measured macromolecular (MM) spec- 
trum should be included in the fitting model.
3 
In addition, 
understanding macromolecules may help to identify valuable 
biomarkers for pathologies and several diseases of clinical 
relevance.
3-6 
The T2 relaxation times of MM peaks have 
been reported in previous studies in rat brain
7-10 
and for the 
M0.92 peak in human brain at 2.1 T by Behar et al.
11 
However, 
T2 relaxation times of multiple individual MM peaks in 
human brain have not been reported to the best of our knowl- 
edge. Estimating the T2 relaxation times of individual macro- 




To derive absolute concentrations of metabolites in MRS, 
several different approaches exist.
13-15 
In one method, the 
unsuppressed internal water signal is used as a reference.
16 
However, the calculation of absolute concentrations from the 
apparent concentrations output by a quantification software 
requires a correction factor, which includes the T2 relaxation 
times of the metabolites of interest.
16 
In addition, to record 
2D-MRS data, it is useful to have a rough estimate of T2 re- 
laxation times to optimize TE range, such that one obtains the 
highest possible SNR.
17,18 
Additionally, altered T2 relaxation 




Several studies have reported the T2 relaxation time for 
metabolites in different regions of the human brain for a 
range of magnetic field strengths.
20-22 
The T2 relaxation times 
were measured at 9.4 T for singlets, but not for J-coupled me- 
tabolites by Deelchand et al
23
; however, this study did not 
consider the influence of T2-dependent MM spectra, which 
affects the T2 relaxation estimation of the singlets. 
 
The primary goal of this study was to measure the effec- 
tive T2 relaxation times (Teff ) of MM peaks, which includes 
both relaxation and J-evolution effects, in a gray matter 
(GM)-rich and a white matter (WM)-rich voxel at 9.4 T in 
human brain. In addition, T2 relaxation times of singlets and 
J-coupled metabolites in the GM-rich voxel were calculated 
after correcting for TE-specific MMBs. Furthermore, abso- 
lute concentrations of metabolites are reported after correct- 
ing for the corresponding T2 and T1 relaxation times.
24 
The 
FWHM (Δv1∕2) of MM peaks and metabolites were analyzed 
quantitatively with respect to T2 relaxation times, in addition 
to microsusceptibility and macrosusceptibility effects. 
 
2 | METHODS  
2.1 | Technical description and subjects 
All measurements were performed on a 9.4 T Magnetom 
whole-body MRI scanner (Siemens Healthineers, Erlangen, 
Germany) using a home-built proton coil with 8 transmit and 
16 receive channels.
25 
For single-voxel spectroscopy experi- 
ments, 3 channels at the bottom of the coil were driven using 
an unbalanced three-way Wilkinson splitter as previously 
described.
26 
Eleven healthy volunteers (8 males, 3 females, 
age: 26.3 ± 2.8 years) participated in this study for data ac- 
quisition in the GM-rich voxel. Data for the WM-rich voxels 
was acquired from 5 healthy volunteers (3 males, 2 females, 
age: 27.8 ± 1.9 years). The study was approved by the local 
ethics board, and written informed consent was given by all 
subjects before the examination. 
 
2.2 | Data acquisition 
Gradient-echo images were acquired using a 2D-FLASH 
sequence (in-plane resolution: 0.7 × 0.7 mm
2
, 3.5-mm slice 
thickness, flip angle: 25º) along axial and sagittal orientations 
to facilitate placement of the spectroscopy voxel. A GM-rich 
voxel with the dimensions of 2 × 2 × 2 cm
3 
was chosen in the 
occipital lobe for T2 measurement of metabolites, whereas 
in addition to the GM-rich voxel, a WM-rich voxel of the 
same size was chosen in the occipital–parietal transition for 
T2 measurement of MM peaks. First-order and second-order 
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Macromolecule This work   
This work 𝚫n1∕2  (Hz)  
Lopez-Kolkovsky et al 2016
7      
Pfeuffer et al 1999
8     
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TABLE 1 Chemical shifts of the modeled MM peaks 
 
 
name δ (ppm) Gray matter White matter δ (ppm) δ (ppm) δ (ppm) 
M0.92 0.916 39.03 ± 4.70 41.87 ± 4.09 0.87 0.916 0.94 
    0.94   
M1.21 1.21 40.59 ± 5.53 38.67 ± 6.24 1.20 1.21 1.22 
M1.39 1.39 43.75 ± 6.23 42.92 ± 5.67 1.39 1.39 1.43 
M1.67 1.67 58.33 ± 8.10 58.33 ± 8.19 1.67 1.67 1.69 
    1.81   
M2.04 2.04 59.28 ± 7.42 58.04 ± 7.30 1.91 2.04 2.04 
    1.93   
    2.04   
    2.13   
M2.26 2.26 62.73 ± 5.59 59.89 ± 5.04 2.26 2.26 2.27 
— —   2.36   
— —   2.46   
— —   2.51   
M2.56 2.56 49.09 ± 2.93 47.46 ± 1.98 2.56 
 2.57 
M2.70 2.70 32.07 ± 2.37 31.80 ± 1.96 2.68 
 2.74 
    2.74   
M2.99 2.99 49.70 ± 1.53 49.28 ± 1.44 2.97 2.99 3.01 
    3.02   
M3.21 3.21 71.81 ± 0.83 71.76 ± 0.84 3.09 
  
    3.22 3.21 3.21 
    3.28   
— — — — 3.54   
M3.62 3.62 44.52 ± 0.65 44.21 ± 0.68 3.62 
 3.71 
M3.75 3.75 35.40 ± 0.49 35.20 ± 0.56 3.75 3.77 3.79 
M3.86 3.86 35.08 ± 2.05 34.79 ± 1.17 3.86 
 3.85 
M4.03 4.03 37.90 ± 0.90 37.53 ± 0.64 3.95 
 3.87 
    4.05   
— — — — 4.17  4.20 
    4.26 4.29  
    4.33  — 
    4.42   
Note: The chemical shifts (in parts per million) of MM peaks modeled with Voigt lines from this work compared with studies on rat brain at 17.2 T,
7 
rat brain at 
9. 4 T,
8 
and human brain at 9.4 T.
30 
The measured FWHM (Δv1∕2) of the MM peaks from this work is also reported. 
 
B0 shimming was performed using FAST(EST)MAP,
27 
and 
then voxel-based power calibration
28,29 
was executed. 
Double inversion recovery (DIR) metabolite-cycled 
semi-LASER
30 
and metabolite-cycled (MC) semi-LASER
26
 
A series of DIR-MC semi-LASER spectra at different non- 
linearly spaced TEs (TE = 24 ms, 32 ms, 40 ms, 52 ms, and 60 
ms; TI1/TI2 = 2360/625 ms; number of excitations = 32; trans- 
mit reference frequency ( ref ) = 2.4 ppm) was acquired to esti- 
spectra were acquired in the same 11 healthy volunteers. mate the Teff of macromolecules. Setting ref to 2.4 ppm led to 
The TR was set to 10 seconds in the case of DIR-MC semi- 
LASER, and to 6 seconds for the MC semi-LASER, respec- 
tively, to ensure complete T1 recovery of MM resonances and 
metabolites.
31 
A 16-step phase-cycling scheme
32 
was imple- 
mented for both spectroscopy sequences. 
maximum chemical shift displacement effects of −11.5% for 
water and +2% for the acetyl moiety of NAA(CH3) due to the 
large bandwidths of the corresponding RF pulses (excitation 
pulse and Adiabatic Full Passage pulse bandwidth of 8 kHz, 




MURALI-MANOHAR ET AL.  
 
To calculate the T2 relaxation times of metabolites, a 
series of MC semi-LASER spectra at different nonlinearly 
spaced TEs (TE = 24 ms, 32 ms, 40 ms, 52 ms, and 60 ms; 
number of excitations = 96; ref = 7.0 ppm) was acquired, 
originally measured to characterize the T2 relaxation times 
of downfield metabolites/resonances in the same healthy vol- 
unteers.
33 
Setting ref to 7.0 ppm led to maximum chemical- 
shift displacement effects of +11.5% for water and +25% for 
NAA(CH3). 
In this study, for absolute quantification of metabolites, 
MC semi-LASER spectra (TE/TR: 24/6000 ms; number of 
excitations = 32) were acquired, with ref set to 2.4 ppm to 
minimize the chemical-shift displacement effect. To avoid 
any influence of MC pulses on quantification based on water, 
water-reference signals (number of excitations = 16) were 
acquired with semi-LASER (TE = 24 ms; ref = 4.7 ppm) 
without metabolite cycling. 
Finally, magnetization-prepared two rapid gradient-echo
34
 
images were acquired using the same coil with RF transmis- 
sion via all eight channels to calculate tissue-volume frac- 
tions for absolute quantification. 
 
2.3 | Data preprocessing 
Raw data were analyzed with in-house-written software in 
MATLAB (version 2016a; MathWorks, Natick, MA). The me- 
tabolite and MM MRS data were processed as described previ- 
ously.
26,30 
The following steps were used in processing the raw 
data: (1) truncation of FIDs at 250 ms for both metabolite and 
MM data; (2) frequency and phase alignment; (3) MC subtrac- 
tion; (4) averaging; (5) zero-order phase and eddy current cor- 
rection using the phase information from the MC water signal; 
(6) coil channel combination using a singular value decompo- 
sition method; (7) peak alignment in the frequency domain to 
3.028 ppm and 3.925 ppm for the metabolite spectra and MM 
data, respectively; (8) residual water removal using a Hankel 
singular value decomposition method; and (9) truncation of 
FIDs at 150 ms for the MM data. 
 
2.4 | Macromolecule fitting 
An MM basis set was created in LCModel V6.3-1L
35 
using 
simulated Voigt peaks, which is the best possible approxi- 
mation used in literature
7,8,30,36 
and does not account for J-
evolution of these MM peaks. The chemical shifts of the 
Voigt lines were varied systematically based on previously 
reported values,
7,8,30 
in which the ones reported by Pfeuffer 
et al
8 
were found to be the best; therefore, the reported chemi- 
cal shifts were chosen for the MM peaks from 0.9 to 2.3 ppm 
and from 2.9 to 3.5 ppm. The values of M2.56 and M2.70 were 
first reported in a human brain study at 9.4 T.
30 
The chemical 
shifts of these two peaks were adapted to fit the shifts reported 
by the 17.2 T rat study.
7 
The chemical shifts for MM peaks 
between 3.5 ppm and 4.2 ppm were chosen based on a pre- 
viously mentioned study,
7 
as the peaks were resolved more 
clearly in Lopez et al
7 
compared with the other two stud- 
ies.
8,30 
All of these chemical shifts are summarized in Table 1. 
The simulated basis set consisted of the following MM 
peaks: M0.92 (0.916 ppm), M1.21 (1.21 ppm), M1.39 (1.39 ppm), 
M1.67 (1.67 ppm), M2.04 (2.04 ppm), M2.26 (2.26 ppm), 
M2.56 (2.56 ppm), M2.70 (2.7 ppm), M2.99 (2.99 ppm), M3.21 
(3.21 ppm), M3.62 (3.62 ppm), M3.75 (3.75 ppm), M3.86 
(3.86 ppm), M4.03 (4.03 ppm), and M4.17 (4.17 ppm). The 
same basis set was used throughout the TE series, with the 
M2.70 peak being simulated with a negative amplitude for 
TE = 52 and 60 ms, as this peak was observed to be fully 
inverted due to J-evolution. A much narrower Voigt line was 
added to fit the residual creatine at 3.925 ppm. The chem- 
ical shifts, Δv1∕2s, and amplitudes were constrained in the 
LCModel as described in Supporting Information Annex B. 
Each individual MM data set and the sum of all data sets 
were fitted to the simulated MM basis set while enforcing a flat 
baseline by setting the LCModel parameter DKNTMN to 99. 
 
2.5 | Metabolite fitting 
The metabolite basis set was simulated in Vespa (ver. 0.9.3)
37 
using full quantum mechanical density matrix calculations 
for the semi-LASER sequence,
38 
including the actual com- 
plex excitation and adiabatic RF pulse shapes for all TEs 
specified in section 2.2. The following 17 metabolites were 
simulated: NAA, NAA glutamate (NAAG), γ-aminobutyric 
acid (GABA), aspartate (Asp), creatine (Cr), glutamate (Glu), 
glutamine (Gln), glutathione, glycerophosphocholine, gly- 
cine (Glyc), myo-inositol (mI), scyllo-inositol (Scy), lactate 
(Lac), phosphocreatine (PCr), phosphocholine (PCho), phos- 
phoethanolamine (PE), and taurine (Tau). Their chemical 
shifts and coupling constants were taken from Govindaraju 
et al,
39,40 
except for the coupling constant of GABA, for 
which the values from Near et al
41 
were chosen. 
Selected metabolites were split into moieties for fitting the 
TE series to calculate the metabolites’ T2 times. As previous 
studies have shown, different moieties of the same metabolite 
have different relaxation times
7,20,21,23
: NAA was split into an 
NAA–acetyl moiety [NAA(CH3)] and an NAA–aspartyl moiety 
[NAA(CH2)], whereas instead of Cr and PCr metabolites, the 
singlets at 3.925 ppm total creatine [tCr(CH2)] and at 3.028 ppm 
[tCr(CH3)] were included in the basis set. The metabolites were 
used in their entirety to calculate absolute concentrations. 
Because of the strong overlap and ill-posed problem of 
fitting PCho and glycerophosphocholine separately, these 
were combined to a total choline metabolite (tCho) with 
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glycerophosphocholine based on the mean concentration respectively. The values of Δv ,   v macro represent the micro- 
values from de Graaf.
42 
Similarly, PCho, glycerophospho- 
choline, and PE were combined with tCho+ (corresponding 
to volume fractions of 0.6 mM PCho, 1.0 mM glycerophos- 
phocholine, and 1.5 mM PE
42
), to obtain a robust metabolite 
fit for the T2 calculations across the TE series. 
Then, all individual metabolite spectra were fitted using 
the LCModel with the simulated basis set, including the re- 
spective MMB summed across subjects for each TE. The 
metabolite spectra summed across subjects were fitted sim- 
ilarly. Because the summed MMB spectra were included 
in the fit, DKNTMN was set to 0.25, resulting in a stiffer 




To further improve the fitting procedure, two soft con- 
straints were introduced into the echo series fit, namely, 
NAA(CH3)/NAA(CH2) = 1.2 ± 0.02 (to account for possi- 
ble faster decay of NAA(CH2) and mI/Glyc = 5 ± 0.5 (value 
extracted from the TE = 24 ms fit) (Supporting Information 
Annex B). No soft constraints were used for GABA or other 
metabolites. 
 
2.6 | T2 relaxation calculations 
susceptibility and macrosusceptibility, respectively. 
 
2.8 | Absolute quantification 
Using Statistical Parametric Mapping 12 software (Wellcome 
Trust Centre for Neuroimaging, London, United Kingdom), 
the acquired magnetization-prepared two rapid gradient-echo 
images were segmented into the following tissues: WM, GM, 
and CSF. Final tissue compositions were calculated using an 
in-house written Python (ver. 3.7) method and were used for 
absolute quantification of metabolites. Obtained tissue com- 
positions for the GM-rich voxels were GM: 69.2% ± 3.9%, 
WM: 25.8% ± 5.0%, and CSF: 4.9% ± 3.0%, and the WM- 
rich voxels were GM: 32.9% ± 9.3%, WM: 64.7% ± 11.1%, 
and CSF: 2.4% ± 3.7%. 
The unsuppressed water-reference signal from the voxel 
was used as the internal concentration reference for absolute 
quantification calculated in millimolal values (millimoles 
per kilogram of solvent [mmol/kg]). The concentrations of 
the metabolites were absolutely quantified using the formula 
(Supporting Information Annex A) given by Gasparovic 
et al
16 
for TE = 24 ms, including corrections for the T1 and 
T2 relaxation times of water in different compartments and 
The concentrations of MM peaks and metabolite peaks 
from the individual data and the summed spectra were fit 
to a mono-exponential decay across the TE series to yield 
the metabolite relaxation times. More specifically, the T1 
and T2 relaxation times of water at 9.4 T in GM (TGM = 2120 ms; 
TGM = 37 ms) and WM (TWM = 1400 ms; TWM = 30 ms) were 
T2 relaxation-time estimates. The mean coefficient of deter- 2 
taken from Hagberg et al.
34 
Relaxation times for CSF were cal- 
culated based on data from the same work (TCSF = 4800 ms; 
mination (R ) value was calculated for the exponential fit 
across the individual subject data and was used to evaluate 
the quality of the exponential fits. Relaxation times with a 
mean R
2 
smaller than 0.5 were discarded. The T2 times for 





2.7 | Linewidth calculations 
After quantification and extracting the fitted lineshapes of 
MM peaks and metabolite singlets from the .coord files of 




T2 relaxation to Δv1∕2  was calculated according 
1 
TCSF = 181 ms). The T1 relaxation times of metabolites were 
taken from Wright et al.
24 
The T2 relaxation times of the 
metabolite peaks calculated in this study were used. For the me- 
tabolites, for which T2 relaxation times could not be estimated, 
the mean T2 relaxation time of all other metabolites was used. 
 
3 | RESULTS 
Spectra without major artifacts were obtained for all 
subjects: The NAA(CH3) SNR ranged from 526 ± 130 to 
334 ± 82 for TE = 24-60 ms, respectively. However, between 
to   лTeff , using the calculated T2 values. 0.9 and 1.8 ppm, some spectra, especially MM spectra from 
WM voxels (Figure 1 and Supporting Information Figure S1), 
The residual linewidth was defined as presented outer-volume lipid impurities for some sub- 
jects, as lipid suppression techniques such as outer-volume 
Δv = Δv 
   −1 –  лTeff − Δv saturation were not used. The value of Δv1∕2 of the unsup- 
residual 1∕2 2 singlet pressed water signal was 17.6 ± 1.3 Hz. The TE series of 
MM and metabolite spectra from the GM-rich voxel are 
The B0 components were calculated from NAA(CH3) and 
tCr(CH2) as 
shown in Figure 1, where the shaded area depicts the SD, 
illustrating the reproducibility of the data quality. Supporting 
Δv = Δv 
   −1 –  лTeff ≈ Δv + Δv Information Figure S1 shows the TE series of WM-MM 
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FIGURE 1 Echo time series (TE = 24, 32, 40, 52, and 60 ms) for metabolite spectra (left) and macromolecular spectra (right) from gray 
matter (GM), with solid lines showing the mean spectra and the shaded area indicating the SD across subjects. The inset shows the voxel placement 
on axial and sagittal magnetization-prepared two rapid gradient-echo images 
 
FIGURE 2 Gray matter 
macromolecular (MM) spectrum summed 
across subjects ( subjects GM MM Spectrum) 
(TE = 24 ms) is shown with the fit using 
simulated Voigt lines. The residual total 
creatine 3.9 singlet [tCr(CH2)] peak in the 























3.1 | Macromolecule fitting 
The spectrum from the GM-rich voxel summed across sub- 
jects, together with all the fitted Voigt lines for the MM 
peaks, is shown in Figure 2 for TE = 24 ms and in Supporting 
Information Figure S2 for the other TEs. Supporting Information 
Figures S3 and S4 show the fit of the WM-TE series spectra 
summed across subjects. The fit residual is minimum without 
structured noise, indicating a high fit quality. Similar fit quality 
was achieved for all data sets across all TEs. The M2.70 peak 
is observed to undergo a full inversion due to J-evolution over 
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between TE = 52 and TE = 60 ms, and was simulated as a 
negative peak. The signal of the MM and the metabolite peaks 
decreased with increasing TE, as expected. 
The residual CH2 resonance of total creatine [tCr(CH2)] 
was modeled by fitting a sharper Voigt line at 3.925 ppm with 
a measured Δv1∕2 of around 0.035 ppm (14 Hz) across sub- 
jects. Next, the residual Cr was extracted from the LCModel 
fit, and was subtracted from the MM spectra to yield a more 
appropriate MMB for the metabolite fits (Figure 3). The re- 
sulting MMB was included in the basis set to fit the metabo- 
lite spectra for T2 relaxation-time calculations as well as for 
absolute quantification. 
 
3.2 | Metabolite fitting 
The fit of the metabolites to the summed metabolite spectra 
is shown in Figure 4. The fit residual is small, indicating a 
high fit quality. For TE = 32, 40, 52 and 60 ms, the basis set 
modeled the J-evolution of mI, NAA(CH2), Asp, Glu, and 
Tau well (Supporting Information Figure S5). 
Adding ascorbic acid or glucose to the simulated basis set 
did not improve the fit in terms of Cramer-Rao lower bounds, 
T2-fit result confidences, and residual artifacts. These reso- 
nances were not found by LCModel in most cases. Hence, 
these metabolites were not included in the final basis set. 
 
3.3 | T2 results 
The calculated Teff and T2 relaxation times (Figure 5) for 
good agreement for the fits of individual subject data and the 
summed spectra. Box plots of the resulting T2 relaxation times 
are shown in decreasing order for metabolites and MM peaks 
in Figure 5. The T2 relaxation time of the residual tCr(CH2) 
peak in the MM spectra was also in agreement with the re- 
laxation time of the tCr(CH2) peak in the metabolite spectra. 
The T2 relaxation times of metabolites and MM peaks 
from the summed spectra and individual data, together with 
the mean and SD of R
2 
of the corresponding exponential fits, 
are listed in Table 2. 
The T2 relaxation times of metabolites were found to lie 
between 55 ms and 105 ms, except for NAAG with approxi- 
mately 40 ms. In contrast, the values of Teff for all MM reso- 
nances were between 13 ms and 40 ms in WM and between 
13 ms and 37 ms in GM. 
The R
2 
for the metabolite exponential decay fits were all 
above 0.70, except for Asp and Glyc. The mean R
2 
of the ex- 
ponential decay fits was above 0.70 for all MM peaks as well, 
except for M4.03, which was subjected to water residuals and 
noise at longer TEs, hence the lower R
2 
value. Furthermore, 
the uncertainties in the Teff relaxation times of the M1.21 and 
M1.39 were influenced by lipid contaminations. 
 
3.4 | Linewidth calculations 
The value of Δv1∕2 of the MM resonances was measured 
to vary betwee n−
3
1 
5 Hz and 85 Hz across all TEs (Table 1), 
whereas   лTeff        was calculated to be between 4 Hz and 
30 Hz (Figure 6). In the case of metabolite resonances, and 
for the residual tCr(CH2) in the MM spectra, a Δv1∕2 of 11 Hz 













FIGURE 3 Echo time series of the 
GM-MM spectra summed across subjects 
with the tCr(CH2) residual subtraction 
shown. The spectra after the residual 
tCr(CH2) subtraction were used as the MM 
baseline in the basis set for the metabolite 
fitting. The red line shows the residual 
tCr(CH2), and the black line shows the 
MM spectra after the residual subtraction. 
Residual tCr(CH2) is extracted from the 
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FIGURE 4  Summed metabolite spectrum 
( subjects Metabolite Spectrum) (TE = 24 ms) 
from GM with fitted metabolites and 
measured macromolecular background 
(MMB). The basis set configuration shown 
here was used to estimate the T2 relaxation 
times and includes the tCr split into its 
moieties [tCr(CH3) and tCr(CH2)], NAA split 
into NAA(CH2) and NAA(CH3) moiety, and 
total choline (tCho) and phosphoethanolamine 
(PE) combined into tCho+. For each TE, 
a corresponding basis set was simulated 
with Vespa. For absolute quantification, the 
NAA moieties were combined, whereas 
creatine (Cr), phosphocreatine (PCr), 
tCho, and PE were fitted as independent 
metabolites. Abbreviations: Asp, aspartate; 
tCr(CH2), GABA, γ-aminobutyric acid; 
Gln, glutamine; Glu, glutamate; Glyc, 
glycine; GSH, glutathione; Lac, lactate; mI, 
myo-inositol; NAA(CH2), NAA–aspartyl 
moiety; NAA(CH3), NAA–acetyl moiety; 
NAAG, NAA glutamate; Scy, scyllo- 
inositol; Tau, taurine; tCho+, combined 
phosphocholine, glycerophosphocholine, and 
phosphoethanolamine molecules; tCr(CH2), 
total creatine 3.9 singlet; tCr(CH3), total 
creatine 3.0 singlet 
and 5 Hz. This led to a Δv value of approximately 12 Hz 
for the metabolite singlets. 
in vivo absolute concentrations of metabolites for single- 
voxel MRS acquisitions from the occipital lobe are reported. 
Supporting Information Figure S7  shows the Δv 
values of metabolites and MM peaks, which were calculated The resulting T2 values and absolute concentrations were 
using the Δv of NAA(CH3) and tCr(CH2) for the metab- 
largely in line with the literature. 
olite and MM spectra, respectively. The values of Δv of 
metabolites were around zero after applying the correction. 
In contrast, MM peaks had Δv       values ranging between 
10 Hz and 60 Hz. 
 
3.5 | Concentrations 
Absolute concentrations in millimoles per kilogram with 
and without T2 correction are shown in Figure 7. The val- 
ues for the metabolites are reported in Table 3 with and 
without the T2 correction factor. In Supporting Information 
Figure S8 and Supporting Information Table S1, absolute 
concentrations are given in millimoles per tissue volume in 
a liter (mmol/L). 
 
4 | DISCUSSION  
In this study, transverse relaxation times of a wide range of 
MM peaks and metabolites at 9.4 T are reported. Additionally, 
4.1 | Spectral quality and fitting of 
MM spectra 
The DIR technique sufficiently nulled all of the metabolites 
except tCr(CH2) for the chosen TI1 and TI2, as the T1 relaxa- 
tion time of this resonance is the shortest among the singlets, 
as reported by Deelchand et al.
23 
Indeed, the difference be- 
tween the T1 relaxation times of some of the MM peaks
44 
and 
the CH2 group of Cr is not large; thus, there is a residual peak 
present in the MM spectra. The residual tCr(CH2) was sub- 
tracted using the fit of the Cr singlet fit from the LCModel. 
The resulting spectra (Figure 3) after the residual subtraction 
visually showed no leftover Cr. 
For the fitting of the MM spectra, the chemical shifts and 
Δv1∕2 were systematically varied to achieve the lowest SD of 
the T2 results among subjects, to maximize the R
2 
values, and 
to minimize the mean Cramer-Rao lower bounds. These sys- 
tematic variations supported that the values chosen by Lopez 
et al
7 
were among the most suitable choices, and these values 
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of NAA(CH2) could be more significant, as metabolites have 
longer T2 relaxation times than macromolecules. 
 
4.2 | Metabolite fitting 
Previous work at 9.4 T reported concentrations of 18 
metabolites in the human brain using an MC semi-LASER 
sequence.
26 
However, due to the complexity of the adiaba- 
tic pulses and their spin locking effect,
46 
the simulated basis 
set was approximated using a spin-echo sequence with 
TE = 6.5 ms.
30 
In this study, the basis set for MC-semi-LASER 
was simulated using actual adiabatic RF pulse shapes. In 
addition, the same TEs were used in the acquisition of both 
metabolite and MM spectra. This allowed to individually 
fit the metabolite spectra with the matching simulated basis 
set and the corresponding MMB for each TE. The fit results 
(Figure 4 and Supporting Information Figure S5) show that 
the simulated basis set represents the J-evolution patterns of 
the acquired spectra well. 
 
4.3 | T2 results 
This study reports the Teff of individual MM peaks as well as 
Calculated T2 relaxation times for metabolites (top) 
and macromolecules (bottom) are shown in descending order. The red 
and pink crosses (X) indicate the calculations for the spectra summed 
across subjects (Teff , sum), while the box plots show the per-subject fits. 
2 
T2 relaxation times of both singlets and J-coupled metabo- 
lites at 9.4 T in human brain. The values of Teff of MM peaks 
are in agreement with previous work. Behar et al reporting 
2 
Horizontal lines inside the boxes indicate median values 
(50% quartile), whereas the bottom and top box boundaries illustrate 
25% and 75% quartiles, respectively. Plus signs (+) show outliers. The 
summed and the individual fits are in good agreement. Abbreviations: 
Glx, total Glu and Gln; tNAA+, NAA(CH3) and NAA(CH2) 
 
Hence, these values were chosen, with minor deviations as 
indicated in Table 1. 
For the first time, the J-evolution of the M2.7 resonance 
(Figures 1 and 3, Supporting Information Figure S1) was 
investigated in this study. This resonance was preliminarily 
assigned to β-methylene protons of aspartyl groups.
30 
The 
Biological Magnetic Resonance Bank amino acid database
45 
lists the following coupling constants for the β-methylene 
protons (δ2.7 ppm) of aspartate amino acids: approximately 
5 and 8 Hz between α-methylene and β-methylene protons, 
and 17.5 Hz between β-methylene protons. These coupling 
constants are comparable to those of Asp and the aspartate 
moieties of NAA and NAAG,
40 
which experience full inver- 
sion between TEs of 52 and 60 ms. All observations support 
the preliminary attribution of the M2.7 resonance to the aspar- 
tyl groups. Nevertheless, the possibility cannot be excluded 
that the MM spectra also included NAA(CH2) residuals, pro- 
vided that this moiety has a short enough T1 relaxation time. 
In particular, at longer TEs (52 and 60 ms), the contribution 
44-ms T2 at 2.1 T for M0.92 in human brain,
11 
which is in 
agreement with a slow decay across field strengths, as shown 
in the rat brain studies.
7-10
 
The T2 of metabolite singlets, such as NAA(CH3), tCr(CH2), 
tCr(CH3) and tCho, are higher than those previously reported 
at 9.4 T.
23 
The higher values in this work can be attributed to 
the fact that a TE-specific experimentally measured MMB was 
included, which is a faster-decaying component. The reported 
T2 relaxation times of the metabolites appear to follow the same 
trend compared with previous results,
7,20,21,47 
with the longest 
relaxation times found for the singlets NAA(CH3), tCho and 
tCr(CH3) [the T2 of tCr(CH3) larger than for tCr(CH2), differ- 
ence decreasing with increasing field strength],
7,20,21,23,47 
and 
significantly shorter T2 for NAAG than for NAA moieties.
20 
All reported T2 relaxation times show the expected negative 
correlation with increasing field strength. Glutamate T2 is 
higher than that of Gln, in agreement with previous studies.
7,20 
However, the difference is unexpected, considering the similar 
molecular weight of the two metabolites and the similar distri- 
bution within the brain
48
; hence, most likely the T2 of Gln is 
underestimated. Nevertheless, differences could arise from the 
presence in different compartments, or bindings to different 
transporters or enzymes. 
The summed and individual fits are in good agreement for 






Metabolite T2  Gray matter White matter 
T (ms) sum 
2 
T2 ± SD (ms) R
2 
± SD T (ms) 
eff , sum 
2 






eff , sum 
2 











TABLE 2 T2 relaxation times for metabolites and macromolecules 
Asp 72 54.4 ± 11.5 0.72 ± 0.12 M0.92 36.9 36.4 ± 7.0 0.91 ± 0.07 31.3 35.1 ± 10.0 0.86 ± 0.09 
tCr(CH3) 95.2 100.2 ± 16.0 0.90 ± 0.10 M1.21 37.4 34.3 ± 13.1 0.79 ± 0.13 — 25.3 ± 0.0 0.98 ± 0.00 
tCr(CH2) 95.4 81.8 ± 10.8 0.83 ± 0.08 M1.39 36.7 31.5 ± 7.4 0.83 ± 0.08 31 39.6 ± 24.2 0.75 ± 0.13 
Glu 76.8 87.0 ± 23.3 0.73 ± 0.10 M1.67 15.9 17.6 ± 3.6 0.92 ± 0.08 17.4 17.5 ± 7.5 0.89 ± 0.11 
Gln 65.9 47.0 ± 8.6 0.81 ± 0.06 M2.04 15.9 15.8 ± 2.1 0.98 ± 0.03 17.1 18.9 ± 1.5 0.98 ± 0.02 
GSH 70.7 74.8 ± 34.2 0.73 ± 0.09 M2.26 19.6 18.4 ± 1.5 0.96 ± 0.03 19.1 18.1 ± 1.0 0.96 ± 0.02 
Glyc — 60.9 ± 11.2 0.60 ± 0.07 M2.56 18.7 20.1 ± 3.2 0.93 ± 0.04 19.3 23.9 ± 3.4 0.84 ± 0.10 
mI 84.5 90.0 ± 18.0 0.70 ± 0.09 M2.70 11.6 13.9 ± 2.9 0.93 ± 0.08 11.6 13.4 ± 1.9 0.94 ± 0.03 
NAA(CH2) 90.4 102.2 ± 23.8 0.92 ± 0.12 M2.99 18.9 18.8 ± 1.6 0.94 ± 0.06 18 19.1 ± 1.3 0.93 ± 0.03 
NAA(CH3) 104.9 110.5 ± 27.7 0.93 ± 0.12 M3.21 18.4 18.4 ± 3.2 0.93 ± 0.08 13.9 16.3 ± 5.4 0.91 ± 0.06 
NAAG 37.7 45.0 ± 16.3 0.87 ± 0.09 M3.62 15.5 13.9 ± 6.4 0.90 ± 0.07 12.4 15.9 ± 4.8 0.85 ± 0.06 
tCho+ 80.4 90.1 ± 23.5 0.92 ± 0.11 M3.75 23.3 25.4 ± 6.8 0.91 ± 0.08 25.6 24.5 ± 6.8 0.82 ± 0.11 
tNAA+ 93.2 100.6 ± 21.8 0.93 ± 0.11 M3.86 19.5 22.0 ± 5.3 0.91 ± 0.12 18.5 24.2 ± 5.2 0.84 ± 0.10 
mI+Glyc 77.8 84.4 ± 16.8 0.77 ± 0.12 M4.03 11.5 20.7 ± 8.2 0.71 ± 0.10 — — — 
Glx 72.8 71.9 ± 10.5 0.76 ± 0.09 tCr(CH2) 65.3 71.3 ± 7.9 0.75 ± 0.11 67.3 61.7 ± 3.1 0.84 ± 0.12 
Note: Calculated T relaxation times for metabolites (left), Teff for MM gray matter (middle), and MM white matter (right) are shown for fitting the spectra summed across subjects (Tsum and Teff , sum), the per-subject fits (mean 
2 2 2 2 
and SD) with the confidence of the exponential fit (R
2
). Some exponential decay fits are shown in Supporting Information Figure S6. The T2 relaxation times of GABA, Lac, Scy, and PE are not included, as they did not satisfy 
the imposed R
2 
> 0.5 criterion. 
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FIGURE 6 Calculated Δv1∕2 for the singlets of the metabolite spectra (left) and individual MM peaks and tCr(CH2) peak of the MM spectra 
(right). The crosses (X) indicate the calculations for the spectra summed across subjects, whereas the box plots show the per-subject fits. Per- 
subject individual fits are shown in the blue b o−x1 plots and red crosses (approximately 15 Hz for metabolite singlets and mostly between 40 Hz and 
80 Hz for macromolecules). Values of vTeff are shown in the green box plots and orange crosses (approximately 3.5 Hz for metabolite singlets 
and mostly between 5 Hz and 20 Hz for macromolecules). Horizontal lines inside the boxes indicate median values (50% quartile), whereas the 
bottom and top box boundaries illustrate 25% and 75% quartiles, respectively. Plus signs (+) show outliers. The value of Δvresidual is displayed in 
Supporting Information Figure S7. Abbreviation: WM, white matter 
 
 
FIGURE 7 Calculated absolute 
concentrations for the metabolites in 
millimoles per kilogram for the different 
subjects. The blue box plots show the 
concentrations when metabolite T2 
correction is applied, whereas the green box 
plots show the concentrations without using 
this correction factor. Horizontal lines inside 
the boxes indicate median values 
(50% quartile), whereas the bottom and 
top box boundaries illustrate 25% and 75% 













(Table 2). It can also be noted that the relaxation time of the 
tCr(CH2) in the metabolite spectra and the residual present 
in the MM spectra are in good agreement. The differences 
between Teff relaxation times of MM peaks in WM-rich and 
GM-rich voxels were never investigated previously, nor were 
the relaxation times calculated for the peaks individually. 
tissue compositions in this work. The Teff relaxation times 
found in this study are comparable between these voxels. 
However, it is known that the region of interest in the 
human brain is crucial when applying T2 correction for abso- 
lute concentrations of metabolites.
20 
Hence, no attempt was 
made to report the T2 relaxation times of metabolites sep- 
Therefore, an attempt was made to calculate Teff for both arately for GM and WM, as the selected voxel was neither 
552 | 
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TABLE 3 Absolute concentrations (mmol/kg ± SD) 
Asp 4.84 ± 1.15
b 
3.12 ± 0.74 2.0 ± 0.4 1 ± 0.26 3.1 ± 0.3 2.9 ± 0.5 2.1 ± 0.5 2.9 ± 0.8 
Asc — — 1.1 ± 0.3 1.2 ± 0.21 — — — 0.4 ± 0.3 
Cr 5.70 ± 0.85 4.38 ± 0.65 4.6 ± 0.3 5 ± 0.26 5.8 ± 0.2 5.0 ± 0.3 3.2 ± 0. 5 — 
PCr 4.43 ± 0.83 3.40 ± 0.64 3.9 ± 0.5 3.4 ± 0.24 2.2 ± 0.19 3.0 ± 0.3 4.5 ± 0.4 — 
GABA 1.87 ± 0.92
d 
1.39 ± 0.68 0.9 ± 0.1 1 ± 0.13 2.5 ± 0.4 1.3 ± 0.15 1.3 ± 0.4 1.5 ± 0.3 
Glucose — — — 1.1 ± 0.28 1.4 ± 0.3 — — w/Tau 
Gln 7.61 ± 0.91
b 
4.56 ± 0.54 2.5 ± 0.2 2.9 ± 0.16 1.6 ± 0.4 2.2 ± 0.4 2.2 ± 0.2 1.5 ± 0.5 
Glu 10.90 ± 0.80 8.27 ± 0.61 8.9 ± 0.3 11 ± 0.22 8.9 ± 0.9 9.9 ± 0.9 9.3 ± 0.9 9.6 ± 1.3 
Glyc 1.11 ± 0.28
b 
0.75 ± 0.19 — — — — — 0.7 ± 0.1 
GSH 1.72 ± 0.16 1.25 ± 0.12 0.7 ± 0.1 1 ± 0.1 1.4 ± 0.11 1.3 ± 0.2 1.1 ± 0.3 1.1 ± 0.1 
Lac — — 0.7 ± 0.1 0.8 ± 0.1 — 0.7 ± 0.1 0.5 ± 0.1 0.8 ± 0.2 
mI 5.22 ± 0.45 4.00 ± 0.34 — — 5.3 ± 0.6 5.7 ± 0.5 5.3 ± 0.4 6.4 ± 0.8 
NAA 12.61 ± 1.02 10.06 ± 0.81 12.4 ± 0.7 10.8 ± 0.14 11.2 ± 0.8 11.8 ± 0.2 13.5 ± 1.6 12.6 ± 1.7 
NAAG 1.42 ± 0.19
a 
0.83 ± 0.11 1.2 ± 0.2 1.4 ± 0.11 1.0 ± 0.2 1.1 ± 0.4 1.1 ± 0.5 0.40 ± 0.2 
tCho 1.03 ± 0.12 0.79 ± 0.09 1.0 ± 0.3 1.3 ± 0.05 1.1 ± 0.13 1.1 ± 0.05 0.9 ± 0.2 0.9 ± 0.1 
PE 2.28 ± 0.95
d 
1.75 ± 0.73 2.1 ± 0.2 1.2 ± 0.19 2.2 ± 0.18 2.5 ± 0.3 1.6 ± 0.4 2.3 ± 0.4 




0.3 ± 0.1 0.4 ± 0.05 0.4 ± 0.11 0.3 ± 0.12 0.3 ± 0.2 0.4 ± 0.1 
Tau 1.58 ± 0.37 1.17 ± 0.27 1.7 ± 0.2 1.9 ± 0.18 1.4 ± 0.5 1.5 ± 0.3 1.3 ± 0.2 2.1 ± 0.3 
NAA+NAAG 13.78 ± 1.01
a 
10.86 ± 0.79 — — 12.3 ± 0.9 12.9 ± 0.4 — — 
mI+Glyc 6.34 ± 0.52 4.77 ± 0.39 6.3 ± 0.9 6.7 ± 0.2 6.2 ± 0.6 6.0 ± 0.4 — — 
Cr+PCr 10.10 ± 0.46
a 
7.76 ± 0.36 8.6 ± 1.2 — 8.0 ± 0.3 8.0 ± 0.4 7.7 ± 0.4 8.7 ± 1.1 
Glu+Gln 17.96 ± 1.49
b 
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GM-rich GM-rich 






Marjańska et al 2012 
7 T21 
Occipital lobe mixed 
tissue 
TABLE 3 (Continued) 







Note: Absolute concentrations for the metabolites are shown (in mmol/kg). Concentrations for this work are reported with the correction of the metabolite T2 values and without this correction. Both reported values use the T1, 
T2, and tissue-compartment corrections of the water signal. The concentrations without metabolite T2 correction are all in good agreement with the millimolal concentrations reported in the literature at different field strengths 
from different studies (sequence and fitting configurations are also summarized). Absolute concentrations for the metabolites (in mmol/L) are found in Supporting Information Table S1 together with the literature comparison. 
Abbreviation: Asc, ascorbic acid; GSH, glutathione. 
a
Concentrations that are higher than the literature values after metabolite T2 correction (small changes). 
b
Concentrations that are higher than the literature values after metabolite T2 correction (large changes). 
c
The Scy concentration is marked because it is possibly underestimated in this study. However, it is not clear whether the other literature used 1 or 6 proton resonances (
1-6
CH) contributing to their Scy basis set simulation. 
d























Metabolite T2 yes no no no no no no yes 
correction         
Tissue fraction, yes yes Assuming 80% Assuming 80% tCr set to 8 tCr set to 8 Not specified yes 
H2O T1, T2  water content water content mmol/kg mmol/kg   
Sequence semi-LASER semi-LASER STEAM STEAM SPECIAL SPECIAL STEAM LASER 
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purely WM nor GM. This difference in T2 relaxation times 
is highly influenced by the iron concentrations across the 
human brain, as shown by Hasan et al.
49 
Hence, the T2 relax- 
ation times of metabolites reported in this work are specific 
to the region of the GM-rich occipital lobe. 
The TE values of 24, 32, 40, 52, and 60 ms were chosen 
for the calculation of T2 relaxation times, while keeping the 
shorter MM Teff in mind. The MM signals were almost en- 
tirely decayed at TE = 60 ms. Having a corresponding MMB 
for the metabolite spectra improves the quantification of me- 
tabolite concentrations, hence the choice of identical TEs. 
The chosen TEs were sufficient to estimate the T2 relaxation 
times of MM peaks and metabolites with shorter T2 times. 
However, including some longer TE values would improve 
the accuracy of the T2 relaxation times of metabolites with 
longer T2s. 
 
4.4 | Linewidth calculations 
For any given voxel, B0 inhomogeneities originate from a 
did not include T2 correction due to the use of ultrashort TEs 
(<10 ms). The concentrations of NAA, NAAG, tCho, PE, 
Tau, Glu, GABA, and mI with T2 correction are overall in 
good agreement with the literature.
21,23,29,50,51
 
Concentrations of Asp, Gln, Glyc, and Glu are sig- 
nificantly higher after including the T2 correction factor. 
However, their concentration values match those from the 
literature when considered without T2 correction. Potential 
overestimations in this study could also arise due to an un- 
derestimation of the T2 relaxation times of Gln, Glu and Asp, 
which exhibit strong J-evolution effects at TE = 52 ms and 
TE = 60 ms. In particular, the Gln concentration is likely 
overestimated, as the spline baseline exhibits negative be- 
haviour in that area, which could not be compensated in the 
LCModel fits. Improved spectral resolution at ultrahigh field 
between Glu and Gln also influenced Gln concentrations in 
the current study. Furthermore, the loss of magnetization for 
individual MM components because of T1 differences in DIR 
semi-LASER compared with semi-LASER could also influ- 
ence our results. All referenced literature used single inver- 
sion recovery sequences to measure the MMB component. 
mixture of effects of Δv ,   v macro as well as tissue com- Similarly, Cr and PCr concentrations match the literature 
partment effects.
23 
This B0 effect experienced by spins is 
identical, whereas T2 relaxation time is metabolite/reso- 
nance-specific. The Δv1∕2 of metabolite singlets, both in 
MC-semiLASER and tCr(CH2) in DIR MC-semiLASER, 
clearly show the two components of the linewidth 
(Figure 6). The Δv1∕2 of tCr(CH2) is in line with the ones pre- 
viously reported.
23 
The large differences between the Δv1∕2s 
of MM peaks and лTeff  
  −1 
(Figure 6, Table 1) indicate that 
these resonances are potentially composed of unresolved mul- 
tiplets and/or different protons resonating at similar chemi- 
cal shifts, which are strongly overlapping. Also, Supporting 
Information Figure S7 shows that the values of Δv 
for MM peaks are between 10 Hz and 60 Hz, whereas for 
without T2 correction, but are somewhat higher (~25%) when 
the T2 correction is applied. This deviation could indicate 
that including the T2 correction factor in the absolute quanti- 
fication yields higher concentrations compared with the liter- 
ature, as in most studies, no correction for the corresponding 
T2 relaxation times of the metabolites was applied, or the 
Cr + PCr concentration was set to 8 mmol/kg. The shorter TEs 
used in the aforementioned studies, however, should not gen- 
erally have a significant impact on metabolite concentrations. 
Concentration of Scy, on the other hand, is lower in this 
study compared with other studies. However, it remains un- 
clear whether care was taken to use all six carbon atoms, 
written as 
1-6
CH in Govindaraju et al,
40 
each having a proton 
metabolites they are closer to 0 Hz. The Δv value is resonating at the same frequency, thus contributing to their 
consistent between GM and WM MM peaks, indicating that 
the magnitude of potential overlap and/or J-evolution
11 
com- 
ponent for each MM peak is similar between different tissue 
types. These peaks could originate from amino acids
45 
which, 
depending on the larger protein structure they belong to, can 
have different chemical shifts, but are distributed around a 
main resonance frequency for the bulk of protein peaks. 
 
4.5 | Concentrations 
Table 3 provides a consolidated comparison of absolute con- 
centrations (millimoles per kilogram) of metabolites from 
literature
21,23,29,50,51 
and this work. 
Metabolite concentrations from this study are reported 
with and without T2 correction for a fair comparison between 
the other studies and this work, as most of the other studies 
Scy basis set simulation. 
Absolute concentrations in millimoles per liter, given 
in Supporting Information Figure S8 and Supporting 
Information Table S1, are in excellent agreement with the 
concentrations that corrected for metabolite relaxations given 
by Penner et al
52 
and with the literature comparison presented 
in the same article. 
 
5 | CONCLUSIONS  
In this study, for the first time, T2 relaxation times of 14 indi- 
vidual macromolecule peaks ranging from 13 ms to 45 ms are 
measured in both GM-rich and WM-rich voxels. 
In addition, in vivo transverse relaxation times of 12 me- 
tabolites and metabolite moieties in a GM-rich voxel in the 
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ranged from 40 ms to 110 ms and were used as a correction 
factor for the absolute quantification of metabolites. The Teff 
and T2 values for MM peaks and metabolites, respectively, 
confirm the decreasing trend of transverse relaxation times 
with increasing static magnetic field. Finally, this work quan- 
titatively shows the contribution of T2 relaxation times and 
B0 components to the linewidth of MM peaks. The residual 
linewidth includes not only components of J-coupling, but 
also chemical-shift distributions of amino acid proton groups. 
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SUPPORTING INFORMATION  
Additional supporting information may be found online in 
the Supporting Information section. 
FIGURE S1 Echo time series (TE = 24, 32, 40, 52, and 
60 ms) for MM spectra (right) from WM, with solid lines 
showing the mean spectra and the shaded area indicating the 
SD across subjects 
FIGURE S2 Gray Matter MM spectra summed across sub- 
jects (TE = 32, 40, 52 and 60 ms) are shown with the fit- 
ted macromolecules and tCr(CH2) moiety. The basis set 
configuration shows the setup for inverting the M2.70 peak at 
TE = 40, 52, and 60 ms 
FIGURE S3 White matter MM spectrum summed across 
subjects (TE = 24 ms) is shown with the fit using simulated 
Voigt lines. The residual tCr(CH2) peak in the spectra is mod- 
eled with a significantly narrower linewidth 
FIGURE S4 White matter MM spectra summed across 
subjects (TE = 32, 40, 52, and 60 ms) are shown with the 
fitted macromolecules and tCr(CH2) moiety. The basis set 
NMR Spectroscopy. Hoboken, New Jersey: John Wiley & Sons; 
2007:43–110. 
43. Giapitzakis IA, Borbath T, Murali-Manohar S, Avdievich N, 
configuration shows the setup for inverting the M2.70 
TE = 40, 52, and 60 ms 
peak at 
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FIGURE S5 Metabolite spectra summed across subjects 
(TE = 32, 40, 52, and 60 ms) are shown with the fitted me- 
tabolites and measured MMB. The basis set configuration 
shown here with the tCr split to its moieties tCr(CH3) and 
tCr(CH2), NAA split to NAA(CH2) and NAA(CH3) moiety, 
and tCho and PE combined with tCho+ was used to estimate 
the T2 relaxation times. For each TE, a corresponding basis 
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FIGURE S6 Exponential decay plots of M0.92, M2.04, M2.26, 
and M2.99 from summed GM and WM spectra. The lines 
show the fit, whereas the scatter shows the quantified data 
points. The y-axis is reported in arbitrary units, and no con- 
clusions should be drawn between GM and WM concentra- 
tion differences 
FIGURE S7 The FWHMs for the singlets of the metabolite 
spectra (left) and individual MM peaks and tCr(CH2) peak of 
the MM spectra (right) after correcting for the T2 component 
of corresponding metabolite/macromolecule, and the B0 com- 
ponents from NAA(CH3) and tCr(CH2), respectively. The me- 
tabolite FWHM of tCho+ and tCr(CH2) reflects the multiple 
components contributing to the singlet peak. The crosses (X) 
indicate the calculations for the spectra summed across subjects, 
whereas the box plots show the per-subject fits. Horizontal lines 
inside the boxes indicate median values (50% quartile), whereas 
the bottom and top box boundaries illustrate 25% and 75% 
TABLE S1 Absolute concentrations for the metabolites (in 
mmol/L) 
Note: Concentrations for this work are reported with the cor- 
rection of the metabolite T2 values. The concentrations are 
all in good agreement with the millimolal concentrations re- 
ported by Penner et al (sequence and fitting configurations 
are also summarized). 
a
Concentrations that are higher than the literature values 
(small changes). 
b
Concentrations that are higher than the literature values 
(large changes). 
c
The Scy concentration is marked, because it is possibly un- 
derestimated in this study. However, it is not clear whether 
the other literature used 1 or 6 proton resonances (
16
NH) con- 
tributing to their Scy basis set simulation. 
d
Metabolites for which the mean T2 relaxation time of all 
other metabolites was taken. 
quartiles, respectively. Plus signs (+) show outliers    
FIGURE S8 Calculated absolute concentrations for the me- 
tabolites for the different subjects (in mmol/L). The blue box 
plots show the concentrations when metabolite T2 correc- 
tion is applied, while the green box plots show the concen- 
trations without applying this correction factor. Horizontal 
lines inside the boxes indicate median values (50% quartile), 
whereas the bottom and top box boundaries illustrate 25% 
and 75% quartiles, respectively. Plus signs (+) show outliers 
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SUPPORTING INFORMATION FIGURES 
 
 
Supporting Information Figure S1: Echo time (TE) series (TE = 24, 32, 40, 52 and 60 ms) 
for macromolecular spectra (right) from white matter with solid lines showing the mean spectra 
and the shaded area indicating the standard deviation across subjects. 
 
 
Supporting Information Figure S2: The gray matter across subjects summed 
macromolecular spectra (TE = 32, 40, 52 and 60 ms) are shown with the fitted macromolecules 
and tCr(CH2) moiety. The basis set configuration shows the setup for inverting the M2.70 peak 




Supporting Information Figure S3: White matter macromolecular spectrum summed 
across subjects (TE = 24 ms) is shown with the fit using simulated Voigt lines. The 
residual total creatine – 3.9 singlet (tCr(CH2)) peak in the spectra is modeled with a 





Supporting Information Figure S4: The white matter across subjects summed 
macromolecular spectra (TE = 32, 40, 52 and 60 ms) are shown with the fitted macromolecules 
and tCr(CH2) moiety. The basis set configuration shows the setup for inverting the M2.70 peak 




Supporting Information Figure S5: The across subjects summed metabolite spectra (TE = 
32, 40, 52 and 60 ms) are shown with the fitted metabolites and measured MMB. The basis 
set configuration shown here with the tCr split to its moieties tCr(CH3) and tCr(CH2) , NAA split 
to NAA(CH2) and NAA(CH3) moiety, and tCho and PE combined to tCho+ was used to 





Supporting Information Figure S6: Exponential decay plots of M0.92, M2.04, M2.26 and M2.99 
from summed GM and WM spectra. The lines show the fit while the scatter shows the 
quantified data points. The y-axis is reported in arbitrary units, and no conclusions should be 













Supporting Information Figure S7: FWHMs for the singlets of the metabolite spectra (left) 
and individual MM peaks and tCr(CH2) peak of the macromolecular spectra (right) after 
correcting for the T2 component of corresponding metabolite/macromolecule, and the B0 
components from NAA(CH3) and tCr(CH2) respectively. The metabolite FWHM of tCho+ and 
tCr(CH2) reflect the multiple components contributing to the singlet peak. The crosses (X) 
indicate the calculations for the spectra summed across subjects, while the box plots show 
the per subject fits. Horizontal lines inside the boxes indicate median values (50% quartile), 
whereas the bottom and top box boundaries illustrate 25% and 75% quartiles, respectively. 






Supporting Information Figure S8: Calculated absolute concentrations for the metabolites 
in mmol/L for the different subjects. The blue box plots show the concentrations when 
metabolite T2 correction is applied, while the green box plots show the concentrations without 
applying this correction factor. Horizontal lines inside the boxes indicate median values (50% 
quartile), whereas the bottom and top box boundaries illustrate 25% and 75% quartiles, 




Supporting Information Table S1: 
Absolute concentrations for the metabolites in mmol/L are shown. Concentrations for this work 
are reported with the correction of the metabolite T2 values. The concentrations are all in good 
agreement with the mmolal concentrations reported by Penner et al., (sequence and fitting 
configurations are also summarized). 
a,b Concentrations which are higher than the literature values are marked with a for small 
changes, and with b for large changes. 
c The Scyllo concentration is marked with since it is possibly underestimated in this study. 
However, it is not clear, whether the other literature used one or six proton resonances 
(1-6NH) contributing to their Scyllo basis set simulation. 
d Metabolites for which the mean T2 relaxation time of all the other metabolites was taken. 
 
Absolute concentrations [mmol/L ± std] 









Asp 3.19 ± 0.75 3.8 ± 1.3 
Cr 4.21 ± 0.64 4.1 ± 0.6 
PCr 3.27 ± 0.61 3.5 ± 0.9 
GABA 1.37 ± 0.67 d - 
Gln 5.43 ± 0.67 b 2.2 ± 0.4 
Glu 8.05 ± 0.63 a 10.7 ± 1.6 
Glyc 0.81 ± 0.21 - 
GSH 1.28 ± 0.12 1.6 ± 0.3 
Lac 1.27 ± 0.58 - 
mI 3.85 ± 0.33 - 
NAA 9.31 ± 0.79 - 
NAAG 1.07 ± 0.15 - 
tCho 0.76 ± 0.09 a 1.8 ± 0.4 
PE 1.68 ± 0.70 d 1.2 ± 0.5 
Scy 0.09 ± 0.04 c, d 0.4 ± 0.1 
Tau 1.15 ± 0.27 1.0 ± 0.5 
NAA+NAAG 10.05 ± 0.78 11.8 ± 0.8 
mI+Glyc 4.68 ± 0.39 a 5.9 ± 0.3 
Cr+PCr 7.46 ± 0.33 7.6 ± 0.9 
Glu+Gln 13.03 ± 1.15 12.9 ± 1.6 








78% fractional water content 
of GM & WM, correction for 
CSF with water reference 
Sequence semiLASER semiLASER 
Echo time 24 ms 38 ms 
 















× 𝑐𝑜𝑛𝑐 (fGM × 𝑅𝐻2𝑂_𝐺𝑀 + fWM × 𝑅𝐻2𝑂_𝑊𝑀+fCSF × 𝑅𝐻2𝑂_𝐶𝑆𝐹) 2 × × 
 
𝑚𝑚𝑜𝑙𝑎𝑙 obs 𝑝𝑢𝑟𝑒_𝐻2𝑂 (1 − fCSF) × 𝑅𝑀 1 + Fs 
 
where 𝑓𝑦 =
 𝑓𝑦_𝑣𝑜𝑙 × 𝑎𝑦  
𝑓𝐺𝑀_𝑣𝑜𝑙 × 𝑎𝐺𝑀 + 𝑓𝑊𝑀_𝑣𝑜𝑙 × 𝑎𝑊𝑀 +𝑓𝐶𝑆𝐹_𝑣𝑜𝑙 × 𝑎𝐶𝑆𝐹 
 
where 𝑦 corresponds to either GM, WM or CSF; 𝑓𝑦_𝑣𝑜𝑙 is the fraction of the respective tissue 
type determined by segmentation; 𝑎𝐺𝑀, 𝑎𝑊𝑀, 𝑎𝐶𝑆𝐹 (78%, 65%, 97% respectively) are the 
relative densities of MR-visible water for the given tissue type; The molal concentration of 
water in metabolite solution is 55510 mmoles/kg and is denoted by 𝑐𝑜𝑛𝑐𝑝𝑢𝑟𝑒_𝐻2𝑂. 
 
 
Concentrations in mmolar 
 
2 
[M]𝑚𝑚𝑜𝑙𝑎𝑟 = [M]obs × 𝑐𝑜𝑛𝑐𝑝𝑢𝑟𝑒_𝐻2𝑂 × 1 + Fs 
(fGM_vol × 𝛼GM × 𝑅𝐻2𝑂_𝐺𝑀 + fWM_vol × 𝛼WM × 𝑅𝐻2𝑂_𝑊𝑀 +fCSF_vol × 𝛼CSF × 𝑅𝐻2𝑂_𝐶𝑆𝐹 ) 
× 
(1 − fCSF ) × 𝑅𝑀 
 
Where 𝑓𝑦_𝑣𝑜𝑙 is the fraction of the respective tissue type determined by segmentation; 𝑎𝐺𝑀, 
𝑎𝑊𝑀, 𝑎𝐶𝑆𝐹 (78%, 65%, 97% respectively) are the relative densities of MR-visible water for the 














]] is the relaxation correction factor 
for each water compartment 𝑦. 𝑇1𝐻2𝑂𝑦 and 𝑇2𝐻2𝑂_𝑦 are the 𝑇1 and 𝑇2 relaxation times of water 








]]   is the relaxation correction 
term for metabolites. The denominator 1 − 𝑓𝐶𝑆𝐹 was implemented for partial-volume 
correction. The factor 2 
1+Fs 
was introduced to correct for the multiplication of even numbered 
acquisitions with the scaling factor (F𝑠). [M]obs is the concentration obtained from LCModel 
divided by the preset value (40873). 
 
While quantifying NAA absolutely, the mean T2 relaxation time of NAA(CH3) and NAA(CH2) 
was used; for Cr and PCr metabolites the mean T2 relaxation time of tCr(CH2) and tCr(CH3) 
singlets was used. Calculating the mean value was numerically equivalent to fitting a T2 
exponential to the combined metabolite moiety concentrations across the TE series. 
ANNEX B - Control files (.control) for LCModel quantification 
 
 
Sample LCModel .control files used for the quantification of the occipital lobe spectra for 
macromolecules and metabolite fitting. 
Macromolecules fitting 
 
Note: NAA_DF_basis.basis contains only the NAA 7.8 ppm peak, which seems 
relatively stable across TE series 
$LCMODL 



























shifmn(2) = -0.07 
shifmx(2) = 0.07 
nratio=0 
nsimul= 15 
chsimu(1)= 'MM09 @ 0.916 +- 0.01 FWHM= .08 < .11 +- .01 AMP= 1.' 
chsimu(2)= 'MM12 @ 1.21 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(3)= 'MM14 @ 1.39 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(4)= 'MM17 @ 1.67 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
 
chsimu(5)= 'MM20 @ 2.04 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(6)= 'MM22 @ 2.26 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(7)= 'MM26 @ 2.56 +- 0.01 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(8)= 'MM27 @ 2.7 +- 0.05 FWHM= .04 < .08 +- .005 AMP= 1.' 
chsimu(9)= 'MM30 @ 2.99 +- 0.01 FWHM= .10 < .12 +- .005 AMP= 1.' 
chsimu(10)= 'MM32 @ 3.21 +- 0.02 FWHM= .12 < .18 +- .005 AMP= 1.' 
chsimu(11)= 'MM36 @ 3.62 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(12)= 'MM37 @ 3.75 +- 0.02 FWHM= .02 < .10 +- .005 AMP= 1.' 
chsimu(13)= 'MM38 @ 3.86 +- 0.01 FWHM= .02 < .10 +- .005 AMP= 1.' 
chsimu(14)= 'MM40 @ 4.03 +- 0.01 FWHM= .05 < .10 +- .005 AMP= 1.' 




Metabolite Fitting Absolute Quantification 
 
$LCMODL 































Metabolite Fitting Absolute Quantification 
 
$LCMODL 


























nsimul = 0 
nnot2= 0 
nratio=2 
chrato(1) = 'NAA_ac/NAA_as=1.2+-0.02' 
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Purpose: Macromolecular peaks underlying metabolite spectra influence the quan- 
tification of metabolites. Therefore, it is important to understand the extent of con- 
tribution from macromolecules (MMs) in metabolite quantification. However, to 
model MMs more accurately in spectral fitting, differences in T1 relaxation times 
among individual MM peaks must be considered. Characterization of T1-relaxation 
times for all individual MM peaks using a single inversion recovery technique is 
difficult due to eventual contributions from metabolites. On the contrary, a dou- 
ble inversion recovery (DIR) technique provided flexibility to acquire MM spectra 
spanning a range of longitudinal magnetizations with minimal metabolite influence. 
Thus, a novel method to determine T1-relaxation times of individual MM peaks is 
reported in this work. 
Methods: Extensive Bloch simulations were performed to determine inversion time 
combinations for a DIR technique that yielded adequate MM signal with varying 
longitudinal magnetizations while minimizing metabolite contributions. MM spectra 
were acquired using DIR-metabolite-cycled semi-LASER sequence. LCModel con- 
centrations were fitted to the DIR signal equation to calculate T1-relaxation times. 
Results: T1-relaxation times of MMs range from 204 to 510 ms and 253 to 564 ms in 
gray- and white-matter rich voxels respectively at 9.4T. Additionally, concentrations 
of 13 MM peaks are reported. 
Conclusion: A novel DIR method is reported in this work to calculate T1-relaxation 
times of MMs in the human brain. T1-relaxation times and relaxation time corrected 
concentrations of individual MMs are reported in gray- and white-matter rich voxels 
for the first time at 9.4T. 
 
1 
K E Y W O R D S   
double inversion recovery, macromolecules, MR spectroscopy, quantification, semiLASER, 
T1-relaxation times, ultra-high magnetic field 
 




1 | INTRODUCTION  
Broad macromolecular resonances underlie metabolite spec- 
tra in 
1
H MR spectroscopy (MRS) at short echo times (TE). 
Macromolecules (MMs) between 0.5 and 4.5 ppm are at- 
tributed to mobile methyl, methylene, and methine groups of 
amino acids from cytosolic peptides and proteins.
1 
Several 
studies at field strengths between 1.5 to 3 T have highlighted 
the clinical relevance of MMs in aging
2 
and in pathologies 









To understand mechanisms 
better in the aforementioned pathologies, it is of interest to 
use advantages of higher field strengths. Due to increased 
spectral dispersion, signal-to-noise ratio (SNR), and resolu- 
tion, more MM peaks are distinguishable at ultra-high field 
(UHF) (B0 ≥ 7 T); hence, it is possible to more accurately 
characterize the behavior of individual MM peaks. 
On the other hand, the well-resolved underlying MM 
spectrum at UHF often distorts the metabolite spectrum. 
Therefore, characterizing MM peaks additionally improves 
accuracy in quantifying metabolites. Various techniques 
have been used to handle MM signals in metabolite spectra 
namely: (1) opting for longer TE while measuring the me- 
tabolite spectra,
7 
(2) applying mathematical models such as 
a flexible spline baseline while fitting metabolite spectra,
8 




The first two techniques (1, 2) do not prove to be the best 
solution at high field strengths (≥3 T). Using longer TEs (1) 
can lead to complications in quantifying metabolites due to 
decreased SNR and evolving J-coupling Therefore, short TEs 
are preferred in studies at UHF due to the generally faster 
transversal relaxation times of metabolites.
7 
With a decrease 
in the amount of overlapping of MM peaks at UHF, a flexi- 
ble spline baseline (2) may not hold to be a good solution to 
the problem of accounting for the MM spectrum accurately.
9 
Work done previously at 14.1 T acquired the MM spectrum 
by nulling metabolite resonances, and reported that the use of 
a prior knowledge MM spectrum in spectral fitting leads to 
more accurate and more reliable metabolite quantification at 
UHF.
10 
Hence, using prior information (3) from experimen- 
tally acquired MM spectra may prove to be a better solution. 
Inversion recovery (IR) techniques are a reliable method 
for acquiring MM spectra due to the relatively fast T1- 
relaxation times of MM peaks compared with those of me- 
tabolites.
11 
However, IR techniques that are used to acquire 
MM spectra introduce T1-weighting to the MM signals which 
depend on the chosen inversion time (TI) and repetition time 
(TR). It is likely that using T1-weighted MM spectra when 
fitting metabolite spectra, that are acquired without inversion 
pulses and typically a shorter TR, will influence quantitative 
accuracy. Indeed, a better characterization of the behavior 
of the relaxation times of the MM spectrum will lead to im- 
proved spectral fitting and fitting reproducibility. 
Previous studies have: characterized the T1-relaxation times 
of MMs in the human brain for MM spectra as a whole
12-14
; 
or for non-overlapping MM peaks
1,15,16
; or for groups of MM 
peaks.
11,17 
The T1-relaxation times of individual MM peaks 
have yet to be reported for any field strength. Characterizing 
T1-relaxation times for all individual MM peaks using a sin- 
gle inversion recovery technique is difficult due to eventual 
contributions from metabolites. More specifically, using a 
single-IR technique would have resulted in metabolites con- 
taminating MM spectra at most TIs through an inversion 
series; consequently, making it challenging to estimate the 
T1-relaxation times of most MM components with a sufficient 
range of longitudinal magnetization. Therefore, a double-IR 
(DIR) technique
18 
was chosen for this study because it per- 
mitted flexibility for more consistent nulling of metabolites 
along with observing a range of magnetizations of MM peaks. 
The flexibility gained with a DIR approach comes from the 
freedom to change the TI for both of the inversion pulses. 
Moreover, when using adiabatic localization sequences such 
as semiLASER, a DIR technique
18 
is more advantageous as 
this technique is shown to be insensitive to B+ effects.19 
Detection of 15 MM peaks between 0.8 and 4.2 ppm 
has been previously reported at 9.4 T by using DIR semi- 
LASER with metabolite cycling (MC).
20 
To measure an MM 
spectrum with minimal metabolite contribution an optimized 
combination of TIs (TI1/TI2 = 2360/625 ms) was required.
20 
However, for the current study, more than a single TI1/TI2 
combination was needed; consequently, several TI1/TI2 
combinations that yielded a range from negative to positive 
longitudinal magnetizations of MMs and simultaneously sup- 
pressed the metabolite signal had to be determined. 
Classically, characterizing T1-relaxation times of metab- 
olites requires either an inversion recovery series or a pro- 
gressive saturation approach with a TR-series to induce a 
sweep from negative to positive longitudinal magnetizations 
of the resonances of interest. The goal of the current study 
was to calculate the T1-relaxation times of 13 MM peaks be- 
tween 0.8 and 4.0 ppm in the human brain. However, simul- 
taneously minimizing metabolite contributions to detect MM 
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longitudinal magnetizations to determine T1-relaxation times 
of the MM peaks required extensive optimization on combi- 
nations of TI1/TI2. 
To determine suitable TI1/TI2 combinations, exhaustive 
Bloch simulations were performed for an optimized DIR 
technique. Ultimately, from all the Bloch simulation results, 
11 TI1/TI2 combinations were chosen for this study. Hence, 
a novel DIR approach with 11 different combinations of two 
inversion delays is described to determine the T1-relaxation 
times of individual MM resonances. Using this approach, 
T1-relaxation times for all MM resonances between 0.8 and 
4.0 ppm are reported for the first time in the human brain at 
9.4 T in both gray matter (GM) and white matter (WM). 
Furthermore, quantification using internal water as refer- 
ence was performed for each MM peak reported in this work 
by using the knowledge gathered for the T1-relaxation times 
of MM peaks and T2-relaxation results from Murali-Manohar 
et al.
21
; thus, concentrations without correction for proton 
density are reported. This work is an extension of the pre- 




2 | METHODS  
2.1 | Study design 
Eleven healthy volunteers (6 males, 5 females, age: 27.7 ± 
2.3 years) were measured on a 9.4 T Siemens Magnetom 
whole-body MRI scanner (Siemens Healthineers, Erlangen, 
Germany) using a home-built 8Tx/16Rx coil.
23 
The coil 
was driven in surface mode by a three-way splitter to drive 
power to the bottom three channel-elements as described in 
Giapitzakis et al.
20 
A 2 × 2 × 2 cm
3 
voxel was placed spanning 
the longitudinal fissure of the occipital lobe for GM meas- 
urements, and a voxel was placed within the left occipital- 
parietal transition for WM measurements (Figure 1). All 
eleven volunteers completed participation for GM measure- 
ments; however, only nine volunteers (4 males, 5 females, 
age: 28.2 ± 2.2 years) finished the second acquisition for 
WM measurements. Studies were performed with approval 
of the local ethics committee, and volunteers provided writ- 
ten informed consent prior to measurements. 
 
2.2 | Bloch Simulation 
A range of longitudinal magnetization values for MM sig- 
nals ranging from negative to positive MZ are required to cal- 
culate T1-relaxation times of MM resonances. To estimate 
individual MM peaks, the metabolite signals must be sup- 
pressed as much as possible. Hence, Bloch simulations were 
performed assuming a single proton spin to determine DIR 
schemes with suitable TIs TI1 and TI2. The magnetization 
vector (M(x, y, z)) was calculated for the actual inversion 
pulse shape implemented at the 9.4 T MRI scanner and the 




FIGURE 1 Top, MC semi-LASER sequence preceded by double inversion recovery scheme. TI1 and TI2 were changed as given in Table 1. 
Bottom, Voxels were placed into GM-rich (left) and WM-rich (right) regions to measure the inversion series. Red within the highlighted region 
represents WM; whereas, blue within the highlighted region represents GM. The average voxel content for GM-rich and WM-rich voxels were 





  MURALI-MANOHAR ET AL. 
 
in Figure 1; the inversion pulse profile is described in fur- 
ther detail by Giapitzakis et al.
19 
The available longitudinal 
magnetization following a DIR block is given by the MZ 
component, and the ratio of Mz to the initial magnetization 
(MZ/M0) was calculated for the inversion pulse profile
19 
with 
a frequency offset range equal to the actual bandwidth of the 
pulse (−2000 to 2000 Hz, Supporting Information Figure S1, 
which is available online).
20
 
Metabolite T1-relaxation times were taken from previ- 
ously acquired in vivo results at 9.4 T.
7 
MM resonances were 
grouped as a single MM spectrum containing all resonances 
with a T1-relaxation time measured in vivo at 7 T.
13 
In addition 
to effects of T1-relaxation, the transmit field strength B+ and 
resonance offset effects were accounted for in the Bloch sim- 
ulations. MZ/M0 for MM spectrum and metabolite peaks were 
systematically simulated in increments of 50 ms for the first 
pass sweeping a range from 800 to 2500 and from 10 to 800 ms 
for TI1 and TI2 respectively. Following the initial simulation, 
tighter increments were simulated for TI1/TI2 combinations 
to find optimal inversion delays. TI1/TI2 combinations were 
chosen such that spectra had minimal metabolite residual Mz 
while sweeping a range of Mz for MM signals as reported in 
the Results section. These resultant TI1/TI2 combinations were 
then further tested in vivo to ensure acquisition of clean MM 
spectra with minimal contribution from metabolites. For addi- 
tional information, the script used for Bloch simulations has 
been provided in Supporting Information Material Annex A. 
 
2.3 | Data acquisition 
High-resolution 2D FLASH images (in-plane resolution: 0.7 × 
0.7 mm
2
, slice thickness: 3.5 mm, 25 slices) were acquired 
in the sagittal and transversal planes to position spectroscopy 




shimming and power optimization
25,26 
were performed to en- 
sure that sufficient linewidths and adiabatic conditions would 
be fulfilled. The shim volume was set to be 150% of the vol- 
ume of the voxel of interest. 
A metabolite-cycled semi-LASER (MC semi-LASER) 
sequence
27 
preceded by a novel DIR technique
20 
(Figure 1) 
was used for spectroscopic acquisition (echo time [TE]/TR = 
24/8000 ms; number of excitations [NEX] = 32) with 11 dif- 
ferent combinations of TI1 and TI2 (Table 1). The TR used in 
all combinations of TI1/TI2 was given such that the following 
inversion pulse (TI1) did not begin until 8000 ms after the 
position of the MC pulse (Figure 1). The transmit reference 
frequency was set at 2.4 ppm, and a 16-step phase cycling 
scheme was implemented. To avoid any influence of MC 
pulses on quantification based on internal water referencing, 
additional unsuppressed water reference signals (NEX: 16) 
were acquired with semi-LASER (TE: 24 ms) without MC. 
TABLE 1 Corresponding ratios of Mz to the initial magnetization 
(Mz/M0) of MMs and a range for metabolite singlets (NAA(CH3), 
tCr(CH3), tCr(CH2), and tCho) are reported from Bloch simulation 
results for each TI1/TI2 combination. Magnetization ratios are reported 
following simulation of the two inversion pulses and prior to any 
magnetization effects from localization pulses. Spin ensemble Bloch 
simulations used T1-relaxation times from 9.4 T for metabolites
49 
and 
from 7 T for the combined MM spectrum.
13 
Ten of the TI1/TI2 
combinations maintain minimal metabolite residuals; while one 
combination (1050/238 ms) was higher in metabolite contributions and 
used as an MM null point spectrum. 
 
MZ/M0 
TI1/TI2 [ms] MMs Metabolites 
2360/625 0.5344 −0.0451 to 0.0200 
2150/600 0.5079 −0.0020 to 0.0220 
2000/575 0.4799 −0.0030 to 0.0225 
1900/550 0.4501 0.0056 to 0.0362 
1800/525 0.4191 0.0079 to 0.0521 
1050/238 −0.0498 −0.0146 to 0.2195 
1300/80 −0.5797 −0.3267 to 0.0080 
1300/60 −0.6549 −0.3528 to −0.0033 
1200/20 −0.7919 −0.3497 to 0.0290 
1250/20 −0.8048 −0.3787 to 0.0011 







) were acquired 
with the same coil mentioned above by driving power to all 
eight channels. MP2RAGE data were used to calculate tis- 
sue volume fractions for each voxel to correct for the tissue 
composition dependence of T1-relaxation as well as for MM 
quantification. 
 
2.4 | Data preprocessing 
The raw data were reconstructed with an in-house MATLAB 
(version 2016a, MathWorks, Natick, MA) tool and were 




Firstly, the FIDs were truncated to 250 ms so that data 
with better SNR were available for the following data prepro- 
cessing steps. Then they were frequency and phase-aligned 
in the time domain. This was followed by metabolite-cycling 
subtraction and the data were then averaged. After this, the 
data were zero-order phase and eddy current corrected using 
the phase information from the MC water signal. Signals 
from all 16 receive channels were then combined using an 
SVD method. The residual water in the spectra was removed 
using a HSVD method, and finally, the FIDs were truncated 
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2.5 | Spectral fitting 
Spectra were fitted with LCModel (v6.3-1L)
29 
using simu- 
lated Voigt lines (CHSIMU) to fit 13 MM peaks. MM data 
were fit from 0.8 to 4.0 ppm. Initial fitting of MM spectra 
was performed using the subject-wise summed results for 
each TI1/TI2 combination. Metabolites predicted to contribute 
by Bloch simulations were initially included as characteristic 
spectral pattern in the basis sets, but only those metabolites 
which were fit in the initial trial (fitting subject-wise summed 
spectra) was kept in the final fit settings to avoid over- 
parameterization (Supporting Information Table S1). Complete 
basis vectors were not suitable for fitting metabolite residuals 
for the NAA(CH3) singlet and tCr resonances at most TI1/TI2 
combinations due to the minor contributions to spectra and dif- 
ferent relaxation of different moieties of the same metabolites. 
Thus, the contributions from these metabolite signals were 
simulated using narrow Voigt line shapes. Following determi- 
nation of metabolite contributions from summed spectra, opti- 
mized basis sets were defined for fitting of the individual data 
sets (Supporting Information Material Annex B). 
The chosen combinations of simulated Voigt lines were 
used to represent residual singlets in the spectra: N-acetyl 
aspartate (NAA(CH3) – 2.008 ppm), and creatine (tCr(CH3) 
– 3.027 ppm and tCr(CH2) – 3.925 ppm) across the inver- 
sion series to handle residual metabolite signals (Supporting 
Information Table S1). myo-Inositol (mI) was simulated 
in VesPA and was included in the basis set with negative a 
phase to fit spectra with TI1/TI2 = 2360/625, 2150/600, and 
2000/575 ms (Supporting Information Table S2). Glycero- 
phosphocholine (GPC), mI, glutamate (Glu), mI and aspar- 
tate moiety of NAA (NAAasp) were simulated in VesPA,
30
 
and were included in the basis set only for TI1/TI2 combina- 
tions that had negative MZ (i.e., inverted peaks with negative 
amplitudes). The chemical shifts of MM peaks were chosen 
from Murali-Manohar et al.
21  
Fit settings files are given in 
 
baseline stiff to allow for a more accurate fit of the MM data, 
and water scaling was performed to more accurately quantify 
the MM resonances. 
LCModel water scaling was performed with respect to 
the downfield NAA amide resonance at 7.79 ppm (wsppm = 
7.79, n1hmet = 1) rather than the LCModel default water 
scaling peak (tCr(CH3) taking three protons contribution). In 
particular, there were no peaks in the upfield range of the 
spectrum that were not affected by the DIR scheme. Thus, the 
downfield NAA amide resonance was chosen as its amplitude 
was stable and was not affected by the DIR scheme. Water 
scaling with the stable NAA-NH resonance not only allowed 
shifting of the spectrum with respect to a known resonance 
frequency, but also was included to account for variations 
in coil loading across subjects. Automated LCModel phase 
correction was also constrained by the downfield NAA peak. 
This approach provided a stable reference for quality control 
of LCModel fitting results. 
 
2.6 | Segmentation 
MP2RAGE images were segmented into GM, WM, and CSF 
probability maps with SPM12.
32 
2D FLASH images used for 
voxel placement were co-registered to the MP2RAGE image 
using SPM12, which returned an affine transformation be- 
tween the image spaces. The affine matrix relating the two 
images was used in a home-built Python (v3.7)
33,34 
tool to 
determine the tissue fraction in spectroscopy voxels. 
 
2.7 | T1 calculation 
Following spectral fitting in LCModel, all data were sorted by 
TI1/TI2 combination and fitted to the DIR signal equation
35
 
Supporting Information Material Annex B. 
To fit the MM null point data (TI1/TI2 = 1050/238 ms), 





1 − 2e 
– 
TI2 
T1 + 2e 
– 
TI1 +TI2 
T1 . (1) 
tCr(CH2), GPC, glutamine (Gln), Glu, gamma-aminobu- 
tyricacid (GABA), glycine (Glycin), Aspartate (Asp), mI, 
NAAasp, and taurine (Tau) were simulated using VeSPA.
30 
Metabolite basis vectors were chosen to be given here be- 
cause of the low MM signals and the strong metabolite contri- 
butions. The simulated basis set was created with a modified 
semiLASER protocol
31 
with sequence parameters and pulses 
adjusted to match those in the present study. 
Individual phases of metabolite residuals were adjusted in 
the LCModel basis sets as necessary depending on the mag- 
netization achieved from a TI1/TI2 combination. Furthermore, 
the observed phase for DIR combinations was adjusted indi- 
vidually for GM- and WM-rich voxels to improve the accu- 
racy of fits. DKNTMN parameter was set to 99 to keep the 
The optimization was done as a four-parameter bi- 
exponential model on the signal curve. In this model, TI1 and 
TI2 were both known parameters while a and T1 were both 
unknown variables which were optimized on. Optimizing 









tool kits with 
a non-linear least squares, Levenberg-Marquardt algorithm; 
where a was assumed as a constant. Individual LCModel 
concentrations from all subjects were used in the curve fitting 
to calculate MM T1-relaxation times. 
T1-relaxation has been shown to vary predominantly due 
to tissue type for water
28,39 
in contrast to T2-relaxation which 
also varies spatially depending on microscopic susceptibil- 
ity differences.
40 
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the relaxation of theoretically pure GM and WM voxels, 
Tpure voxel and Tpure voxel respectively, was used. The following 
to be that of pure water (55,510 mmol/kg). SMM is the signal 
from an MM peak; 
1, GM 1,WM 
two linear equations were concurrently solved by assuming 
a linear relationship of relaxation time to the contribution of 
tissue type: 
 
R = exp −





1 − exp −
  TR 
 
T1H2O 









(2) is the relaxation correction factor for each water compartment 
y. T1H2Oy and T2H2Oy are the T1- and T2-relaxation times of 
water in the compartment y; in particular, the relaxation times 
ff ⋅Tpure voxel + ff ⋅Tpure voxel = Trich voxel ⋅ 1 − ff 
     of water in GM are T1 = 2120 ms, T2 = 37 ms; 
(3) 
where fy_vol represents the tissue fraction in measures from GM- 
in WM are T1H20_WM = 1400 ms, T2H20_WM = 30 ms; and in 
CSF are T1H20_CSF = 4800 ms, T2H20_CSF = 181 ms at 9.4 T.
28
 
rich voxels and ff represents the tissue fraction measures TI2 RMM =   1 − 2e T1   + 2e 
– 
 TI1 +TI2 T1 exp  −   TE   1 − exp  −
TR
 
from WM-rich voxels. More specifically, by solving Equations 
(2) and (3) as a linear system, it allows us to then approximate 
T2MM T1 
the T1-relaxation time of voxels with arbitrary ratios of GM and 
WM. 
 
2.8 | Quantification of MM peaks 
MM concentrations were quantified in protons mmol/kg 
by using spectra acquired with a TI1/TI2 combination of 
2360/625 ms from all subjects in both GM- and WM-rich 
voxels. Spectra corresponding to TI1/TI2 combination of 
2360/625 ms were chosen for quantification because it of- 
fered maximal MM signal retention as well as minimal me- 
tabolite residuals. 
For internal water referencing, the concentrations result- 
ing from LCModel fitting were corrected for tissue water 
fractions and relaxation times as follows
41
: 
SMM × fGM ×RH20 +fWM ×RH20 +fCSF ×RH20 
[M] = GM WM CSF  
 
is the relaxation correction term for macromolecules. T2MM 
were considered from Murali-Manohar et al
21 
and T1MM de- 
termined from this work were taken. The denominator 1 −fCSF 
was implemented for partial-volume correction arising from 
contributions of CSF to the voxel volume. The factor 2 was 
introduced to correct for the multiplication of even numbered 
acquisitions with the scaling factor (Fs) from metabolite cycling. 
 
3 | RESULTS 
3.1 | Bloch simulations 
Bloch simulation results for TI1/TI2 = 2000/575 and 
2150/600 ms are shown in Supporting Information Figure S1. 
Simulations estimated similar metabolite nulling efficiency 
for the all chosen TIs retaining the MM signal at different ob- 





MM ×#HMM The MM null spectrum resulted in a maximum Mz/M0 
× 
2 of 0.22 of metabolites and −0.05 of MM  spectrum; this 
   × H2O specific TI /TI combination was optimized by confirm- 
1 +FS 1 2 
 
f × a 
ing spectral quality in vivo from two healthy volunteers. 
Table 1 shows the chosen TIs and the corresponding 
where f = y_vol y .
 M /M for each MM spectrum. The M /M for MM spectrum y fGM_vol× aGM + fWM_vol× aWM + fCSF_vol× aCSF z 0 z 0 
Here y corresponds to either GM, WM, or CSF; fy_vol is 
the fraction of the respective tissue type determined by seg- 
mentation; ay are the relative densities of MR-visible water 
for the given tissue types (78%, 65%, 97% for GM, WM and 
CSF respectively
42
); these ay remain uncorrected for the rela- 
tive densities of GM and WM tissue (1.04 g/ml
43-45
) and were 
taken to be 1.0 g/ml. #HMM is the number of protons that con- 
tribute to the signal of an MM peak, and was not accounted 
in this work. To arrive at proton mmol/kg concentrations, the 
concentration of water within a voxel, [H2O], was assumed 
after DIR range block from −0.82 to 0.58 for the 11 chosen 
TI1/TI2 combinations. 
 
3.2 | Inversion series of spectra and 
voxel content 
Metabolite-nulled spectra were obtained with the 11 chosen 
TI1/TI2 combinations encompassing a range of magnetiza- 
tions. Summed spectra from the inversion series for GM and 
WM MM spectra are displayed in Figure 2. 
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FIGURE 2 DIR series spectra from GM-rich (left) and WM-rich (right) voxels summed subject-wise. The same TI1/TI2 combinations were 
used to measure the T1-relaxation times for GM- and WM-rich voxels. The DIR series shows a broad range of signal intensities measured for MM 
peaks while having simultaneously minimized metabolite peaks 
 
The subject-wise summed spectra display good spectral 
quality with 13 resolved MM peaks across the 11 TI1/TI2 
combinations. However, there was noticeable noise and 
sometimes slight lipid contamination in the individual, non-
summed spectra. Nevertheless, 13 MM peaks could be 
observed in a majority of spectra in both GM-rich and WM-
rich voxels. Therefore, all data sets were included in the 
analysis. 
On average, the tissue content for GM-rich and WM-rich 
voxels were found to be GM/WM/CSF = 72 ± 2/22 ± 3/6 
± 4% and 35 ± 6/62 ± 7/3 ± 3% respectively. Indeed, resid- 
ual metabolite signals were observed in several DIR spectra 
at various TI1/TI2 combinations, and the residual metabolite 
resonances corresponding to each TI1/TI2 combination is 
given in Supporting Information Table S1. 
 
3.3 | Spectral fitting 
Figure 3 shows fits and residues from LCModel for TI1/TI2 = 
2360/625, 1300/20, and 1050/238 ms subject-wise summed 
spectra from GM-rich voxels. Fits corresponding to the same 
3.4 | T1 relaxation times 
Figure 5 and Supporting Information Figure S4 show all MM 
peak data fitted to Equation (1) to calculate the T1-relaxation 
times of MM peaks in 3D signal plot diagrams. Black crosses 
represent individual data points from the TI1/TI2 series. The 
dashed, blue line represents the result from fitting the data 
to Equation (1) with a Levenberg-Marquardt algorithm. 
Resultant T1-relaxation times of 13 MM peaks are reported 
for GM-rich and WM-rich voxels in Table 2 and shown in 
Figure 6. T1-relaxation times of MM peaks range from 204 to 
510 ms and 253 to 564 ms in GM-rich and WM-rich voxels 
respectively. M3.62 had the longest T1-relaxation time in both 
GM- and WM-rich voxels. The results from GM-rich and 
WM-rich voxels were used to solve for the T1-relaxations of 
theoretically pure GM and WM voxels with a linear system 
of two equations and are reported in Table 2. 
The goodness of fit for each MM T1-relaxation time cal- 
culated was assessed by the coefficient of determination 
(R
2
). The differences in T1-relaxation times between GM- 
and WM-rich voxels were evaluated using Welch’s t-test 
(α = 0.05) for all MM peaks. Adjusted P-values were cal- 
TI1/TI2 combinations from WM-rich voxels are given in culated using the Bonferroni correction α   
tests 
to cor- 
Supporting Information Figure S2. Supporting Information 
Figure S3 shows fits for the remaining eight TI1/TI2 com- 
binations for subject-wise summed spectra from GM-rich 
voxels. The tailored basis sets, for each TI1/TI2 combination 
and according to tissue type, fit the pre-processed data well. 
Furthermore, the residual for summed spectra fit from both 
GM-rich and WM-rich voxels showed minimized metabo- 
lite residuals. The fit residuals lacked structure in individual 
per subject fits (Figure 4). Metabolite residual fitting using 
basis vectors and fitted Voigt lines (Supporting Information 
Table S1) for residual peaks was sufficient for 10 TI1/TI2 
combinations spectra; for the TI1/TI2 = 1050/238 ms combi- 
nation yielding almost MM nulled spectra, a metabolite basis 
set was included, and it accurately accounted for metabolite 
contributions to spectra. 
rect for multiple comparisons. Significant differences in T1-
relaxation times between GM- and WM-rich voxels are 
denoted in Figure 6 and Table 2 by an asterisk: *P < .0038. 
Results from Welch’s t-test and P -values are reported in 
Supporting Information Table 3. 
 
3.5 | Quantification of MM peaks 
The TI1/TI2 combination of 2360/625 ms was chosen for 
quantification of MM peaks by means of internal water 
referencing. The unsuppressed water spectrum used for in- 
ternal water referencing. The concentration results are thus 
reported in Figure 7 and Supporting Information Table S4. 
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times of MMs from this work and for T2-relaxation times 
from Murali-Manohar et al,
21 
with corrections as described 
in the Methods section. M2.04 has the highest concentration 
in both GM- and WM-tissue types with 78.4 ± 10.7 and 76.6 
± 10.9 protons mmol/kg respectively. M0.92 has similar con- 
centrations in GM- and WM-voxels, 21.1 ± 3.3 and 21.0 ± 
 
 
FIGURE 3 LCModel fits of summed spectra for 2360/625, 
1200/20, and1050/238 ms for GM-rich voxel. Summed spectra 
were fitted using simulated Voigt lines for MM peaks. Metabolite 
contributions were accounted for using sharp Voigt lines to fit 
metabolite singlet residuals (NAA(CH3), tCr(CH2), and tCr(CH3)) and 
basis vectors to fit other metabolite residuals. Fitting results from the 
subject-wise summed spectra were used to guide creation of basis sets 
for fitting of individual spectra. Corresponding subject-wise summed 
spectra for WM voxels are shown in Supporting Information Figure S2. 
The remaining inversion series fit for subject-wise summed spectra for 




2.6 protons mmol/kg, respectively. Wilcoxon rank-sum tests 
(α = 0.05) were performed to assess for differences in con- 
centrations between tissue types for all MM peaks. After 
correcting for multiple comparisons, using a Bonferroni cor- 
rection α = 0.0038 , a significant difference for the con- 
centration of M3.75 (P = .0009) between GM and WM was 
found (Figure 7 and Supporting Information Table S4). 
 
4 | DISCUSSION  
While it is possible to estimate T1-relaxation time of the MM 
spectrum when using a single inversion recovery approach by 
simultaneously fitting metabolites, SIR techniques have been 
used to measure T1-relaxation times of non-overlapping MM 
resonances as well as the whole MM spectrum. However, 
this could lead to misestimation of the MM peaks underlying 
metabolites and to ambiguities with respect to distinguish- 
ing metabolite and MM signals during spectral fitting.
46,47 
Although there were also metabolite residuals present in the 
proposed DIR technique, this approach reduced metabolite 
residuals better at the expense of T1-weighting. Bloch simu- 
lations were used to predict where metabolites would be con- 
tributing to the MM spectra. Supporting Information Table S1 
shows in detail where metabolite vectors or singlets were in- 
cluded in the MM spectral fitting. Albeit, T1-relaxation time 
estimates for individual MM peaks were possible. 
Careful evaluation of Bloch simulation results helped de- 
termine valid sets of TI1/TI2 combinations. While there were 
many simulated TI1/TI2 combination results that maintained 
high MZ of MMs, the contributions of metabolites in many 
of these cases led to heavy contamination in MM spectra or 
noisy MM spectra. While the chosen TI1/TI2 combinations 
provided good MM spectra there were still metabolite resid- 
uals that required fitting. 
All 11 TI1/TI2 combinations were used in the calculation 
of T1-relaxation times for MM peaks. The five TI1/TI2 com- 
binations with negative Mz/M0 covered a range from −0.82 
to −0.58, and the five TI1/TI2 combinations with positive 
Mz/M0 covered a range from 0.42 to 0.53 as can be seen from 
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standard deviation and R
2 
of the curve fit for T1-relaxation 
values which imply good confidence. Previous results
48 
sug- 
gested a TR of 8000 ms to be the best bet for a comfortable 
scan duration and to stay within specific absorption rate 
limits. 
It was expected that WM-rich voxels may be slightly 
noisier and lower in SNR. This arose from the fact that WM- 
rich voxels were typically further away from the transmit 
coil elements; thus, the achieved B1 was lower for WM-rich 
voxels compared to GM-rich voxels. As was evidenced by 
the data in this study, WM data tended to be slightly noisier 
(Figure 2), but the metabolite residuals in MM spectra for 
GM-rich and WM-rich voxels were similar. However, MM 
peaks were T1-weighted slightly differently in GM-rich and 
WM-rich voxels due to the differences in their T1-relaxation 
times. 
Reliable HSVD for residual metabolite suppression was 
not achievable for particular TI1/TI2 combinations poten- 
tially due to the broad linewidths encountered and low SNR. 
A detailed list of all the metabolite residuals present in the 
corresponding TI1/TI2 combination spectra that were fitted 
is given in Supporting Information Table S1. M4.03 and M4.20 
were excluded from analysis due to water contamination in 
the spectra in multiple TI1/TI2 combinations. 
NAAasp, mI, Glu, and GPC were predicted to be metab- 
olite residuals in the negative MZ MM spectra due to their 
T1-relaxation times,
49 
and were furthermore visible when fit- 
ting spectra. To correct for the contribution these metabolites, 
they were simulated and added to all basis sets corresponding 
to TI1/TI2 combinations resulting in negative magnetization. 
From Supporting Information Figure S4, it can be seen 
that the negative Mz points had larger amounts of signal 
for M2.99, M3.62, and M3.75 which skewed the signal fit re- 
sulting in a longer calculated T1-relaxation time. It could 
be that lower weight metabolites contributed to the reso- 
nances within these peaks, which led to the increased es- 
timation of the T1-relaxation time. Attempts to account 
for metabolite resonances at these peaks were performed 
by including metabolite basis vectors; however, it was 
not possible to reliably fit all potential contributions from 
lower weight metabolites with this scheme. The increased 
T1-relaxation times for these peaks at 3T have been re- 
ported by Hoefemann et al
17
; in their study the observed 
T1-relaxation times reached the “predefined borders of … 
400 ms for T1.” 
T1-relaxation times of MM peaks in GM- and WM-rich 
FIGURE 4 A representative subject fit for 2360/625, 1200/20, 
and1050/238 ms for GM-rich voxel. All three spectra are from the 
same subject. The peaks for metabolite residuals were modeled based 
on the summed spectra fit shown in Figure 3 
be sampled due to the additional need to suppress metabolite 
signal, the chosen approach appears to be adequate for mod- 
eling the T1-relaxation of MM peaks evidenced by the low 
voxels range from 204 to 510 ms and from 253 to 564 ms, re- 
spectively. For pure GM and WM voxels, T1-relaxation times 
are between 189 and 478 ms, and between 220 and 612 ms 
respectively. Indeed, the linear relationship used to calculate 
T1-relaxation times likely simplifies the complex nature of 
the MM spectrum. However, it could be useful in modelling 
MM spectra voxel-wise where T1-weighting of MMs is pres- 
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FIGURE 5 A signal scatter plot and 
fitted solution (blue dashed line) from the 
inversion series for M0.92 fitted by Equation 
(1). Black crosses represent data points 
from the 11 volunteers acquired in GM-rich 
voxels, and the blue line is the fitted solution 
to Equation (1). T1-relaxation calculation 
plots for the other MM peaks are reported 
in Supporting Information Figure S4. Points 
were excluded when the CRLB was equal 
to 999 because these points were not fitted 
in LCModel. In the present fit of M0.92, no 

















326 ± 21 0.867 270 ± 24 0.828 358 ± 57 220 ± 50 
M1.67 231 ±13 0.903 253 ± 17 0.894 218 ± 37 273 ± 32 
 
TABLE 2 T1-relaxation times of 
13 MM peaks in both GM-rich and 
WM-rich voxels at 9.4T are presented in the 
table with accompanying R
2 
values for the 
fit of the data to Equation (1). Furthermore, 
T1-relaxation times of pure GM and WM 
voxels for these peaks are also reported as 
solved by Equations (3) and (4). MM peaks 
that have significant differences between 
GM- and WM-rich voxels are indicated 
M 
* 
279 ± 8 0.971 319 ± 9 0.974 256 ± 22 355 ± 19 
2.04 
2.26 










The broad range of MM peak T1-relaxation times suggests 
that approximating the T1-relaxation time of the MM spectrum 
as single value may not be ideal for quantifying MM peaks 
with high accuracy. Furthermore, when a measured IR MM 
spectrum is included to fit metabolites, T1-weighting within 
the MM spectrum could lead to misestimates of metabolite 
concentrations. For example, the MM spectrum correspond- 
ing to TI1/TI2 = 2360/625 ms was used in fitting metabo- 
lites in previous works.
21,27 
However, as seen from Table 3, 
T1-weighting for MM peaks following this DIR scheme range 
from 42% to 87% in a GM-rich voxel and 35% to 83% in 
a WM-rich voxel. Hence, quantifying metabolites with this 
particular MM spectrum could lead to over- or under-fitting 
of metabolites amplitudes depending on the T1-weighting of 
different MM peaks. 
While comparing differences between GM- and WM- 
rich T1-relaxation times, significant differences (P < .0038) 
between tissue types were found for all MM peaks except 
M0.92, M1.21, M1.67, M2.56, and M3.86 as shown in Figure 6 and 
Supporting Information Table S3. Based on T1-relaxation 
differences between GM and WM, tissue type specific MM 
models could be more appropriate than using averaged MM 
spectra to fit MM signals especially in metabolite spectra. 
The relaxation times of MM peaks do not follow a clear 





measured the T1-relaxation 
610 | 
T1 Relaxation times of Macromolecules 
GM-rich 









M0.92 280 ± 10 0.959 284 ± 10 0.966 278 ± 26 288 ± 23 




281 ± 7 0.977 313 ± 9 0.972 263 ± 20 342 ± 17 results are in Supporting Information 
M2.56 309 ± 20 0.866 327 ± 18 0.915 299 ± 50 343 ± 44 Table S3 
M 
* 
306 ± 19 0.879 383 ± 22 0.902 262 ± 52 452 ± 45  
M 
* 
463 ± 15 0.953 518 ± 15 0.966 431 ± 39 567 ± 34  
M 
* 
204 ± 20 0.785 379 ± 29 0.836 103 ± 59 535 ± 51  
M 
* 
510 ± 30 0.846 564 ± 35 0.853 479 ± 82 612 ± 71  
M 
* 
280 ± 24 0.805 434 ± 25 0.887 191 ± 63 571 ± 55  
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FIGURE 6 T1-relaxation times for 13 MM peaks are reported. Results are shown for GM- and WM-rich voxels as well as for GM- and 
WM-pure voxels. The T1-relaxation estimates for pure voxels were extrapolated by means of Equations (2) and (3). Additionally, these values are 
reported in Table 2. MM peaks that have significant differences following Welch’s t-test and Bonferroni correction between GM- and WM-rich 
voxels are indicated by an asterisk *P < .0038. Full statistical results are in Supporting Information Table S3 
 
 
TABLE 3 Calculated T1-weighting in percent of MM peaks following DIR scheme (TI1/TI2 = 2360/625 ms; TR = 10 s) using T1-relaxation 
times from measured GM- and WM-rich voxels in this work 
T1-weighting [%] 
 M0.92 M1.21 M1.39 M1.67 M2.04 M2.26 M2.56 M2.70 M2.99 M3.21 M3.62 M3.75 M3.86 
GM 78 80 71 87 79 78 74 74 48 91 42 79 79 
WM 78 78 80 83 72 73 70 61 41 62 35 53 74 
 
of the M0.93 peak as 250 ms at 4.0T, which is slightly lower 
compared to the T1-relaxation time measured in this work 
at 9.4 T confirming the field strength trend for this non- 
overlapping MM peak. However, recent work at 3 T found the 
T1-relaxation time of M0.92 to be about 290 ms.
17
 
For the first time, concentrations of 13 MM peaks are re- 
ported (Supporting Information Table S4) for both GM- and 
WM-rich voxels after correcting for T1- and T2-relaxation 
times. Previous works
5,20,53,54 
have reported concentrations for 
some or all peaks without correcting for T1- or T2-relaxation 
times. Inversion recovery preceding the localization scheme 
will lead to strong T1- weighting of the MM spectrum, and 
not correcting for the relaxation times will result in discrep- 
ancies in concentrations across sites while using different in- 
version recovery techniques. Due to severe overlap of MM 
peaks, the number of protons contributing to each peak is 
not easily accountable; hence, the concentration values were 
not corrected for the number of contributing protons. The 
concentration of M0.92 agrees with the values reported by 
Hofmann et al
55 
and Snoussi et al,
53 
and are slightly less than 
the recent results from Landheer et al.
54 
However, concen- 
trations for other MM peaks or groups of MM peaks vary 
among literature.
20,53-55 
The results from Landheer et al
54 
ap- 
pear that they could be in agreement with the current work 
at 9.4 T; however, the uncorrected T1-weighting could be a 
cause of discrepancy between results. 
Statistical tests highlighted a significant difference for ele- 
vated concentration of M3.75 (P = .0009) in WM. Furthermore, 
the results suggest that there could be slight variation between 
tissue types for M1.39, M2.99, and M3.21; whereas the differ- 
ences between GM and WM tissue signal for M2.26 have 
been reported in MRSI results.
56 
Figure 7 and Supporting 
Information Table S4 suggest that there are trends toward ele- 
vated concentrations of M1.39 in GM and for M2.99, and M3.21 
in WM; however, this study was not able to claim with cer- 
tainty that these concentrations vary in a significant manner. 
Further work focusing on specific MM peaks is necessary to 
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FIGURE 7   MM concentrations are reported in protons mmol/kg for each MM peak. Black crosses represent data points that were not within 
the 95% confidence interval (assuming a Gaussian distribution). Mann-Whitney U-tests (α = 0.05), with Bonferroni adjustment α = 0.0038 for 
multiple comparisons were performed to test for statistical significance in differences between GM- and WM-rich voxels. Supporting Information 
Table S4 lists the results from Mann-Whitney U-tests 
 
Finally, it has been previously reported by Giapitzakis et al
57 
that significant differences arise in some of the metabolite con- 
centrations while using MM spectrum from different brain re- 
gion to account for MM contribution underlying the metabolite 
spectrum. Based on the differences in T1-relaxation times of 
MM peaks in GM- and WM-rich voxels reported in this work, 
we believe that it could be beneficial to account for underlying 
MM spectra with tissue content considered in order to maintain 
quantitative accuracy in spectral fitting of metabolites. 
 
5 | CONCLUSIONS  
In this work, we report a novel DIR technique to measure T1- 
relaxation times of individual macromolecular peaks. The study 
here is performed at 9.4 T; however, this technique is extendible 
to all field strengths. T1-relaxation times for 13 MM resonances 
in vivo at 9.4 T are reported for the first time. The differences 
in the T1-relaxation times between the MM resonances suggest 
that T1-weighting from inversion pulses and short TRs should 
be considered while using experimentally acquired MM spectra 
in fitting metabolite spectra. Alternatively, simulation models 
which account for relaxation effects of MMs could also provide 
a solution for estimating MM contributions to metabolite spectra 
where overlapping peaks are difficult to distinguish. This will 
allow us to produce more accurate quantitative results by correct- 
ing for the influence of MMs in short TE spectra. Furthermore, 
concentrations of 13 MM peaks after correcting for both 
T1- and T2-weighting are reported. 
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Additional Supporting Information may be found online in 
the Supporting Information section. 
FIGURE S1 Bloch Simulation results for an inversion pulse 
profile
20 
(pulse duration: 15 ms) after a DIR scheme with TIs 
(A) TI1/TI2 = 2000/575 ms and (B) TI1/TI2 = 2150/600. The 
being elevate
n
d in WM was found when assessing MM 
concentrations 
Video S1 The cine representation of Figure 5 shows a rota- 
tion of the 3D space of the T1-relaxation time curve fitting for 
M0.92. TI1 and TI2 are given in the x- and y- axes respectively 
in seconds; z-axis represents the normalized signal [a.u.]. The 
black crosses are individual data points from eleven volunteers 
and the blue line is the projected fitting to equation 1. 
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Supporting Information Figure S1: Bloch Simulation results for an inversion pulse profile27 (pulse 
duration: 15 ms) after a DIR scheme with inversion times a) TI1/TI2 = 2000/575 ms and b) TI1/TI2 = 
2150/600. The resulting inversion bandwidth is represented by the frequency axis (x-axis); while the y- 
axis depicts the resulting MZ/M0 of MM and metabolites at the end of the DIR sequence block. MZ/M0 of 




Supporting Information Figure S2: Fit of WM subject-wise summed spectra of TI1/TI2 combinations 







Supporting Information Figure S3: Fits of subject-wise summed GM spectra of TI1/TI2 combinations 






















Supporting Information Figure S4: Surface Curve fitted to TI1/TI2 series for M1.21, M1.39, M1.67, M2.04, M2.26, 
M2.56, M2.70, M2.99, M3.21, M3.62, M3.75, and M3.96 from GM-rich voxel to calculate T1-relaxation times. For 












Supporting Information Table S1: Residual peaks present corresponding to each TI1/TI2 are given in the 
table. tCr(CH2), tCr(CH3), and NAA(CH3) residual peaks were added as singlets using simulated Voigt lines 
in LCModel for fitting spectra. NAAasp, mI, GPC, and Glu were added to handle the residuals in negative 
Mz spectra. For TI1/TI2 = 1050/238 ms, a complete basis set was provided which was simulated for a 







[ms] Residual peaks present 
2360/625 tCr(CH2), mI* 
2150/600 tCr(CH2), tCr(CH3), NAA(CH3), mI* 
2000/575 tCr(CH2), tCr(CH3), NAA(CH3), mI* 
1900/550 tCr(CH2), tCr(CH3), NAA(CH3) 
1800/525 tCr(CH2), tCr(CH3), NAA(CH3) 
1300/20 tCr(CH2), NAA(CH3), GPC, mI, Glu, NAAasp 
1300/60 tCr(CH2), NAA(CH3), GPC, mI, Glu, NAAasp 
1200/20 tCr(CH2), NAA(CH3), GPC, mI, Glu, NAAasp 
1250/20 tCr(CH2), NAA(CH3), GPC, mI, Glu, NAAasp 
1300/80 tCr(CH2), NAA(CH3), GPC, mI, Glu, NAAasp 
1050/238 tCr(CH2), tCr(CH3), NAA(CH3), GPC, GABA, Glu, 
Gln, Glycin, Tau, mI, Asp, NAAasp 
*mI was added with a negative phase 
 
Supporting Information Table S2: Bloch simulation considering DIR scheme for mI has a negative 
contribution in TI1/TI2 = 2360/625, 2150/575, 2000/550 ms spectra (considering T1-relaxation times from 
Wright et al.46) 
 
TI1/TI2 [ms] mI: MZ/M0 
 GM (T1 = 1470 ms) WM (T1 = 1423 ms) 
2360/625 -0.0448 -0.0436 
2150/600 -0.0217 -0.0224 
2000/575 -0.0056 -0.0077 
 
Supporting Information Table S3: Differences in T1-relaxation times between GM- and WM-rich tissue 




= 0.0038). Significant differences are denoted by an asterisk, and p-values are given 
for all analyses. 
 
T1-relaxation times 
MM peak p-value 
M0.92 0.3858 
M1.21 0.5793 
M1.39* < 0.0001 
M1.67 0.0056 
M2.04* < 0.0001 
M2.26* < 0.0001 
M2.56 0.0489 
M2.70* < 0.0001 
M2.99* < 0.0001 
M3.21* < 0.0001 
M3.62* 0.0020 
M3.75* < 0.0001 
M3.86 0.0242 
 
Supporting Information Table S4: Concentrations (protons mmol / kg) of 13 MM peaks are given in the 
table below after correcting for T1 and T2 relaxation times. Mann-Whitney U-tests were performed with 
𝛼 
multiple comparisons being accounted using Bonferroni corrections ( 
𝑛 
= 0.0038). A significant 
difference for M3.75 being elevated in WM was found when assessing MM concentrations. 
 
Concentration [protons mmol/kg] 
 GM WM p-value 
M0.92 21.1 ± 3.3 21.0 ± 2.6 0.4697 
M1.21 8.2 ± 4.6 7.9 ± 2.2 0.5000 
M1.39 20.4 ± 5.3 12.6 ± 6.4 0.0061 
M1.67 48.0 ± 11.2 46.7 ± 12.6 0.4396 
M2.04 78.4 ± 10.7 76.6 ± 10.9 0.4099 
M2.26 50.4 ± 6.8 49.0 ± 7.9 0.2717 
M2.56 11.9 ± 2.0 13.0 ± 3.7 0.5000 
M2.70 7.1 ± 1.1 8.6 ± 2.6 0.1617 
M2.99 29.1 ± 3.0 34.7 ± 6.5 0.0138 
M3.21 10.0 ± 2.1 14.9 ± 4.6 0.0049 
M3.62 23.5 ± 8.1 30.3 ± 17.7 0.1437 
M3.75* 4.8 ± 1.0 7.0 ± 1.5 0.0009 
M3.86 11.8 ± 1.3 11.9 ± 2.3 0.5000 
 
ANNEX A – Matlab script for Bloch Simulation 
%pulse profile 
time = 15*1e-3; %s 
freqOffset = (-2000:10:2000); 
nPoints = 512; 
timeAxis = linspace(0,time,nPoints)*1e+3; 
x = linspace(-pi,pi,nPoints); 
b = 1.904; 
AM = sech(b*x); 
FM = 1017*tanh(-x*1.89); 
PM = (2*pi*cumsum(FM)*time/length(FM)); 
 
%Magnetization vectors 
M0 = zeros(length(freqOffset),3); 
M0(:,3) = 1; 
M = applyRotation( alpha,beta, M0 ); 
 
ih = [0 1 2 -2 -1]; 
for i = 1:5 
Bampl = (1+ih(i)*0.15)*15 *1e-6; %in T 
B = Bampl*AM.*exp(1i*PM); 
 
Bampl = 24 *1e-6; %in T 
B = Bampl*AM.*exp(1i*PM); 
TE = 24; %ms 
TR = 8000; %ms 
[alpha, beta] = fSLR( B', freqOffset, time/length(B),0); 
 
 
T1 = [430 1030 1513 1746 1777]; % MM Cr-CH2 Cho Cr-CH3 NAA (Values for 
metabolites are from Deelchand et al at 9.4 T and MM is from Xin et al at 7 
T) 
 
T2 = [23.88 81.82 
al at 9.4 T) 
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20         
for i = 1:length(T1) 
M = applyRotation( alpha, beta, M0 ); 
Mrelax = applyRelaxation( M,T1(i),T2(i),TI1); 
Mrelax = applyRotation( alpha,beta, Mrelax ); 
Mrelax = applyRelaxation( Mrelax,T1(i),T2(i),TI2 ); 
mag.Data{i} = min(Mrelax(:,3)); 
 
function [alpha, beta] = fSLR( B1, freqOffset, deltaT,rephasePoint) 
%FSLR Summary of this function goes here 
% B1 profile in T 
% freqOffset in Hz 
% deltaT in secs 
 
gammaHz = 42.576 *1e+6; %Hz/T 
 
gammaRads = gammaHz*2*pi; %rad/(s*T) 
freqOffset = freqOffset.'; 
G = freqOffset./gammaHz; %Tesla 
a = zeros(length(freqOffset),2); 
b = zeros(length(freqOffset),2); 
a(:,1) = ones(length(freqOffset),1); 
flagRephase = true; 
for i=1:length(B1) 
if flagRephase 
if (i == rephasePoint +1 ) 
G= -G; 




B1eff = B1(i).*ones(size(freqOffset)); 
phi = -gammaRads * deltaT * sqrt( abs(B1eff).^2 + G.^2 ); 
n0 = (gammaRads*deltaT./abs(phi)); 
n = [real(B1eff).*n0, imag(B1eff).*n0, G.*n0]; 
 
av = cos(phi/2) -1i*n(:,3).*sin(phi/2); 
bv = -1i*(n(:,1)+1i*n(:,2)).*sin(phi/2); 
 
a(:,2) = av.*a(:,1) - conj(bv).*b(:,1); 
b(:,2) = bv.*a(:,1) + conj(av).*b(:,1); 
 
a(:,1) = a(:,2); b(:,1) = b(:,2); 
end 
 
alpha = a(:,2); beta = b(:,2); 
 
function M = applyRotation( a,b, M0 ) 
M = zeros(length(M0),3); 
 
M1tmp = conj(a).^2 .*M0(:,1) - b.^2 .*M0(:,2) + 2*conj(a).*b 
.*M0(:,3); 
 
M2tmp = -conj(b).^2 .*M0(:,1) + a.^2 .*M0(:,2) + 2*conj(b).*a 
.*M0(:,3); 
 
M3tmp = -conj(a.*b) .*M0(:,1) - a.*b .*M0(:,2) + (abs(a).^2- 
abs(b).^2) .*M0(:,3); 
 
M(:,1)= M1tmp; M(:,2)= M2tmp; M(:,3)= M3tmp; 
end 
 
function M = applyRelaxation( M0,T1,T2,time ) 
M = zeros(length(M0),3); 
M(:,1) = M0(:,1)*exp(-time/T2); 
M(:,2) = M0(:,2)*exp(-time/T2); 




ANNEX B – Example Control files (.control) for LCModel quantification 
Control file to fit TI1/TI2 = 1050/238 ms DIR spectrum 
 
The sample fit settings file is given to fit TI1/TI2 = 1050/238 ms DIR spectrum with a semiLASER basis set 
included. The basis set included NAA downfield peak, NAA(CH3), tCr(CH3), tCr(CH2), GPC, glutamine 
(Gln), glutamate (Glu), glycine (Glycin), GABA, NAAasp, mI (myo-inositol) and taurine (Tau). 
$LCMODL 



























shifmn(2) = -0.04 







chsimu(1)= 'MM09 @ 0.916 +- 0.02 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(2)= 'MM12 @ 1.21 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(3)= 'MM14 @ 1.39 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
 
chsimu(4)= 'MM17 @ 1.67 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(5)= 'MM20 @ 2.04 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(6)= 'MM22 @ 2.26 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(7)= 'MM26 @ 2.56 +- 0.005 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(8)= 'MM27 @ 2.7 +- 0.01 FWHM= .04 < .08 +- .005 AMP= 1.' 
chsimu(9)= 'MM30 @ 2.99 +- 0.005 FWHM= .07 < .09 +- .005 AMP= 1.' 
 
chsimu(10)= 'MM32 @ 3.21 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(11)= 'MM36 @ 3.62 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(12)= 'MM37 @ 3.75 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(13)= 'MM38 @ 3.86 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 




For the other TI1/TI2 combinations DIR spectra resulting in a positive MM magnetization, a basis set 
containing the NAA downfield peak was given. mI was included in the basis set with a negative phase for 
TI1/TI2 = 2360/625, 2150/600 and 2000/575 ms. Simulated Voigt lines (chsimu) were included to fit the 
residual singlets [tCr(CH2), tCr(CH3) and NAA(CH3)] as specified in the Supporting Information Table S1. 
 





chsimu(1)= 'MM09 @ 0.916 +- 0.02 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(2)= 'MM12 @ 1.21 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(3)= 'MM14 @ 1.39 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(4)= 'MM17 @ 1.67 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(5)= 'MM20 @ 2.04 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(6)= 'MM22 @ 2.26 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(7)= 'MM26 @ 2.56 +- 0.005 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(8)= 'MM27 @ 2.7 +- 0.01 FWHM= .04 < .08 +- .005 AMP= 1.' 
chsimu(9)= 'MM30 @ 2.99 +- 0.005 FWHM= .07 < .09 +- .005 AMP= 1.' 
chsimu(10)= 'MM32 @ 3.21 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(11)= 'MM36 @ 3.62 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(12)= 'MM37 @ 3.75 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(13)= 'MM38 @ 3.86 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(14)= 'MM39 @ 4.03 +- 0.01 FWHM= .10 < .14 +- .005 AMP= 1.' 
chsimu(15)= 'Cr39 @ 3.925 +- 0.04 FWHM= .006 < .06 +- .003 AMP= 1.' 
$END 
 





chsimu(1)= 'MM09 @ 0.916 +- 0.02 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(2)= 'MM12 @ 1.21 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(3)= 'MM14 @ 1.39 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(4)= 'MM17 @ 1.67 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(5)= 'MM20 @ 2.04 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(6)= 'MM22 @ 2.26 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(7)= 'MM26 @ 2.56 +- 0.01 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(8)= 'MM27 @ 2.7 +- 0.05 FWHM= .04 < .08 +- .005 AMP= 1.' 
chsimu(9)= 'MM30 @ 2.99 +- 0.01 FWHM= .10 < .12 +- .005 AMP= 1.' 
chsimu(10)= 'MM32 @ 3.21 +- 0.02 FWHM= .12 < .18 +- .005 AMP= 1.' 
chsimu(11)= 'MM36 @ 3.62 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(12)= 'MM37 @ 3.75 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(13)= 'MM38 @ 3.86 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(14)= 'MM39 @ 4.03 +- 0.01 FWHM= .10 < .14 +- .005 AMP= 1.' 
chsimu(15)= 'Cr39 @ 3.925 +- 0.04 FWHM= .006 < .06 +- .003 AMP= 1.' 
chsimu(16)= 'Cr30 @ 3.028 +- 0.01 FWHM= .002 < .05 +- .003 AMP= 1.' 
chsimu(17)= 'NAA @ 2.008 +- 0.02 FWHM= .003 < .03 +- .003 AMP= 1.' 
$END 
 





chsimu(1)= 'MM09 @ 0.916 +- 0.02 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(2)= 'MM12 @ 1.21 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(3)= 'MM14 @ 1.39 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(4)= 'MM17 @ 1.67 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(5)= 'MM20 @ 2.04 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(6)= 'MM22 @ 2.26 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(7)= 'MM26 @ 2.56 +- 0.01 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(8)= 'MM27 @ 2.7 +- 0.05 FWHM= .04 < .08 +- .005 AMP= 1.' 
chsimu(9)= 'MM30 @ 2.99 +- 0.01 FWHM= .10 < .12 +- .005 AMP= 1.' 
chsimu(10)= 'MM32 @ 3.21 +- 0.02 FWHM= .12 < .18 +- .005 AMP= 1.' 
chsimu(11)= 'MM36 @ 3.62 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(12)= 'MM37 @ 3.75 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(13)= 'MM38 @ 3.86 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(14)= 'MM39 @ 4.03 +- 0.01 FWHM= .10 < .14 +- .005 AMP= 1.' 
chsimu(15)= 'Cr39 @ 3.925 +- 0.04 FWHM= .006 < .06 +- .003 AMP= 1.' 
chsimu(16)= 'Cr30 @ 3.028 +- 0.01 FWHM= .002 < .05 +- .003 AMP= 1.' 
chsimu(17)= 'NAA @ 2.008 +- 0.02 FWHM= .003 < .03 +- .003 AMP= 1.' 
$END 
 





chsimu(1)= 'MM09 @ 0.916 +- 0.02 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(2)= 'MM12 @ 1.21 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(3)= 'MM14 @ 1.39 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(4)= 'MM17 @ 1.67 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(5)= 'MM20 @ 2.04 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(6)= 'MM22 @ 2.26 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(7)= 'MM26 @ 2.56 +- 0.005 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(8)= 'MM27 @ 2.7 +- 0.01 FWHM= .04 < .08 +- .005 AMP= 1.' 
chsimu(9)= 'MM30 @ 2.99 +- 0.005 FWHM= .07 < .09 +- .005 AMP= 1.' 
chsimu(10)= 'MM32 @ 3.21 +- 0.005 FWHM= .12 < .18 +- .005 AMP= 1.' 
chsimu(11)= 'MM36 @ 3.62 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(12)= 'MM37 @ 3.75 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(13)= 'MM38 @ 3.86 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(14)= 'MM39 @ 4.03 +- 0.01 FWHM= .10 < .14 +- .005 AMP= 1.' 
chsimu(15)= 'Cr39 @ 3.925 +- 0.02 FWHM= .006 < .06 +- .003 AMP= 1.' 
chsimu(16)= 'Cr30 @ 3.028 +- 0.01 FWHM= .002 < .05 +- .003 AMP= 1.' 
chsimu(17)= 'NAA @ 2.008 +- 0.02 FWHM= .003 < .03 +- .003 AMP= 1.' 
$END 
 





chsimu(1)= 'MM09 @ 0.916 +- 0.02 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(2)= 'MM12 @ 1.21 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(3)= 'MM14 @ 1.39 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(4)= 'MM17 @ 1.67 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(5)= 'MM20 @ 2.04 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(6)= 'MM22 @ 2.26 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(7)= 'MM26 @ 2.56 +- 0.005 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(8)= 'MM27 @ 2.7 +- 0.01 FWHM= .04 < .08 +- .005 AMP= 1.' 
chsimu(9)= 'MM30 @ 2.99 +- 0.005 FWHM= .07 < .09 +- .005 AMP= 1.' 
chsimu(10)= 'MM32 @ 3.21 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(11)= 'MM36 @ 3.62 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(12)= 'MM37 @ 3.75 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(13)= 'MM38 @ 3.86 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(14)= 'MM39 @ 4.03 +- 0.01 FWHM= .10 < .14 +- .005 AMP= 1.' 
chsimu(15)= 'Cr39 @ 3.925 +- 0.04 FWHM= .006 < .06 +- .003 AMP= 1.' 
chsimu(16)= 'Cr30 @ 3.028 +- 0.01 FWHM= .002 < .05 +- .003 AMP= 1.' 
chsimu(17)= 'NAA @ 2.008 +- 0.02 FWHM= .003 < .03 +- .003 AMP= 1.' 
$END 
chsimu(12)= 'MM37 @ 3.75 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.'  
For the ones resulting in a negative MM magnetization, GPC, mI, Glu, and NAAasp were also given in the 
basis set in addition to the NAA downfield peak. Simulated Voigt lines (chsimu) were included to fit the 
residual singlets [tCr(CH2), tCr(CH3) and NAA(CH3)] as specified in the Supporting Information Table S1. 




degzer = 180 
… 
nsimul= 16 
chsimu(1)= 'MM09 @ 0.916 +- 0.02 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(2)= 'MM12 @ 1.21 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(3)= 'MM14 @ 1.39 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(4)= 'MM17 @ 1.67 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(5)= 'MM20 @ 2.04 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(6)= 'MM22 @ 2.26 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(7)= 'MM26 @ 2.56 +- 0.005 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(8)= 'MM27 @ 2.7 +- 0.01 FWHM= .04 < .08 +- .005 AMP= 1.' 
chsimu(9)= 'MM30 @ 2.99 +- 0.005 FWHM= .07 < .09 +- .005 AMP= 1.' 
chsimu(10)= 'MM32 @ 3.21 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(11)= 'MM36 @ 3.62 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(12)= 'MM37 @ 3.75 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(13)= 'MM38 @ 3.86 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(14)= 'MM39 @ 4.03 +- 0.01 FWHM= .10 < .14 +- .005 AMP= 1.' 
chsimu(15)= 'Cr39 @ 3.925 +- 0.06 FWHM= .0008 < .06 +- .003 AMP= 1.' 
chsimu(16)= 'NAA @ 2.008 +- 0.02 FWHM= .003 < .03 +- .003 AMP= 1.' 
$END 
 




degzer = 180 
… 
nsimul= 16 
chsimu(1)= 'MM09 @ 0.916 +- 0.02 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(2)= 'MM12 @ 1.21 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(3)= 'MM14 @ 1.39 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(4)= 'MM17 @ 1.67 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(5)= 'MM20 @ 2.04 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(6)= 'MM22 @ 2.26 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(7)= 'MM26 @ 2.56 +- 0.005 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(8)= 'MM27 @ 2.7 +- 0.01 FWHM= .04 < .08 +- .005 AMP= 1.' 
chsimu(9)= 'MM30 @ 2.99 +- 0.005 FWHM= .07 < .09 +- .005 AMP= 1.' 
chsimu(10)= 'MM32 @ 3.21 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(11)= 'MM36 @ 3.62 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(10)= 'MM32 @ 3.21 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.'  
chsimu(13)= 'MM38 @ 3.86 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(14)= 'MM39 @ 4.03 +- 0.01 FWHM= .10 < .14 +- .005 AMP= 1.' 
chsimu(15)= 'Cr39 @ 3.925 +- 0.06 FWHM= .0008 < .06 +- .003 AMP= 1.' 
chsimu(16)= 'NAA @ 2.008 +- 0.02 FWHM= .003 < .03 +- .003 AMP= 1.' 
$END 
 




degzer = 180 
… 
nsimul= 16 
chsimu(1)= 'MM09 @ 0.916 +- 0.02 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(2)= 'MM12 @ 1.21 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(3)= 'MM14 @ 1.39 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(4)= 'MM17 @ 1.67 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(5)= 'MM20 @ 2.04 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(6)= 'MM22 @ 2.26 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(7)= 'MM26 @ 2.56 +- 0.005 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(8)= 'MM27 @ 2.7 +- 0.01 FWHM= .04 < .08 +- .005 AMP= 1.' 
chsimu(9)= 'MM30 @ 2.99 +- 0.005 FWHM= .07 < .09 +- .005 AMP= 1.' 
chsimu(10)= 'MM32 @ 3.21 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(11)= 'MM36 @ 3.62 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(12)= 'MM37 @ 3.75 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(13)= 'MM38 @ 3.86 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(14)= 'MM39 @ 4.03 +- 0.01 FWHM= .10 < .14 +- .005 AMP= 1.' 
chsimu(15)= 'Cr39 @ 3.925 +- 0.06 FWHM= .0008 < .06 +- .003 AMP= 1.' 
chsimu(16)= 'NAA @ 2.008 +- 0.02 FWHM= .003 < .03 +- .003 AMP= 1.' 
$END 
 




degzer = 180 
… 
nsimul= 16 
chsimu(1)= 'MM09 @ 0.916 +- 0.02 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(2)= 'MM12 @ 1.21 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(3)= 'MM14 @ 1.39 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(4)= 'MM17 @ 1.67 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(5)= 'MM20 @ 2.04 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(6)= 'MM22 @ 2.26 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(7)= 'MM26 @ 2.56 +- 0.005 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(8)= 'MM27 @ 2.7 +- 0.01 FWHM= .04 < .08 +- .005 AMP= 1.' 
chsimu(9)= 'MM30 @ 2.99 +- 0.005 FWHM= .07 < .09 +- .005 AMP= 1.' 
 
chsimu(11)= 'MM36 @ 3.62 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(12)= 'MM37 @ 3.75 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(13)= 'MM38 @ 3.86 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(14)= 'MM39 @ 4.03 +- 0.01 FWHM= .10 < .14 +- .005 AMP= 1.' 
chsimu(15)= 'Cr39 @ 3.925 +- 0.06 FWHM= .0008 < .06 +- .003 AMP= 1.' 
chsimu(16)= 'NAA @ 2.008 +- 0.02 FWHM= .003 < .03 +- .003 AMP= 1.' 
$END 
 




degzer = 180 
… 
nsimul= 16 
chsimu(1)= 'MM09 @ 0.916 +- 0.02 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(2)= 'MM12 @ 1.21 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(3)= 'MM14 @ 1.39 +- 0.01 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(4)= 'MM17 @ 1.67 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(5)= 'MM20 @ 2.04 +- 0.01 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(6)= 'MM22 @ 2.26 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(7)= 'MM26 @ 2.56 +- 0.005 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(8)= 'MM27 @ 2.7 +- 0.01 FWHM= .04 < .08 +- .005 AMP= 1.' 
chsimu(9)= 'MM30 @ 2.99 +- 0.005 FWHM= .07 < .09 +- .005 AMP= 1.' 
chsimu(10)= 'MM32 @ 3.21 +- 0.005 FWHM= .10 < .13 +- .005 AMP= 1.' 
chsimu(11)= 'MM36 @ 3.62 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(12)= 'MM37 @ 3.75 +- 0.005 FWHM= .08 < .11 +- .005 AMP= 1.' 
chsimu(13)= 'MM38 @ 3.86 +- 0.02 FWHM= .09 < .11 +- .005 AMP= 1.' 
chsimu(14)= 'MM39 @ 3.98 +- 0.01 FWHM= .10 < .14 +- .005 AMP= 1.' 
chsimu(15)= 'Cr39 @ 3.925 +- 0.06 FWHM= .0008 < .06 +- .003 AMP= 1.' 
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7 Several localization schemes and data processing techniques have been developed for better 
8 detection and accurate quantification of metabolites in the human brain. This study proposes a 
9 two-dimensional (2D) J-resolved metabolite-cycled (MC) semiLASER localization sequence at 




14 Initially, the J-resolved MC semiLASER localization sequence with maximum echo sampling 
15 (MES) scheme was optimized using phantom measurements. Then metabolite spectra were 
16 acquired using the developed sequence from a voxel in the occipital lobe at 9.4 T. In order to 
17 account for the underlying macromolecular (MM) spectrum, J-resolved MM spectra were acquired 
18 using a double inversion recovery (DIR) J-resolved MC semiLASER with MES scheme. Spectral 
19 fitting was performed with ProFit 2.0 using simulated basis set from VesPA. Metabolite 
21 concentrations were calculated using internal water referencing. 
22 Results: 
24 J-resolved MC semiLASER with optimized sequence parameters was developed at 9.4 T to 
25 quantify human brain metabolites. Quantification values for 16 metabolites in mmol/kg are 
26 reported after correcting for proton contribution, tissue content, and relaxation effects of both 
28 water and metabolites at 9.4 T. Bland-Altman plots were calculated in order to compare the 
29 differences in concentration values from this study versus values from a previous 1D MRS study. 
30 
31 Conclusion: 
32 2D J-resolved MC semiLASER sequence was optimized for the first time at 9.4 T. The sensitivity 
33 in the detection of J-coupled metabolites such as glutamine, glucose, lactate etc., improved with 
35 the use of 2D MRS technique along with MES scheme. 
36 Keywords: 2D J-resolved spectroscopy, Ultra-high field, Maximum echo sampling, ProFit 2.0, 
































3 1. Introduction 
4 
5 Single voxel proton magnetic resonance spectroscopy (1H-MRS) is a popular non-invasive 
6 technique used to study the metabolism in the human brain. It enables detection and 
7 quantification of the neurochemical profile in a particular region of interest, thereby aids in setting 
8 appropriate biomarkers for various pathologies in the human brain1. However, complex spectral 
9 patterns and severe spectral overlap often pose a challenge in quantifying individual metabolite 
11 concentrations
2. Therefore, enhancing the signal-to-noise ratio (SNR) and spectral resolution has 
12 always been one of the aims of the MRS community. 
13 
14 One technique used by the NMR community to reduce spectral overlap is multi-dimensional 
15 spectroscopy
3,4. Homonuclear two-dimensional (2D) techniques such as correlation spectroscopy 
16 and J-resolved spectroscopy were shown to be feasible in vivo at 1.5, 3 and 7 T
5–7 and hold the 
17 promise to yield accurate quantification results for a large number of metabolites in clinical trials 
18 of neurological and psychiatric disorders
8–14. Nevertheless, this technique owes to longer 
19 measurement durations and requires non-standard pre-processing, fitting and quantification 
20 routines. 
22 In two-dimensional (2D) J-resolved spectroscopy15, the spectral information is spread into two 
23 orthogonal axes by adding a step-wise increasing evolution delay in the pulse sequence. This 
24 helps improve specificity in the detection of J-coupled metabolites. To further improve detection 
26 sensitivity maximum echo sampling (MES)
16 was introduced for in vivo 2D 1H MRS8,17. In MES 
27 scheme, acquisition begins right after the final crusher gradient of the last refocusing pulse in the 
28 localization technique. Later Schulte et al
15 compared the sensitivity values of short-echo point- 
29 resolved spectroscopy (PRESS), JPRESS with traditional half echo sampling (where the 
30 acquisition begins at the echo top) and JPRESS with MES. JPRESS with MES had increased 
31 sensitivity in comparison to traditional half echo sampling. Yet another advantage of MES is that 
32 it adds a tilt to the peak tails in the spectrum
15 and thus largely reduces overlap of the water peak 
34 tail with the metabolites peaks of interest. 
35 Another means to clearly distinguish more peaks is ultra-high field (UHF) (≥ 7 T) 
1H MRS18,19. It 
36 is well known that spectroscopy studies at UHF benefit from both increased spectral resolution 
38 and improved SNR in comparison to lower field strengths. However, at UHF B + inhomogeneity 
39 is one of the crucial challenges posed. Also with increasing static B0 field strength, chemical shift 
40 displacement error between the metabolite peaks increases. 
41 
42 Using simulation and experimental methods at 3 T and 7 T Edden et al20 showed that the chemical 
43 shift displacement effect causes spatially dependent differences in J-evolution of coupled spin 
44 systems in JPRESS spectra. Due to the larger spectral dispersion along with reduced peak 
45 transmit field strength B +, the chemical shift displacement error is increasing with increasing field 
46 strength. The appearance of additional J-refocused peaks result in loss of intensity in the J- 
47 resolved peaks and more spectral overlap thereby leading to uncertain spectral quantification. 
49 However, Lin et al
6 compared the spectral quality of JPRESS, J-resolved semiLASER and J- 
50 resolved LASER sequences and demonstrated that the use of adiabatic pulses reduced the 
51 appearance of J-refocused peaks to a great extent due to their higher bandwidth. Adiabatic pulses 
52 in the localization schemes are also effective in reducing the effect of B 
+ inhomogeneity at UHF21. 
53 Both the implications discussed above emphasize the need to use adiabatic localization when 

















3 Therefore, in this work, we developed a 2D J-resolved metabolite-cycled (MC) semiLASER 
4 sequence at 9.4 T for the first time. Implementing MC21,22 for J-resolved spectroscopy eliminates 
5 the need for acquiring an interleaved water reference for the sake of eddy current correction or 
7 frequency alignment. This in turn significantly reduces the scan duration when the aim is to 
8 calculate metabolite ratios, thereby tackling one of the problems of 2D spectroscopy in vivo. 
9 Spectral fitting was performed using ProFit v2.0
23, a dedicated 2D fitting software, which 
11 incorporates the theory of LCModel
24 and VARPRO25 in attaining a global minimum. The non- 
12 linear fitting routine iterates four times, each time with increasing degrees of freedom. Fuchs et 
13 al
26 enhanced the software by adding a spline baseline fit and a spline lineshape model using 
14 self-deconvolution. Additionally, in order to account for the MM contribution in the 2D metabolite 
15 spectra, an experimentally acquired 2D MM spectra was used during the fitting procedure. 
16 
17 Subsequently, quantification of metabolites was performed using the internal water referencing 
18 method taking into account the tissue composition in the voxel of interest, and water 
19 concentration. The concentration values were also further corrected for T1 relaxation times of both 
20 metabolites27 and water28 at 9.4 T. Finally, quantification results obtained with 2D J-resolved 
21 spectroscopy and 1D MRS at 9.4 T were compared with each other and against concentrations 
23 published in previous literature. To the best of our knowledge, the effect of bringing together the 
24 two complementary approaches of UHF and 2D J-resolved spectroscopy to enhance spectral 
25 resolution and hence spectral quantification has not been evaluated yet. This work is an extension 
26 of the initial results reported earlier in a conference abstract29. 
27 
28 2. Methods 
29 
30 2.1 Study Design 
31 All measurements were performed on a 9.4 T Siemens Magnetom whole-body MRI scanner 
33 (Siemens Healthineers, Erlangen, Germany) using a home-built coil
30 with eight transmit and 
34 sixteen receive channels. Eleven healthy volunteers (6 male and 5 female, age: 28.0 ± 2.3 years) 
35 participated in this study. Five volunteers returned for a second visit for the acquisition of 2D MM 
36 signal. The study was approved by the local ethics board, and written informed consent was 
37 provided by the volunteers prior to the measurements. 
38 
39 2.2 MRS Sequence 
40 
41 Figure 1a shows the J-resolved metabolite-cycled (MC) semiLASER sequence diagram. The 
42 asymmetric adiabatic MC31 pulse (duration: 22.4 ms) preceded the conventional semiLASER31 
43 block. A hamming filtered 90 degree-sinc pulse31 (bandwidth: 8000 Hz) was used for excitation. 
44 This pulse was followed by two pairs of adiabatic full passage pulses (duration: 3.5 ms, bandwidth: 
45 8000 Hz). The indirect dimension (t1) was created by inserting an incrementally increasing time 
46 delay of ∆t/2 between the last pair of adiabatic full passage pulses31, which encodes the J- 
48 evolution. The acquisition of the signal began immediately after the final crusher gradient of the 
49 last adiabatic full passage pulse which is called maximum echo sampling (MES) scheme
15. 
50 
51 In order to optimize the number of TE steps 𝑛, knowledge of T2 relaxation times of metabolites in 
52 vivo at 9.4 T was utilized from Murali-Manohar et al
32. Additionally, phantom measurements 
53 (Figure 2) were performed with different time increment steps (∆t: 2, 3, and 4 ms) and different 
54 number of TE steps (𝑛: 50, 85) to confirm the absence of J-refocused peaks and whether the 


















3 A double inversion recovery (DIR) block preceding the J-resolved MC semiLASER sequence 
4 (Figure 1b) was used for the acquisition of macromolecular signal. The inversion pulse33 duration 
5 was 15 ms and the inversion bandwidth was approximately 1650 Hz. The optimized inversion 
7 times
33,34 (TI1/TI2) combination of 2360 and 625 ms was used in the DIR block. 
8 2.3 Data Acquisition 
10 2.3.1 Anatomical Imaging 
11 
12 MP2RAGE28 images (resolution: 0.6 × 0.6 × 0.6 mm3) were acquired while using the coil in volume 
13 mode driving power to all the eight transmit coil elements. Following this, the volunteer was 
14 instructed to remain stationary on the patient table while the coil setup was changed to suit the 
15 spectroscopy measurements (see 2.3.2). 
17 For the MM acquisition, only 2D FLASH images were acquired which then were co-registered to 
18 the previously acquired MP2RAGE images using rigid body transformation. 
19 
20 2.3.2 Spectroscopy Measurements 
21 
22 For the spectroscopy measurements, power was driven to the bottom three coil elements near 
23 the region of interest using unbalanced three-way Wilkinson splitter31. A localizer was reacquired 
24 to ensure there was no motion of the volunteer between the anatomical and the spectroscopy 
25 scan. This was followed by acquisition of high-resolution 2D FLASH images (in-plane resolution: 
26 0.7 × 0.7 mm2, slice thickness: 3.5 mm, 25 slices) in the sagittal and transversal orientations to 
28 position the spectroscopy voxel (2 × 2 × 2 cm
3) in the occipital lobe. Localized second-order 
29 shimming was performed using FAST(EST) MAP
35 setting the shim volume to be 150% of the 
30 volume of the voxel of interest. Then, voxel-based power optimization
36,37 was performed to 
31 ensure that the adiabatic conditions were fulfilled. 
32 
33 Two-dimensional metabolite spectra were acquired using the J-resolved MC semiLASER 
34 sequence (Figure 1a) (TR: 6000 ms, averages: 8 per TE step, four-step phase cycling) described 
35 above in the MRS Sequence section. TE ranged from 24 to 194 ms (𝑛: 85) incremented in steps 
36 of ∆t = 2ms. In addition, 2D water reference signals were acquired (average per TE: 1) to avoid 
37 any effect due to MC pulse. The transmit reference frequency for the water reference sequence 
39 was set to 4.7 ppm. 
40 In order to account for the MM contribution in the 2D metabolite spectra, 2D MM spectra were 
41 acquired from five healthy volunteers using the DIR sequence (TI /TI : 2360/625 ms) shown in 
42 1 2 
43 Figure 1b. TE ranged from 24 to 144 ms (𝑛: 60) since MM signal decays faster in comparison to 
44 metabolite signal
32. All the other acquisition parameters were identical to the metabolite spectra 
45 except the TR which was set to 8000 ms. 
46 
47 2.4 Data Preprocessing 
48 Spectroscopy raw data were preprocessed using an in-house MATLAB (version 2016a, 
50 MathWorks, Natick, MA) tool. Both metabolite and MM data were reconstructed as described in 
51 Giapitzakis et al
31. Firstly, the data were frequency and phase-aligned based on the water signal 
52 in the time domain for 85 and 60 blocks for metabolite and MM data respectively. This was 
53 followed by metabolite-cycling subtraction and then the data were averaged within each TE block. 
54 Then Eddy current correction was performed using the phase information from the MC water 

















3 metabolite and MM data were truncated at 250 and 150 ms respectively for better SNR. 
4 Automated zeroth- and first-order phase corrections were performed in the J-resolved 
5 spectroscopy preprocessing tool15,38 which is a part of ProFit. The applied phase correction was 
7 visually verified for correctness as recommended by the recent consensus article
39. Using the 
8 same ProFit preprocessing tool, residual water in both the dimensions in the spectra was removed 
9 using a HSVD method. The final 2D spectrum displayed is after applying Fourier transformation 
10 to the data in both the dimensions. SNR of the NAA(CH3) peak at 2.008 ppm was calculated as 
11 the peak intensity from the real part of the spectrum with respect to the noise window from -4.0 to 
12 -1.0 ppm. 
13 
14 2.5 MP2RAGE Segmentation 
15 
16 The high-resolution MP2RAGE images were segmented into gray matter (GM), white matter 
17 (WM) and cerebrospinal fluid (CSF) fractions using SPM1240. 2D FLASH images acquired during 
18 the MM scan session were co-registered to the MP2RAGE images acquired during the first scan 
19 session for four volunteers. A home-built Python (v3.7) tool was used to determine the tissue 
20 fractions in the voxels of interest. 
22 2.6 Spectral Fitting 
23 
24 Metabolite basis sets corresponding to 85 TE steps were simulated using VesPA considering full 
25 quantum mechanical density matrix calculations for the semiLASER sequence including the 
26 excitation and adiabatic full passage pulse shapes. The simulation also incorporated the 
27 sequence timings including the MES scheme. The following metabolites were simulated: n-acetyl 
29 aspartate (NAA), NAA glutamate (NAAG), 𝛾‐aminobutyric acid (GABA), aspartate (Asp), creatine 
30 (Cr), glutamate (Glu), glutamine (Gln), glucose (Glc), glutathione (GSH), glycerophosphocholine 
31 (GPC), glycine (Glyc), myo‐inositol (mI), scyllo‐inositol (Scy), lactate (Lac), phosphocreatine 
32 (PCr), phosphocholine (PCho), phosphoethanolamine (PE), and taurine (Tau). Their chemical 
33 shifts and coupling constants were chosen according to Govindaraju et al
41, except for the 
34 coupling constant of GABA, for which the values from Near et al
42 were chosen. Subsequently 
35 different metabolite peaks were scaled to correct for the number of proton contributions. GPC, 
37 PCho and PE combined together is denoted by tCho. Finally, all the 85 1D basis sets and the 
38 measured MM spectra were combined to form a complete 2D basis set using an in-house written 
39 MATLAB script. 
40 
41 All the metabolite spectra were fitted using ProFit 2.026 (2D PRiOr knowledge FITting). It takes 
42 the exponential decay of the metabolite signal and the scalar coupling constants into account and 
43 fits the J-resolved spectrum after 2D Fourier transform in both the direct and the indirect 
44 dimensions. 
45 
46 2.7 Quantification 
47 
48 Metabolite concentrations [M] were quantified in mmol/kg from the ProFit 2.0 concentration 
49 results after fitting the metabolite spectra acquired from all subjects. 
50 
51 For internal water referencing, the concentration values from fitting were corrected for tissue water 

















3 SMet × (fGM × RH20GM + fWM × RH20WM + fCSF × RH20CSF) 2 
4 [M] = S (1 ― f ) × R × 
(1 + FS) 
× [H2O] 
5 
6 fy_vol × ay 
H20 CSF Met 
7 where fy = fGM_vol × aGM + fWM_vol × aWM + fCSF_vol   × aCSF 
8 
9 Here y corresponds to either GM, WM, or CSF; fy_vol is the fraction of the respective tissue type 
10 determined by segmentation; ay are the relative densities of MR-visible water for the given tissue 
11 types (78%, 65%, 97% for GM, WM and CSF respectively); these ay values were further scaled for 
13 the relative densities of GM and WM tissue (1.04 g/ml)43–46. To arrive at mmol/kg units , the 
14 concentration of the MR-visible water [H2O] within a voxel was considered in molal concentration 
15 and assumed to be that of pure water (55,510 mmol / kg)47. SMet is the signal from the metabolite 
16 peak. 
17 
18 ProFit 2.0 accounts for the T2 relaxation times of water and metabolites between the second TE 
19 and the last TE by including respective line shape models specific to each metabolite in the fitting 
20 algorithm . Therefore, T correction was included only for the first TE = 24 ms. 
21 
22 




25 is the relaxation correction factor for each tissue type y. T1H2Oy is the T1 relaxation time of water 
26 in the tissue type y; in particular, the T1 relaxation times of water in GM are T1H20_GM = 2120 ms; 
27 in WM are T1H20_WM= 1400 ms; and in CSF are T1H20_CSF = 4800 ms at 9.4 T28. T2H2O is the T2 
29 relaxation time of water in the tissue type y; T2H2O_GM = 37 ms, T2H2O_WM = 30 ms, and T2H2O_CSF 
30 = 181 ms. 
31 





35 is the relaxation correction term for metabolites. T1Met values from were taken Wright et al
27 and 
36 T2Met values were taken from Murali-Manohar et al
32. The denominator 1 ― fCSF was implemented 




39 1 + Fs was introduced to correct for the multiplication of even numbered acquisitions with the 
40 scaling factor (Fs) from metabolite cycling. 
41 
42 2.8. Statistics 
43 
44 The concentration values reported in this study are mean values from eleven healthy volunteers 
45 and the standard deviation between them. Recent 1D MRS studies
27,48–52 at ultra-high field 
46 reporting concentrations in mmol/kg from a similarly located voxel in the occipital lobe as chosen 
47 for this study were considered for comparison. 
48 
49 For a more thorough statistical comparison data from previous 1D MRS study27,48 at 9.4 T was 
50 used. The study27,48 used MC-semiLASER sequence with same sequence parameters (TE/TR: 
51 24/6000 ms) as used in this study. Seven out of eleven healthy volunteers participated in both 
52 studies and hence paired values were considered for statistical analysis. Spectral fitting was 
53 performed in LCModel53 and MM contribution was accounted for from experimentally measured 
54 MM spectra with DIR method (TI /TI : 2360/625 ms). Two-tailed nonparametric Wilcoxon signed 
















3 rank test was performed (𝛼 < 0.05) for matched data. Adjusted p-values were obtained using 




7 Bland-Altman plots54 were calculated to show the differences in the quantification values between 
8 this study (2D MRS) and the previous 1D MRS study27,48. The most updated concentration values 
9 from the 1D MRS study27,48 were considered. Let 𝑖 denote the subject and 𝑘 the metabolite of 
10 interest; superscripts 2𝐷 and 1𝐷 represent the 2D and 1D MRS study respectively. Then, the 
11 Bland-Altman calculations for metabolite concentrations in mmol/kg is given by 
12 
13 (𝑐2𝐷 ― 𝑐1𝐷) 





17 3. Results 
18 3.1 Voxel Content and Spectral Quality 
𝑖,𝑘  𝑖,𝑘 
20
The spectra from the phantom tests (𝑛: 50, ∆𝑡: 2, 3, and 4 ms) showed stronger ‘t1 ridges’20 when 
21 
22 TEmax was shorter (Figure 2). In other words, when TE 
 
max = 124 ms, the ‘t1 ridges’20 were the 
23 strongest. t1 noise was the least when TEmax = 224 ms. When TEmax was set to 100, 99, and 100 
24 ms for ∆𝑡: 2 ms (𝑛: 50), 3 ms (𝑛: 33), and 4 ms (𝑛: 25) respectively, the ‘t1 ridges’ were not seen 
25 to be impacted (Supporting information figure S1). However, ∆𝑡: 2 ms corresponded to higher 
26 SNR since it allows for more number of averages. 
27 
28 Figure 3 shows a phantom metabolite spectrum (𝑛: 85, ∆𝑡: 2 ms, TEmax: 194 ms) in the absolute 
29 magnitude mode. There are no prominent J-refocused peaks appearing in the spectrum or there 
30 are no visible truncation artifacts or t1 noise in the indirect dimension. Even though the t1 noise 
31 seemed minimum for a TEmax = 224 ms, TEmax = 194 ms was chosen for in vivo studies as T2 
32 relaxation times are generally longer in phantom than in in vivo tissues. ∆𝑡 was set to 2 ms since 
34 this allows for a higher number of averages within the given range of TE which is essential for a 
35 good SNR in vivo spectrum. 
36 
37 Figure 4  shows a  representative single  subject 2D  MC J-resolved  semiLASER metabolite 
38 spectrum (𝑛: 85, ∆𝑡: 2 ms) with an inlay showing the voxel position. The average tissue content 
39 of the metabolite spectroscopy measurement voxel in the occipital lobe of eleven healthy 
40 volunteers was GM/WM/CSF = 67 ± 8/ 29 ± 9/ 4 ± 1 % respectively. The 2D metabolite spectra 
41 obtained from voxels in the occipital lobe showed uncoupled peaks lying on the f1 = 0 Hz axis. 
42 This is because during t1, only the coupling information is obtained. However, the J-coupled 
43 multiplets are resolved at an angle of 45° with respect to f1 = 0 Hz since t2 holds both chemical 
45 shift and coupling information. The SNR of the NAA(CH3) peak was 906 ± 147 indicating that the 
46 spectra were of good quality. Also, the spectra did not show any major artifacts such as lipid 
47 contamination or water tails. Therefore, no data sets were excluded from further analysis. 
48 
49 The summed MM spectrum from five healthy volunteers is shown in Figure 5. M0.92, M1.21, M1.39, 
50 M1.67, M2.04, M2.26, M2.56, M2.70, M2.99 and M3.86 are clearly seen to have J-resolved peaks. On an 
51 average, the MM spectroscopy voxel (five healthy volunteers) had GM/WM/CSF = 61 ± 10/ 35 ± 
52 8/ 4 ± 3 % respectively. 
53 
54 Figure 6a shows the summed downfield spectrum (5.1 to 9.5 ppm) from eleven healthy 
















3 spectrum. Also, the DF5.97 peak begins to J-resolve into a doublet. In addition, the zoomed view 
4 of the downfield spectrum (Figure 6b) from 8.7 to 9.45 ppm shows the two low SNR NAD+ multiplet 
5 peaks of nicotinamide moiety that are present at 8.83 and 9.33 ppm. 
7 3.2 Spectral Fitting 
8 
9 A representative metabolite 2D spectral fit is shown in Figure 7. The minimum residual shows the 
10 good quality of fit indicating that the metabolites included in the basis set modeled the acquired 
11 data sufficiently well. The fit quality was similar for all the datasets. 
12 
13 3.3 Concentrations 
14 
15 Supporting information figure S2 shows a bar plot of concentrations of metabolites calculated in 
16 mmol/kg. Table 1 and Figure 8 compares the quantification results in mmol/kg from this study 
17 with previous literature27,48–52. 
18 
19 Significant differences in concentrations obtained from 1D27,48 and 2D MRS data (p < 0.0038) are 
20 denoted by an asterisk (*) in Table 1. Bland Altman plots are shown for 12 metabolites in Figure 
21 9 comparing 2D MRS data and 1D MRS data27,48. The most updated concentration values from 
22 the 1D MRS study27,48 are used here. 
24 4. Discussion 
25 
26 4.1 Spectral Quality 
27 
28 The phantom tests performed to optimize the step size (∆𝑡) along with the knowledge of T2 
29 relaxation times of metabolites in vivo at 9.4 T from Murali-Manohar et al.,32 led to the choice of 
30 ∆𝑡 = 2 ms and number of steps, 𝑛 = 85 for acquisition in vivo. There was sufficient sampling (500 
31 Hz) in the indirect dimension to cover the frequency range of interest in all cases. The final choice 
32 of the scan parameters was made since the appearance of ‘t1-ridges’20 due to t1 noise and sinc 
34 character from t1 truncation was diminished significantly by longer TEmax keeping in mind also 
35 comfortable scan durations. Furthermore, T2-weighting signal loss was avoided largely by setting 
36 the first echo time TEmin to be 24 ms, as short as possible. According to Murali-Manohar et al
52, 
37 the T2 relaxation times in the gray-matter rich voxel present in the occipital lobe ranged from ~45 
38 to 110 ms. Thus, the chosen parameters swept a decent range of TEs from 24 to 194 ms. 
39 
40 Using the adiabatic J-resolved semiLASER localization sequence proposed herein resulted in a 
41 chemical shift displacement of 5% per ppm for each voxel dimension (bandwidth: 8000 Hz). Lin 
42 et al6 showed that the intensity of the J-refocused peaks can be reduced by a factor of 
43 
44 ∆𝛿.𝐵0 





47 where ∆𝛿 is the chemical shift difference in ppm of the spins A and X in an AX spin system, 𝐵0 is 
48 the frequency of the static magnetic field in MHz and 𝐵𝑊 is the bandwidth of the refocusing pulse. 
49 Considering lactate coupled peaks at 1.31 and 4.09 ppm, the resulting reduction in the intensity 
51 of the J-refocused peaks is 86%. Therefore, there were barely any J-refocused peaks (please see 
52 Figure 3) and no J-refocused peaks in Figure 4 that usually appear because of spatially dependent 
53 evolution (because of limited bandwidth refocusing pulses) of the J-coupled peaks
20. 


















3 Implementation of the MES scheme resulted in tilt of the peak tails and hence y avoids the overlap 
4 of phase-twisted line shapes when f1 = 0 Hz. For each TE increment, when the time delay 
5 introduced is ∆𝑡, the acquisition starts ∆𝑡/2 earlier with respect to the echo top. Therefore, data 
7 corresponding to each TE had to be aligned with the corresponding echo tops by shifting them in 
8 the time domain as described in Schulte et al
15. The tilt created in the time domain directly 
9 translates after a Fourier transform to the frequency domain where the peak tails along the direct 
10 dimension (f2) are also tilted by 26.6°. This minimizes the overlap of the peak tails with the 
11 metabolite peaks, thus reducing contamination and allowing for better quantification of the 
12 metabolite signals especially of J-coupled spin systems. 
13 
14 The knowledge of T2 relaxation times of MM (approximately ranging from 15 to 37 ms in GM-rich 
15 voxel) at 9.4 T from Murali-Manohar et al32 was utilized in setting 𝑛 = 60 (covering TE: 24 to 144 
16 ms) for the acquisition of MM spectra using DIR MC J-resolved semiLASER. By TEmax = 144 ms, 
17 MM signal decayed completely. Therefore, for 𝑛 = 61 to 85 no corresponding MM spectra were 
19 provided in the basis set for metabolite spectral fitting. This also reduced the acquisition duration 
20 making it feasible for in vivo investigations. M0.92, M1.21, M1.39, M1.67, M1.75, M2.04, M2.26, M2.56, M2.70, 
21 M2.99 and M3.86 are observed to undergo J-evolution and they appear as multiplets in the 2D J- 
22 resolved spectrum shown in Figure 5 indicating that these peaks have J-coupled spin systems. 
23 This observation agrees with Behar et al55 who reported the above-mentioned peaks (except M2.56 
24 and M2.70) as J-coupled MM observed from COSY and J-resolved spectra of dialyzed human 
25 cerebral cytosol at 8.4 T. Giapitzakis et al56 reported M  
2.56 and M 
 
2.70 peaks for the first time and 
27 assigned them to β-methylene protons of aspartyl groups which correspond to doublet-of- 
28 doublets. Figure 5 also shows M1.75, M1.91, M1.95, M2.32, M2.36, M3.02, M3.09, M3.17, and M3.28 peaks 
29 which are observed here in 2D MRS, but not in 1D MRS32–34 in the human brain at 9.4 T. These 
30 MM peaks other than M1.75, M2.32 and M3.28 were previously only reported at 17.2 T in rat brain by 
31 Lopez et al57. 
32 
33 All the downfield peaks reported by Borbath et al58 at 9.4 T in vivo were present also in the 2D 
34 downfield spectra in this study (Figure 6). Since there was no water suppression scheme 
35 implemented it was also possible to detect some of the exchanging downfield peaks (DF5.75, 
36 DF6.83)59 in 2D. It was unclear from the 1D spectra58 whether the DF6.83 peak could be assigned 
38 to Gln (a singlet) or Tyrosine (multiplets). However, it can be seen from Figure 6 that the DF6.83 
39 resonance splits into two peaks across f1 = 0 axis. Nagarajan et al
60 reported that the four phenyl 
40 ring protons of tyrosine give rise to multiplets in their 2D L-COSY study in the human brain at 3 
41 T
60. Also, fitting of amino acid spectral models to the downfield spectra results in fitting Tyrosine 
42 multiplet to the DF6.83 peak
61. This leads to potentially assigning the peak detected at DF6.83 to 
43 Tyrosine. A quadruplet splitting (DF5.48) at around 5.48 ppm can also be observed from the 2D 
44 downfield spectrum. This peak has not been reported earlier and further investigation is necessary 
45 in order to confirm the peak presence. Since this study focused on the upfield metabolites, the 
47 transmit reference frequency was set to 2.4 ppm in the upfield part of the spectrum. However, a 
48 study focusing on the downfield part of the 
1H spectra in the human brain using 2D MRS with the 
49 transmit reference frequency set to 7.0 ppm could be of interest since it could lead to better 
50 characterization of some of the unassigned peaks. 
51 
52 2D MRS acquisition technique has longer scan durations, especially at UHF due to SAR 
53 constraints. In particular, 2D J-resolved MC-semiLASER and 2D J-resolved DIR MC-semiLASER 
54 sequences had an acquisition duration of 68 and 128 minutes respectively. This is a disadvantage 



















3 comparison and are thus better suited for clinical applications. On the other hand, the 2D MRS 
4 technique at UHF looks promising to answer some basic research questions such as assigning 
5 unlabeled peaks in the downfield part of the spectrum or in understanding the overlap and J- 
7 coupling behavior of the MM peaks. It could also be utilized in quantifying lower SNR J-coupled 
8 metabolites in order to understand mechanisms of brain energy metabolism, neurotransmission, 
9 or antioxidants. 
10 
11 4.2 Spectral Fitting 
12 Edden and Barker
20 suggested that it is important to include the bandwidth of the refocusing pulse 
14 while simulating the basis sets in order to also account for the J-refocused peaks if any. Therefore, 
15 the basis sets simulated to fit the 2D metabolite spectra using VesPA included real pulse shapes 
16 with exact durations, bandwidths and the MES scheme. Therefore, it can be seen from Figure 7 
17 that the simulated 2D basis set fits the data very well. 
18 
19 Spectral fitting of 2D J-resolved data using Profit 2.0 can also be used to determine T2 relaxation 
20 times of metabolites as shown by Wyss et al62. 
21 
22 4.3 Metabolite Concentrations 
23 This study quantifies and reports concentration values of 16 metabolites in mmol/kg using an 
25 adiabatic 2D J-resolved localization technique at 9.4T in the human brain for the first time. The 
26 calculated millimolal concentration values lie within the range of values that were reported in 
27 previous literature27,48–52 for most of the metabolites. Mekle et al50 and Deelchand et al49 did not 
28 perform T2 relaxation correction. However, these studies used shorter TE times; therefore, the 
29 contribution from T2 weighting may have been insignificant. All the studies included experimentally 
30 acquired MM spectrum during the fitting procedure. Mekle et al50 set tCr to 8 mmol/kg. 
32 For metabolites with J-coupled spin systems, low peak amplitudes and/or overlap with larger 
33 singlets such as GABA, GSH, NAAG and Tau the concentrations measured from this study are 
34 in line with previous 1D MRS studies at 7T51,63 and 9.4T27,48. Moreover, the 2D MRS technique 
36 could decently quantify Glc, Lac, and Glyc, which are otherwise challenging to quantify in 1D MRS 
37 studies even at 9.4 T. Separation of PCr and Cr was achieved in this study along with two previous 
38 9.4T study
32 and two previous 7T studies51,63. The concentration of Asp measured in this study is 
39 in line with two out of three previous 9.4T
27,48,64 and two 7T human brain studies51,63. Gln 
40 concentrations from this study are closely matching those measured in two previous 7T 
41 studies
50,65 and one 9.4T study49, but deviate from results of two other previous 1D MRS studies 
42 at 9.4T
27,48,52. mI concentrations are higher in this study in comparison to all previous studies due 
44 to a possible oppositely phased residual mI peak in the experimental MM spectra
34. 
45 Figure 9 shows Bland-Altman plots
54   for 12 metabolites indicating changes in metabolite 
46 concentrations of individual subjects while using 1D and 2D MRS at 9.4T (seven healthy 
48 volunteers were considered as paired datasets). The mean of the metabolite concentrations are 
49 plotted along the x-axis and the difference in the measured concentration of metabolites between 
50 1D and 2D MRS along the y-axis. These Bland-Altman plots enable us to visually assess the 
51 differences in the concentrations measured using 1D versus 2D MRS. A statistical significant 
52 difference is found in the concentration of Gln between 1D and 2D MRS study. Gln concentration 
53 estimate from the 1D MRS study
27,48 is higher than expected. Tau also has a significant difference; 
54 however, the concentration of Tau varies across different studies and the concentration from 2D 
56 MRS data agrees with Marjanska et al




















3 the test-retest reliability of measuring GABA and Glx with JPRESS, PRESS, and MEGA-PRESS 
4 at 3T. They concluded that MEGA-PRESS and JPRESS reliably detected GABA at 3T when 
5 compared to PRESS. However, Glx was measured reliably with PRESS, MEGA-PRESS and 
7 JPRESS
66. 
8 5. Conclusion 
10 The 2D J-resolved MC-semiLASER sequence implemented at 9.4 T quantified the lower SNR 
11 and J-coupled metabolites such as GABA, Gln, Lac, and Glc. Despite longer acquisition durations 
12 of 2D J-resolved MRS at UHF, it still seems beneficial to answer open questions in the field of 
14 MRS including assigning unlabeled peaks in the downfield part of the spectrum, understanding J- 
15 coupling behavior of the MM peaks (which are severely overlapped broad peaks in 1D MRS), and 
16 to quantify the lower SNR J-coupled metabolites with accuracy. The quantification results in 
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7 List of Figures: 
8 
9 Figure 1: Pulse sequence diagram of J-resolved metabolite-cycled semiLASER localization 
10 scheme. The two inversion pulses were turned off when acquiring the metabolite spectra. For the 
11 acquisition of macromolecular spectra, double inversion recovery technique was used with TI1/TI2 
12 set to 2360/625 ms. The indirect dimension is created by increasing the time interval between the 
13 last two AFP pulses by ∆t/2. Both the sequences have maximum echo sampling scheme 
14 implemented i.e., acquisition begins right after the final crusher gradient of the last AFP. 
15 
16 Figure 2: (Top to bottom) 2D J-resolved MC semiLASER spectra from Braino phantom containing 
17 NAA, Cr, Cho, Glu and Lac with n = 50 and ∆t = 2, 3 and 4 ms. White arrows indicate the t1-ridges 
18 as a result of t1 noise and truncation sinc artifacts in the indirect dimension. The ridges are strongly 
19 pronounced when TE  
max = 124 ms and minimum when TE 
 
max = 224 ms. 
21 Figure 3: a) 2D metabolite spectrum from Braino phantom (n = 85, ∆t = 2ms) in magnitude mode 
22 b) Zoomed in view of the lactate peak showing a J-resolved doublet but barely any J-refocused 
23 peaks. An 86% suppression (considering Lac peaks at 1.31 and 4.09 ppm since they have a 
25 maximum separation of values in the observable range of the spectrum) of the J-refocused peaks 
26 is expected when calculated as suggested by Lin et al
6 resulting in barely any visible J-refocused 
27 peaks. This in turn leads to maximum intensity of the J-resolved peaks. 
28 
29 Figure 4: 2D J-resolved MC semiLASER spectrum from a representative subject with 𝑛 = 85 and 
30 ∆𝑡 = 2 ms. The figure inlay shows the voxel positioning on the MP2RAGE image in transversal 
31 view. Additionally, the observed metabolites are labeled in the figure. 
32 
33 Figure 5: 2D DIR J-resolved MC semiLASER (TI1/TI2: 2360/625 ms, 𝑛 = 60, ∆𝑡 = 2 ms) summed 
34 spectrum from five healthy volunteers. The subscripts in the labelled MM peaks are the chemical 
35 shift in ppm at which the respective MM resonance occurs. 
36 
37 Figure 6: a) Subject-wise summed (eleven healthy volunteers) two-dimensional downfield (5.1 to 
38 9.5 ppm) spectrum b) Low SNR NAD+ peaks of nicotinamide moiety at 8.7 and 9.45 ppm detected 
39 in a zoomed view. 
40 
41 Figure 7: A representative fit of 2D J-resolved MC semiLASER data acquired at 9.4 T. The figure 
42 shows the data, the fit and the residual from top to bottom scaled similarly. The fitting was 
43 performed in ProFit 2.0 using a tailored 2D basis set created using VesPA. 
44 
45 Figure 8: The figure shows the metabolite concentration values in the occipital lobe of healthy 
46 volunteers at 9.4T measured using 2D J-resolved MC semiLASER localization technique. The 
47 concentration values obtained using 2D spectral fitting for Asp, Gln and GABA are in line with 
49 previous literature. However, the previous 1D MRS studies
27,48,52 using MC semiLASER reported 
50 elevated values of these metabolites in comparison to previous literature. In conclusion, 2D MRS 
51 may perform better for the quantification of overlapped and J-coupled resonances such as Gln 
52 and GABA, and additionally also allows for the quantification of Glc and Lac. 
53 
54 Table 1: Quantification results from this study in mmol/kg are reported for 16 metabolites after 
55 correcting for tissue content and water and metabolite relaxation times. T1 and T2 relaxation times 














3 of metabolites. Additionally, results from the previous 1D MRS studies27,48–52 are also presented 
4 for comparison. The tissue content and water and metabolite relaxation times included for these 
5 studies are briefly given in the Discussion section. 
7 Figure 9: Bland-Altman plots54 for 12 metabolites comparing concentration values from this 
8 study with the 1D MRS study. The center line shows the mean value of the 
9 concentrations of respective metabolite between the measurements performed using 1D 
10 and 2D MRS. The lines at the top and the bottom represent mean + 1.96 SD and mean – 
11 1.96 SD respectively. 
13 Supporting information figure captions 
14 
15 Supporting information figure S1: (Top to bottom) Phantom spectrum with TEmax = 100, 99, 
16 and 100 ms for ∆𝑡: 2 ms (𝑛: 50), 3 ms (𝑛: 33), and 4 ms (𝑛: 25) respectively. SNR is higher 
17 when ∆𝑡: 2 ms compared to 3 and 4 ms; t1 ridges are not seen to be impacted. 
18 
19 Supporting information figure S2: Box plots of metabolite concentrations in mmol/kg measured 
20 using 2D J-resolved MC semiLASER spectra. Horizontal lines inside the box plots show median 
21 values (50% quartile). The bottom and the top boundaries of the boxes indicate 25% and 75% 





























































19 Figure 1: Pulse sequence diagram of J-resolved metabolite-cycled semiLASER localization scheme. The two 
20 inversion pulses were turned off when acquiring the metabolite spectra. For the acquisition of 
21 macromolecular spectra, double inversion recovery technique was used with TI1/TI2 set to 2360/625 ms. 
22 The indirect dimension is created by increasing the time interval between the last two AFP pulses by ∆t/2. 
Both the sequences have maximum echo sampling scheme implemented i.e., acquisition begins right after 
24 
the final crusher gradient of the last AFP. 
























































































45 Figure 2: (Top to bottom) 2D J-resolved MC semiLASER spectra from Braino phantom containing NAA, Cr, 
46 Cho, Glu and Lac with n = 50 and ∆t = 2, 3 and 4 ms. White arrows indicate the t1-ridges as a result of t1 
47 noise and truncation sinc artifacts in the indirect dimension. The ridges are strongly pronounced when TEmax 
48 = 124 ms and minimum when TEmax = 224 ms. 
49 






































19  Figure 3: a) 2D metabolite spectrum from Braino phantom (n = 85, ∆t = 2ms) in magnitude mode b) 
Zoomed in view of the lactate peak showing a J-resolved doublet but barely any J-refocused peaks. An 86% 
suppression (considering Lac peaks at 1.31 and 4.09 ppm since they have a maximum separation of values 
21 in the observable range of the spectrum) of the J-refocused peaks is expected when calculated as suggested 
22 by Lin et al6 resulting in barely any visible J-refocused peaks. This in turn leads to maximum intensity of the 
23 J-resolved peaks. 
24 


































































Figure 4: 2D J-resolved MC semiLASER spectrum from a representative subject with n = 85 and ∆t = 2 ms. 
23 
The figure inlay shows the voxel positioning on the MP2RAGE image in transversal view. Additionally, the 
24 
observed m tabolites are labeled in the figure. 
25 

































































23 Figure 5: 2D DIR J-resolved MC semiLASER (TI1/TI2: 2360/625 ms, n = 60, ∆t = 2 ms) summed spectrum 
24 from five healthy volunteers. The subscripts in the labelled MM peaks are the chemical shift in ppm at which 
25 the respective MM resonance occurs. 
26 


















































































40 Figure 6: a) Subject-wise summed (eleven healthy volunteers) two-dimensional downfield (5.1 to 9.5 ppm) 
41 spectrum b) Low SNR NAD
+ peaks of nicotinamide moiety at 8.7 and 9.45 ppm detected in a zoomed view. 
42 




















































25 Figure 7: A representative fit of 2D J-resolved MC semiLASER data acquired at 9.4 T. The figure shows the 
data, the fit and the residual from top to bottom scaled similarly. The fitting was performed in ProFit 2.0 
using a tailored 2D basis set created using VesPA. 
27 

































































25 Figure 8: The figure shows the metabolite concentration values in the occipital lobe of healthy volunteers at 
26 9.4T measured using 2D J-resolved MC semiLASER localization technique. The concentration values obtained 
27 using 2D spectral fitting for Asp, Gln and GABA are in line with previous literature. However, the previous 1D 
MRS studies27,48,52 using MC semiLASER reported elevated values of these metabolites in comparison to 
previous literature. In conclusion, 2D MRS may perform better for the quantification of overlapped and J- 
29 coupled resonances such as Gln and GABA, and additionally also allows for the quantification of Glc and Lac. 
30 















































































Table 1: Quantification results from this study in mmol/kg are reported for 16 metabolites after correcting 
41 
for tissue content and water and metabolite relaxation times. T1 and T2 relaxation times at 9.4 T from 
42 
Wright et al27,48 and Murali-Manohar et al52 were used to account for the T1-weighting of metabolites. 
43 
Additionally, results from the previous 1D MRS studies27,48–52 are also presented for comparison. The tissue 
44 





























































36 Figure 9: Bland-Altman plots54 for 12 metabolites comparing concentration values from this study with the 
37 1D MRS study. The center line shows the mean value of the concentrations of respective metabolite between 
38 the measurements performed using 1D and 2D MRS. The lines at the top and the bottom represent mean + 
39 1.96 SD and mean – 1.96 SD respectively. 
40 
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Supporting information figure S1: (Top to bottom) Phantom spectrum with TEmax = 100, 99, 
and 100 ms for ∆𝑡: 2 ms (𝑛: 50), 3 ms (𝑛: 33), and 4 ms (𝑛: 25) respectively. SNR is higher 
when ∆𝑡: 2 ms compared to 3 and 4 ms; t1 ridges are not seen to be impacted. 
 
 
Supporting information figure S2: Box plots of metabolite concentrations in mmol/kg measured 
using 2D J-resolved MC semiLASER spectra. Horizontal lines inside the box plots show median 
values (50% quartile). The bottom and the top boundaries of the boxes indicate 25% and 75% 
quartiles respectively. Plus signs (+) show outlier values. 
 
